[
  {
    "id": "1",
    "name": "Abilify Mycite Kits",
    "genericName": "Abilify Mycite Kits",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Tablet with sensor. Drug-device combination. Do not divide, crush or chew. Swallow the tablet whole",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8787c3f-5e41-42d1-8091-44b56346620f"
      }
    ],
    "form": "Tablet",
    "alteration": "Tablet with sensor. Drug-device combination. Do not divide, crush or chew. Swallow the tablet whole",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8787c3f-5e41-42d1-8091-44b56346620f"
  },
  {
    "id": "2",
    "name": "Absorica, Absorica Ld",
    "genericName": "Absorica, Absorica Ld",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Mucous membrane irritant, teratogenic potenital. Must be swallowed whole and not \nchewed, cut, or crushed",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3ef0cff8-19c1-4441-b780-fca6c7ee1615"
      }
    ],
    "form": "Capsule",
    "alteration": "Mucous membrane irritant, teratogenic potenital. Must be swallowed whole and not \nchewed, cut, or crushed",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3ef0cff8-19c1-4441-b780-fca6c7ee1615"
  },
  {
    "id": "3",
    "name": "Abstral",
    "genericName": "Abstral",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Sublingual Tablet",
        "alteration": "SL Tablet , do not suck, chew, swallow. Place ABSTRAL tablets on the floor of the mouth directly under the tongue immediately after removal from the blister unit",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f969e2bc-6297-4e29-89d3-a3685a2c7c6b"
      }
    ],
    "form": "Sublingual Tablet",
    "alteration": "SL Tablet , do not suck, chew, swallow. Place ABSTRAL tablets on the floor of the mouth directly under the tongue immediately after removal from the blister unit",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f969e2bc-6297-4e29-89d3-a3685a2c7c6b"
  },
  {
    "id": "4",
    "name": "Acetaminophen ER Tablet",
    "genericName": "Acetaminophen Er Tablet",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Extended Released Tablet.  Do not crush, chew, split, or dissolve. Must be swallow whole",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=179c221d-c099-400c-b3ac-124e26947620&utm_source=chatgpt.com"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Extended Released Tablet.  Do not crush, chew, split, or dissolve. Must be swallow whole",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=179c221d-c099-400c-b3ac-124e26947620&utm_source=chatgpt.com"
  },
  {
    "id": "5",
    "name": "Aciphex",
    "genericName": "Aciphex",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Tablet",
        "alteration": "Do not Chew, crush or Split tablet. Swallow Rabeprazole sodium tablet whole",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5d103551-978f-472a-9c62-51e6e4dea068"
      }
    ],
    "form": "Delayed released tablet",
    "alteration": "Do not Chew, crush or Split tablet. Swallow Rabeprazole sodium tablet whole",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5d103551-978f-472a-9c62-51e6e4dea068"
  },
  {
    "id": "6",
    "name": "Aciphex Sprinkle",
    "genericName": "Aciphex Sprinkle",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Do not swallow the whole capsule. Open capsule and spinkle entire contents on small amount of soft food or empty contents into a small amout of liquid. Do not chew",
        "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204736"
      }
    ],
    "form": "Delayed released Capsule",
    "alteration": "Do not swallow the whole capsule. Open capsule and spinkle entire contents on small amount of soft food or empty contents into a small amout of liquid. Do not chew",
    "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204736"
  },
  {
    "id": "7",
    "name": "Rabeprazole",
    "genericName": "Rabeprazole",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Do not swallow the whole capsule. Open capsule and spinkle entire contents on small amount of soft food or empty contents into a small amout of liquid. Do not chew",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5b1b1530-abc8-487a-b673-2b35cbf14e0c"
      },
      {
        "form": "Delayed Released Tablet",
        "alteration": "Do not Chew, crush or Split tablet. Swallow Rabeprazole sodium tablet whole",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=951caefe-6e18-48ff-9567-beb545b09c25"
      }
    ],
    "form": "Delayed Released Capsule",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5b1b1530-abc8-487a-b673-2b35cbf14e0c"
  },
  {
    "id": "8",
    "name": "Acticlate",
    "genericName": "Acticlate",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Do not break, open, crushm dissolve or chew capsule. Swallow capsule whole",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5e96d473-63dd-4446-88cf-eef2cd3339f0"
      }
    ],
    "form": "Capsule",
    "alteration": "Do not break, open, crushm dissolve or chew capsule. Swallow capsule whole",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5e96d473-63dd-4446-88cf-eef2cd3339f0"
  },
  {
    "id": "9",
    "name": "Doxycycline Hyclate",
    "genericName": "Doxycycline Hyclate",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Manufacture does not have recommendation. May crushed if difficulty swallow tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/050006s096,050007s040,050480s064,050533s051lbl.pdf"
      },
      {
        "form": "Delayed Released Tablet",
        "alteration": "Do not chew or crush tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050795s030lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/050006s096,050007s040,050480s064,050533s051lbl.pdf"
  },
  {
    "id": "10",
    "name": "Doryx",
    "genericName": "Doryx",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Tablet",
        "alteration": "Do not chew or crush tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050795s030lbl.pdf"
      }
    ],
    "form": "Delayed Released Tablet",
    "alteration": "Do not chew or crush tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050795s030lbl.pdf"
  },
  {
    "id": "11",
    "name": "Actoplus Met Xr",
    "genericName": "Actoplus Met Xr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "must be swallowed whole and not \nchewed, cut, or crushed",
        "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022024"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "must be swallowed whole and not \nchewed, cut, or crushed",
    "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022024"
  },
  {
    "id": "12",
    "name": "Piglitazone And Metformin",
    "genericName": "Piglitazone And Metformin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "must be swallowed whole and not \nchewed, cut, or crushed",
        "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022024"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "must be swallowed whole and not \nchewed, cut, or crushed",
    "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022024"
  },
  {
    "id": "13",
    "name": "Risedronate Sodium",
    "genericName": "Risedronate Sodium",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Irritant.  Swallow whole tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020835s052lbl.pdf"
      },
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not chew, cut, or crush Atelvia tablets. Take as a whole tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022560s011lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020835s052lbl.pdf"
  },
  {
    "id": "14",
    "name": "Actonel",
    "genericName": "Actonel",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Irritant.  Swallow whole tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020835s052lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Irritant.  Swallow whole tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020835s052lbl.pdf"
  },
  {
    "id": "15",
    "name": "Adalat Cc",
    "genericName": "Adalat Cc",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Adalat CC is an extended release dosage form and tablets should be swallowed whole, not bitten or divided.",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8d247bfb-8309-4cb8-847c-b4619a3d36d8"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Adalat CC is an extended release dosage form and tablets should be swallowed whole, not bitten or divided.",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8d247bfb-8309-4cb8-847c-b4619a3d36d8"
  },
  {
    "id": "16",
    "name": "Nifedipine",
    "genericName": "Nifedipine",
    "category": "Medication",
    "description": "Available in 3 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Do not open, crush. Swallow whole",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0cc236dc-95fa-49cc-aeb8-6590de157585"
      },
      {
        "form": "Liquid-Filled Capsule",
        "alteration": "Do not open, crush. Swallow whole",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5733e038-7cb5-434b-aa8e-abb25e6252c9"
      },
      {
        "form": "Extended Released Tablet",
        "alteration": "Nifedipine extended-release tablets are an extended release dosage form and tablets should be swallowed whole, not bitten or divided",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eb70b7ff-f9f0-41d0-901a-f4c04ae9ed46"
      }
    ],
    "form": "Capsule",
    "alteration": "Multiple forms available (3 forms)",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0cc236dc-95fa-49cc-aeb8-6590de157585"
  },
  {
    "id": "17",
    "name": "Procardia",
    "genericName": "Procardia",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "capsules are given orally and either swallowed whole, bitten and swallowed, or bitten and held sublingually",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018482s052lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "capsules are given orally and either swallowed whole, bitten and swallowed, or bitten and held sublingually",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018482s052lbl.pdf"
  },
  {
    "id": "18",
    "name": "Procardia Xl",
    "genericName": "Procardia Xl",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "PROCARDIA XL Extended Release Tablets should be swallowed whole and should not be bitten or divided",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ebcb33c-f43b-4b36-9f94-9774b2a59e06"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "PROCARDIA XL Extended Release Tablets should be swallowed whole and should not be bitten or divided",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ebcb33c-f43b-4b36-9f94-9774b2a59e06"
  },
  {
    "id": "19",
    "name": "Adderall Xr",
    "genericName": "Adderall Xr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "ADDERALL XR extended-release capsules may be taken whole, or the capsule may be opened and the entire contents sprinkled on applesauce. If the patient is using the sprinkle administration method, the sprinkled applesauce should be consumed immediately; it should not be stored. Patients should take the applesauce with sprinkled beads in its entirety without chewing",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021303s038lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "ADDERALL XR extended-release capsules may be taken whole, or the capsule may be opened and the entire contents sprinkled on applesauce. If the patient is using the sprinkle administration method, the sprinkled applesauce should be consumed immediately; it should not be stored. Patients should take the applesauce with sprinkled beads in its entirety without chewing",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021303s038lbl.pdf"
  },
  {
    "id": "20",
    "name": "Adderall",
    "genericName": "Adderall",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/011522s045lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/011522s045lbl.pdf"
  },
  {
    "id": "21",
    "name": "Astagraf",
    "genericName": "Astagraf",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Swallow as a whole. Do not chew, divide or crush the capsule",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204096s003s004lbl.pdf"
      }
    ],
    "form": "Extended release capsule",
    "alteration": "Swallow as a whole. Do not chew, divide or crush the capsule",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204096s003s004lbl.pdf"
  },
  {
    "id": "22",
    "name": "Envarsus Xr",
    "genericName": "Envarsus Xr",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow ENVARSUS XR whole with fluid (preferably water); do not chew, divide, or crush the tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206406s000lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206406s000lbl.pdf"
  },
  {
    "id": "23",
    "name": "Prograf",
    "genericName": "Prograf",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "package insert for more information",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/050708s055,010115s007lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "package insert for more information",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/050708s055,010115s007lbl.pdf"
  },
  {
    "id": "24",
    "name": "Tacrolimus",
    "genericName": "Tacrolimus",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Package insert for more information",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/065461s000lbl.pdf"
      },
      {
        "form": "Extended Released Tablet",
        "alteration": "Advise patients to swallow  tablets whole with fluid (preferably water); patients must not chew, divide, crush or dissolve the tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/206406s009lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/065461s000lbl.pdf"
  },
  {
    "id": "25",
    "name": "Advicor",
    "genericName": "Advicor",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "ADVICOR tablets should be taken whole and should not be broken, crushed, or chewed before swallowing",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dbdee4c0-86fa-4857-b536-79bf9ebb911a"
      }
    ],
    "form": "Tablet",
    "alteration": "ADVICOR tablets should be taken whole and should not be broken, crushed, or chewed before swallowing",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dbdee4c0-86fa-4857-b536-79bf9ebb911a"
  },
  {
    "id": "26",
    "name": "Adzenys Xr-Odt",
    "genericName": "Adzenys Xr-Odt",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended-Release Orally Disintegrating Tablet",
        "alteration": "Allow tablet to disintegrate in saliva then swallow",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204326s018lbl.pdf"
      }
    ],
    "form": "Extended-release orally disintegrating tablet",
    "alteration": "Allow tablet to disintegrate in saliva then swallow",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204326s018lbl.pdf"
  },
  {
    "id": "27",
    "name": "Aemcolo",
    "genericName": "Aemcolo",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Tablet",
        "alteration": "Swallow the tablets whole. Do NOT crush, break or chew the delayed-release tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210910s000lbl.pdf"
      }
    ],
    "form": "Delayed Released Tablet",
    "alteration": "Swallow the tablets whole. Do NOT crush, break or chew the delayed-release tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210910s000lbl.pdf"
  },
  {
    "id": "28",
    "name": "Afeditab Cr",
    "genericName": "Afeditab Cr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Discontinued medication",
        "reference": ""
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Discontinued medication",
    "reference": ""
  },
  {
    "id": "29",
    "name": "Afinitor",
    "genericName": "Afinitor",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "AFINITOR should be swallowed whole with a glass of water. Do not break or crush tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203985s023,022334s051lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "AFINITOR should be swallowed whole with a glass of water. Do not break or crush tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203985s023,022334s051lbl.pdf"
  },
  {
    "id": "30",
    "name": "Everolimus",
    "genericName": "Everolimus",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "should be swallowed whole with a glass of water. Do not break or crush tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203985s023,022334s051lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "should be swallowed whole with a glass of water. Do not break or crush tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203985s023,022334s051lbl.pdf"
  },
  {
    "id": "31",
    "name": "Aggrenox",
    "genericName": "Aggrenox",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Swallow capsules whole without chewing",
        "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020884"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Swallow capsules whole without chewing",
    "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020884"
  },
  {
    "id": "32",
    "name": "Aspirin And Dipyridamole",
    "genericName": "Aspirin And Dipyridamole",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Swallow capsules whole without chewing",
        "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020884"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Swallow capsules whole without chewing",
    "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020884"
  },
  {
    "id": "33",
    "name": "Alavert",
    "genericName": "Alavert",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Disintegrating Tablet",
        "alteration": "Let tablet melt in mouth. Can be taken with or without water",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/021375lbl.pdf"
      }
    ],
    "form": "Disintergrating tablet",
    "alteration": "Let tablet melt in mouth. Can be taken with or without water",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/021375lbl.pdf"
  },
  {
    "id": "34",
    "name": "Alavert Allergy And Sinus",
    "genericName": "Alavert Allergy And Sinus",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow the tablets whole. Do NOT crush, break or chew the delayed-release tablet",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1a669f3c-36a6-439e-843d-47638fa217e8"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow the tablets whole. Do NOT crush, break or chew the delayed-release tablet",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1a669f3c-36a6-439e-843d-47638fa217e8"
  },
  {
    "id": "35",
    "name": "Alecensa",
    "genericName": "Alecensa",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow capsules whole, do not open or dissolve the contents of the capsule",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/208434s015lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow capsules whole, do not open or dissolve the contents of the capsule",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/208434s015lbl.pdf"
  },
  {
    "id": "36",
    "name": "Alkindi Spinkle",
    "genericName": "Alkindi Spinkle",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Do not swallow the capsules. Do not chew or crush the granules. Long instruction. check package insert",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213876s000lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Do not swallow the capsules. Do not chew or crush the granules. Long instruction. check package insert",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213876s000lbl.pdf"
  },
  {
    "id": "37",
    "name": "Allegra-D",
    "genericName": "Allegra-D",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow the tablets whole. Do NOT crush, break or chew the delayed-release tablet",
        "reference": ""
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow the tablets whole. Do NOT crush, break or chew the delayed-release tablet",
    "reference": ""
  },
  {
    "id": "38",
    "name": "Fexofenadine And Pseudoephedrine",
    "genericName": "Fexofenadine And Pseudoephedrine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow the tablets whole. Do NOT crush, break or chew the delayed-release tablet",
        "reference": ""
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow the tablets whole. Do NOT crush, break or chew the delayed-release tablet",
    "reference": ""
  },
  {
    "id": "39",
    "name": "Alprazolam Xr",
    "genericName": "Alprazolam Xr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow tablets whole; do not divide, crush, or chew",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c8990714-c2f5-4b0c-9f1c-91d77156d962"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow tablets whole; do not divide, crush, or chew",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c8990714-c2f5-4b0c-9f1c-91d77156d962"
  },
  {
    "id": "40",
    "name": "Ramipril",
    "genericName": "Ramipril",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow ramipril capsules whole. The ramipril capsule can also be opened and the contents sprinkled on a small amount (about 4 oz.) of applesauce or mixed in 4 oz. (120 mL) of water or apple juice",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d6d57158-e8f9-4c91-8317-0374e0c87d33"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow ramipril capsules whole. The ramipril capsule can also be opened and the contents sprinkled on a small amount (about 4 oz.) of applesauce or mixed in 4 oz. (120 mL) of water or apple juice",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d6d57158-e8f9-4c91-8317-0374e0c87d33"
  },
  {
    "id": "41",
    "name": "Altace",
    "genericName": "Altace",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow ALTACE capsules whole. The ALTACE capsule can also be opened and the contents sprinkled on a small amount (about 4 oz.) of applesauce or mixed in 4 oz. (120 mL) of water or apple juice",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0fc34cd8-86e6-4034-73bd-4263a68ba046"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow ALTACE capsules whole. The ALTACE capsule can also be opened and the contents sprinkled on a small amount (about 4 oz.) of applesauce or mixed in 4 oz. (120 mL) of water or apple juice",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0fc34cd8-86e6-4034-73bd-4263a68ba046"
  },
  {
    "id": "42",
    "name": "Lovastatin",
    "genericName": "Lovastatin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019643s088lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019643s088lbl.pdf"
  },
  {
    "id": "43",
    "name": "Mevacor",
    "genericName": "Mevacor",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019643s088lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019643s088lbl.pdf"
  },
  {
    "id": "44",
    "name": "Altoprev",
    "genericName": "Altoprev",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow tablets whole. Do not split, crush, or chew the extended-release tablet",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8c0db100-5df9-49c3-8af9-1bc03ae609b9"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow tablets whole. Do not split, crush, or chew the extended-release tablet",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8c0db100-5df9-49c3-8af9-1bc03ae609b9"
  },
  {
    "id": "45",
    "name": "Alunbrig",
    "genericName": "Alunbrig",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow tablets whole. Do not crush or chew tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208772lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow tablets whole. Do not crush or chew tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208772lbl.pdf"
  },
  {
    "id": "46",
    "name": "Ambien",
    "genericName": "Ambien",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Film Coated Tablet",
        "alteration": "Film coated Tablet . Tablets are not scored.  Swallow whole tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019908s40s044s047lbl.pdf"
      },
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019908s40s044s047lbl.pdf"
      }
    ],
    "form": "Film Coated tablet",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019908s40s044s047lbl.pdf"
  },
  {
    "id": "47",
    "name": "Ambien Cr",
    "genericName": "Ambien Cr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "AMBIEN CR extended-release tablets should be swallowed whole, and not be divided, crushed, or chewed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021774s021s025s028lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "AMBIEN CR extended-release tablets should be swallowed whole, and not be divided, crushed, or chewed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021774s021s025s028lbl.pdf"
  },
  {
    "id": "48",
    "name": "Lubiprostone",
    "genericName": "Lubiprostone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "must be swallowed whole and not",
        "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021908"
      }
    ],
    "form": "Capsule",
    "alteration": "must be swallowed whole and not",
    "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021908"
  },
  {
    "id": "49",
    "name": "Amitiza",
    "genericName": "Amitiza",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "must be swallowed whole and not",
        "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021908"
      }
    ],
    "form": "Capsule",
    "alteration": "must be swallowed whole and not",
    "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021908"
  },
  {
    "id": "50",
    "name": "Amnesteem",
    "genericName": "Amnesteem",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "chewed, cut, or crushed",
        "reference": "https://www.uptodate.com/contents/isotretinoin-drug-information?search=amnesteem&source=panel_search_result&selectedTitle=1~125&usage_type=panel&kp_tab=drug_general&display_rank=1#F185157"
      }
    ],
    "form": "Capsule",
    "alteration": "chewed, cut, or crushed",
    "reference": "https://www.uptodate.com/contents/isotretinoin-drug-information?search=amnesteem&source=panel_search_result&selectedTitle=1~125&usage_type=panel&kp_tab=drug_general&display_rank=1#F185157"
  },
  {
    "id": "51",
    "name": "Isotretinoin",
    "genericName": "Isotretinoin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "capsules should be swallowed whole with a full glass of liquid; do not chew or suck on the capsule. For patients unable to swallow capsule whole, an oral liquid may be prepared (see \"Extemporaneously Prepared\"); may irritate esophagus if contents are removed from the capsule",
        "reference": "https://www.uptodate.com/contents/isotretinoin-drug-information?search=amnesteem&source=panel_search_result&selectedTitle=1~125&usage_type=panel&kp_tab=drug_general&display_rank=1#F185157"
      }
    ],
    "form": "Capsule",
    "alteration": "capsules should be swallowed whole with a full glass of liquid; do not chew or suck on the capsule. For patients unable to swallow capsule whole, an oral liquid may be prepared (see \"Extemporaneously Prepared\"); may irritate esophagus if contents are removed from the capsule",
    "reference": "https://www.uptodate.com/contents/isotretinoin-drug-information?search=amnesteem&source=panel_search_result&selectedTitle=1~125&usage_type=panel&kp_tab=drug_general&display_rank=1#F185157"
  },
  {
    "id": "52",
    "name": "Ampyra",
    "genericName": "Ampyra",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Administer tablets whole; do not divide, crush, chew, or dissolve AMPYRA tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022250s019lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Administer tablets whole; do not divide, crush, chew, or dissolve AMPYRA tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022250s019lbl.pdf"
  },
  {
    "id": "53",
    "name": "Dalfampridine",
    "genericName": "Dalfampridine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Administer tablets whole; do not divide, crush, chew, or dissolve AMPYRA tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022250s019lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Administer tablets whole; do not divide, crush, chew, or dissolve AMPYRA tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022250s019lbl.pdf"
  },
  {
    "id": "54",
    "name": "Flexeril",
    "genericName": "Flexeril",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Film Coated Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/017821s051lbl.pdf"
      }
    ],
    "form": "Film Coated tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/017821s051lbl.pdf"
  },
  {
    "id": "55",
    "name": "Cyclobenzaprine",
    "genericName": "Cyclobenzaprine",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Film Coated Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/017821s051lbl.pdf"
      },
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/017821s051lbl.pdf"
      }
    ],
    "form": "Film Coated tablet",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/017821s051lbl.pdf"
  },
  {
    "id": "56",
    "name": "Amrix",
    "genericName": "Amrix",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "swallow AMRIX capsules intact. Alternatively, the contents of the AMRIX capsule may be sprinkled over applesauce and then swallowed. Do not chew",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021777s019lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "swallow AMRIX capsules intact. Alternatively, the contents of the AMRIX capsule may be sprinkled over applesauce and then swallowed. Do not chew",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021777s019lbl.pdf"
  },
  {
    "id": "57",
    "name": "Bupropion",
    "genericName": "Bupropion",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Film Coated Tablet",
        "alteration": "tablets should be swallowed whole and not crushed, divided, or chewed",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6563b923-269f-40c3-b992-cbacdfca6e16"
      }
    ],
    "form": "Film Coated tablet",
    "alteration": "tablets should be swallowed whole and not crushed, divided, or chewed",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6563b923-269f-40c3-b992-cbacdfca6e16"
  },
  {
    "id": "58",
    "name": "Wellbutrin Sr",
    "genericName": "Wellbutrin Sr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "WELLBUTRIN SR tablets should be swallowed whole and not crushed, divided, or chewed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020358s068lbl.pdf"
      }
    ],
    "form": "Exented Released Tablet",
    "alteration": "WELLBUTRIN SR tablets should be swallowed whole and not crushed, divided, or chewed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020358s068lbl.pdf"
  },
  {
    "id": "59",
    "name": "Wellbutrin Xl",
    "genericName": "Wellbutrin Xl",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "swallow WELLBUTRIN XL Tablets whole so that the release 366 rate is not altered. Do not chew, divide, or crush tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21515_wellbutrin_lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "swallow WELLBUTRIN XL Tablets whole so that the release 366 rate is not altered. Do not chew, divide, or crush tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21515_wellbutrin_lbl.pdf"
  },
  {
    "id": "60",
    "name": "Bupropion Xl",
    "genericName": "Bupropion Xl",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "swallow WELLBUTRIN XL Tablets whole so that the release 366 rate is not altered. Do not chew, divide, or crush tablets",
        "reference": ""
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "swallow WELLBUTRIN XL Tablets whole so that the release 366 rate is not altered. Do not chew, divide, or crush tablets",
    "reference": ""
  },
  {
    "id": "61",
    "name": "Aplenzin",
    "genericName": "Aplenzin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "APLENZIN should be swallowed whole and not crushed, divided, or chewed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022108lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "APLENZIN should be swallowed whole and not crushed, divided, or chewed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022108lbl.pdf"
  },
  {
    "id": "62",
    "name": "Mesalamine Er",
    "genericName": "Mesalamine Er",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Swallow the capsules whole. Do not cut, break, crush or chew the capsules",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022301s022lbl.pdf"
      },
      {
        "form": "Delayed Released Tablet",
        "alteration": "Swallow  tablets whole; do not split or crush",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/091640Orig1s000lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022301s022lbl.pdf"
  },
  {
    "id": "63",
    "name": "Apriso",
    "genericName": "Apriso",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Swallow the capsules whole. Do not cut, break, crush or chew the capsules",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022301s022lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Swallow the capsules whole. Do not cut, break, crush or chew the capsules",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022301s022lbl.pdf"
  },
  {
    "id": "64",
    "name": "Aptensio Xr",
    "genericName": "Aptensio Xr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "APTENSIO XR may be taken whole or the capsule may be opened and the entire contents sprinkled onto \napplesauce",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205831s003lbl.pdf"
      }
    ],
    "form": "Extended Released Capsule",
    "alteration": "APTENSIO XR may be taken whole or the capsule may be opened and the entire contents sprinkled onto \napplesauce",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205831s003lbl.pdf"
  },
  {
    "id": "65",
    "name": "Methylphenidate",
    "genericName": "Methylphenidate",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Capsule may be taken whole or the capsule may be opened and the entire contents sprinkled onto \napplesauce",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205831s003lbl.pdf"
      },
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/010187s094lbl.pdf"
      }
    ],
    "form": "Extended Released Capsule",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205831s003lbl.pdf"
  },
  {
    "id": "66",
    "name": "Aptivus",
    "genericName": "Aptivus",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "APTIVUS capsules must be swallowed whole and must not be opened or \nchewed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021814s030lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "APTIVUS capsules must be swallowed whole and must not be opened or \nchewed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021814s030lbl.pdf"
  },
  {
    "id": "67",
    "name": "Arakoda",
    "genericName": "Arakoda",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow the tablet whole. Do not break, crush or chew the tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210607lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow the tablet whole. Do not break, crush or chew the tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210607lbl.pdf"
  },
  {
    "id": "68",
    "name": "Aricept",
    "genericName": "Aricept",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Tablet should not be split, crushed, or chewed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020690s042,021720s014,022568s011lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Tablet should not be split, crushed, or chewed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020690s042,021720s014,022568s011lbl.pdf"
  },
  {
    "id": "69",
    "name": "Donepezil",
    "genericName": "Donepezil",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Tablet should not be split, crushed, or chewed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020690s042,021720s014,022568s011lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Tablet should not be split, crushed, or chewed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020690s042,021720s014,022568s011lbl.pdf"
  },
  {
    "id": "70",
    "name": "Aricept Odt",
    "genericName": "Aricept Odt",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "ODT Tablet",
        "alteration": "Discontinued medication",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020690s042,021720s014,022568s011lbl.pdf"
      }
    ],
    "form": "ODT Tablet",
    "alteration": "Discontinued medication",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020690s042,021720s014,022568s011lbl.pdf"
  },
  {
    "id": "71",
    "name": "Leflunomide",
    "genericName": "Leflunomide",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Teratogenic potential, hazardous substances",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020905s033lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Teratogenic potential, hazardous substances",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020905s033lbl.pdf"
  },
  {
    "id": "72",
    "name": "Arava",
    "genericName": "Arava",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Teratogenic potential, hazardous substances",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020905s033lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Teratogenic potential, hazardous substances",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020905s033lbl.pdf"
  },
  {
    "id": "73",
    "name": "Arthrotec",
    "genericName": "Arthrotec",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Tablet",
        "alteration": "Delayed release tablet. Do not crush",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020607s043lbl.pdf"
      }
    ],
    "form": "Delayed released tablet",
    "alteration": "Delayed release tablet. Do not crush",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020607s043lbl.pdf"
  },
  {
    "id": "74",
    "name": "Arymo Er (Morphine)",
    "genericName": "Arymo Er (Morphine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Discontinued medication",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208603s005lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Discontinued medication",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208603s005lbl.pdf"
  },
  {
    "id": "75",
    "name": "Lialda",
    "genericName": "Lialda",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Tablet",
        "alteration": "Swallow LIALDA tablets whole; do not split or crush",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022000s027lbl.pdf"
      }
    ],
    "form": "Delayed Released Tablet",
    "alteration": "Swallow LIALDA tablets whole; do not split or crush",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022000s027lbl.pdf"
  },
  {
    "id": "76",
    "name": "Asacol Hd",
    "genericName": "Asacol Hd",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Discontinued medication",
        "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021830"
      }
    ],
    "form": "Tablet",
    "alteration": "Discontinued medication",
    "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021830"
  },
  {
    "id": "77",
    "name": "Aspirin",
    "genericName": "Aspirin",
    "category": "Medication",
    "description": "Available in 4 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Chewable Tablet",
        "alteration": "Crushable, may split in half",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c8484998-e0e1-ffce-e053-2995a90aa7de"
      },
      {
        "form": "Delayed Released Tablet",
        "alteration": "must be swallowed whole and not",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c3c4854e-726e-4926-b044-a5094943c306"
      },
      {
        "form": "Enteric Coated Tablet",
        "alteration": "chewed, cut, or crushed",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d21a68ad-981b-b4f9-e053-2995a90a358b"
      }
    ],
    "form": "Chewable tablet",
    "alteration": "Multiple forms available (4 forms)",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c8484998-e0e1-ffce-e053-2995a90aa7de"
  },
  {
    "id": "78",
    "name": "Astagraf Xl",
    "genericName": "Astagraf Xl",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Capsules must be taken whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204096s011lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Capsules must be taken whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204096s011lbl.pdf"
  },
  {
    "id": "79",
    "name": "Atelvia",
    "genericName": "Atelvia",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not chew, cut, or crush Atelvia tablets. Take as a whole tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022560s011lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Do not chew, cut, or crush Atelvia tablets. Take as a whole tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022560s011lbl.pdf"
  },
  {
    "id": "80",
    "name": "Atorvastatin",
    "genericName": "Atorvastatin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Film Coated Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9adb9e4-c495-9530-e5e3-7e3b01d53e4c"
      }
    ],
    "form": "Filmed Coated Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9adb9e4-c495-9530-e5e3-7e3b01d53e4c"
  },
  {
    "id": "81",
    "name": "Amoxicillin And Clavulanate",
    "genericName": "Amoxicillin And Clavulanate",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7989371d-feed-6c25-e053-2991aa0a967d"
      },
      {
        "form": "Extended Released Tablet",
        "alteration": "AUGMENTIN XR can be split in half along the score line for patients with difficulty swallowing the tablets whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/050785s019lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7989371d-feed-6c25-e053-2991aa0a967d"
  },
  {
    "id": "82",
    "name": "Augmentin",
    "genericName": "Augmentin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Film Coated Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/050564s060,050575s051,050597s052,050720s037,050725s036,050726s027lbl.pdf"
      }
    ],
    "form": "Filmed Coated Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/050564s060,050575s051,050597s052,050720s037,050725s036,050726s027lbl.pdf"
  },
  {
    "id": "83",
    "name": "Augmentin Xr",
    "genericName": "Augmentin Xr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "AUGMENTIN XR can be split in half along the score line for patients with difficulty swallowing the tablets whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/050785s019lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "AUGMENTIN XR can be split in half along the score line for patients with difficulty swallowing the tablets whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/050785s019lbl.pdf"
  },
  {
    "id": "84",
    "name": "Auryxia",
    "genericName": "Auryxia",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Film Coated Tablet",
        "alteration": "tablets must not be chewed or crushed because it may cause discoloration of mouth and teeth",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/205874s029lbl.pdf"
      }
    ],
    "form": "Filmed Coated Tablet",
    "alteration": "tablets must not be chewed or crushed because it may cause discoloration of mouth and teeth",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/205874s029lbl.pdf"
  },
  {
    "id": "85",
    "name": "Ferric Citrate",
    "genericName": "Ferric Citrate",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Film Coated Tablet",
        "alteration": "tablets must not be chewed or crushed because it may cause discoloration of mouth and teeth",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/205874s029lbl.pdf"
      }
    ],
    "form": "Filmed Coated Tablet",
    "alteration": "tablets must not be chewed or crushed because it may cause discoloration of mouth and teeth",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/205874s029lbl.pdf"
  },
  {
    "id": "86",
    "name": "Austedo Xr",
    "genericName": "Austedo Xr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow AUSTEDO whole. Do not chew, crush, or break tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208082s018,216354s008lbl.pdf"
      }
    ],
    "form": "Extended Released tablet",
    "alteration": "Swallow AUSTEDO whole. Do not chew, crush, or break tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208082s018,216354s008lbl.pdf"
  },
  {
    "id": "87",
    "name": "Austedo",
    "genericName": "Austedo",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow AUSTEDO whole. Do not chew, crush, or break tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208082s018,216354s008lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow AUSTEDO whole. Do not chew, crush, or break tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208082s018,216354s008lbl.pdf"
  },
  {
    "id": "88",
    "name": "Auvelity",
    "genericName": "Auvelity",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow tablets whole, do not crush, divide, or chew",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215430s008lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow tablets whole, do not crush, divide, or chew",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215430s008lbl.pdf"
  },
  {
    "id": "89",
    "name": "Avelox",
    "genericName": "Avelox",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "must be swallowed whole and not",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-085S010_Avelox_prntlbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "must be swallowed whole and not",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-085S010_Avelox_prntlbl.pdf"
  },
  {
    "id": "90",
    "name": "Avodart",
    "genericName": "Avodart",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "chewed, cut, or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021319s023s025lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "chewed, cut, or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021319s023s025lbl.pdf"
  },
  {
    "id": "91",
    "name": "Dutasteride",
    "genericName": "Dutasteride",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "The capsules should be swallowed whole and not chewed or opened, as contact with the \n16 capsule contents may result in irritation of the oropharyngeal mucosa",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021319s023s025lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "The capsules should be swallowed whole and not chewed or opened, as contact with the \n16 capsule contents may result in irritation of the oropharyngeal mucosa",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021319s023s025lbl.pdf"
  },
  {
    "id": "92",
    "name": "Azulfidine En-Tabs",
    "genericName": "Azulfidine En-Tabs",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Tablet",
        "alteration": "Patients should be instructed to take AZULFIDINE EN-tabs in evenly divided doses, preferably after meals, and to swallow the tablets whole.",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b9ef5"
      }
    ],
    "form": "Delayed released tablet",
    "alteration": "Patients should be instructed to take AZULFIDINE EN-tabs in evenly divided doses, preferably after meals, and to swallow the tablets whole.",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b9ef5"
  },
  {
    "id": "93",
    "name": "Sulfasalazine Dr",
    "genericName": "Sulfasalazine Dr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Tablet",
        "alteration": "Patients should be instructed to take AZULFIDINE EN-tabs in evenly divided doses, preferably after meals, and to swallow the tablets whole.",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b9ef5"
      }
    ],
    "form": "Delayed released tablet",
    "alteration": "Patients should be instructed to take AZULFIDINE EN-tabs in evenly divided doses, preferably after meals, and to swallow the tablets whole.",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b9ef5"
  },
  {
    "id": "94",
    "name": "Bafiertam",
    "genericName": "Bafiertam",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Swallow BAFIERTAM capsules whole and intact. Do not crush, chew, or mix contents with food",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210296s007lbl.pdf"
      }
    ],
    "form": "Delayed released capsule",
    "alteration": "Swallow BAFIERTAM capsules whole and intact. Do not crush, chew, or mix contents with food",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210296s007lbl.pdf"
  },
  {
    "id": "95",
    "name": "Balcoltra",
    "genericName": "Balcoltra",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "swallowed whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208612s005lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "swallowed whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208612s005lbl.pdf"
  },
  {
    "id": "96",
    "name": "Balversa",
    "genericName": "Balversa",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow tablets whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/212018s010lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow tablets whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/212018s010lbl.pdf"
  },
  {
    "id": "97",
    "name": "Aspirin Chewable Tablet",
    "genericName": "Aspirin Chewable Tablet",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Chewable Tablet",
        "alteration": "Crushable, may split in half",
        "reference": ""
      }
    ],
    "form": "Chewable tablet",
    "alteration": "Crushable, may split in half",
    "reference": ""
  },
  {
    "id": "98",
    "name": "Bayer Aspirin, Ec Low Dose 81Mg",
    "genericName": "Bayer Aspirin, Ec Low Dose 81Mg",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Tablet",
        "alteration": "Swallow whole, do not chew or crush",
        "reference": ""
      }
    ],
    "form": "Delayed Released Tablet",
    "alteration": "Swallow whole, do not chew or crush",
    "reference": ""
  },
  {
    "id": "99",
    "name": "Bayer Aspirin, Ec 81Mg",
    "genericName": "Bayer Aspirin, Ec 81Mg",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Enteric Coated Tablet",
        "alteration": "Swallow whole, do not chew or crush",
        "reference": ""
      }
    ],
    "form": "Enteric Coated Tablet",
    "alteration": "Swallow whole, do not chew or crush",
    "reference": ""
  },
  {
    "id": "100",
    "name": "Bayer Aspirin , Ec 325Mg",
    "genericName": "Bayer Aspirin , Ec 325Mg",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Enteric Coated Tablet",
        "alteration": "Swallow whole, do not chew or crush",
        "reference": ""
      }
    ],
    "form": "Enteric Coated Tablet",
    "alteration": "Swallow whole, do not chew or crush",
    "reference": ""
  },
  {
    "id": "101",
    "name": "Belbuca",
    "genericName": "Belbuca",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Buccal Film",
        "alteration": "BELBUCA buccal film is for oral buccal use only. Chew or swallow may result in lower bioavailability",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207932s023lbl.pdf"
      }
    ],
    "form": "Buccal Film",
    "alteration": "BELBUCA buccal film is for oral buccal use only. Chew or swallow may result in lower bioavailability",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207932s023lbl.pdf"
  },
  {
    "id": "102",
    "name": "Buprenorphine",
    "genericName": "Buprenorphine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Buccal Film",
        "alteration": "BELBUCA buccal film is for oral buccal use only. Chew or swallow may result in lower bioavailability",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207932s023lbl.pdf"
      }
    ],
    "form": "Buccal Film",
    "alteration": "BELBUCA buccal film is for oral buccal use only. Chew or swallow may result in lower bioavailability",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207932s023lbl.pdf"
  },
  {
    "id": "103",
    "name": "Belsomra",
    "genericName": "Belsomra",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Film Coated Tablet",
        "alteration": "Pharmacykinetic amorphous solid dispersion technology may be affected if tablet is altered",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204569s010lbl.pdf"
      }
    ],
    "form": "Filmed Coated Tablet",
    "alteration": "Pharmacykinetic amorphous solid dispersion technology may be affected if tablet is altered",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204569s010lbl.pdf"
  },
  {
    "id": "104",
    "name": "Tessalon Perle",
    "genericName": "Tessalon Perle",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "TESSALON should be swallowed whole. TESSALON Capsules and Perles are not to be broken, chewed, dissolved, cut or crushed.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/011210s053lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "TESSALON should be swallowed whole. TESSALON Capsules and Perles are not to be broken, chewed, dissolved, cut or crushed.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/011210s053lbl.pdf"
  },
  {
    "id": "105",
    "name": "Benzonatate",
    "genericName": "Benzonatate",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Benzonatate should be swallowed whole. TESSALON Capsules and Perles are not to be broken, chewed, dissolved, cut or \ncrushed.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/011210s053lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Benzonatate should be swallowed whole. TESSALON Capsules and Perles are not to be broken, chewed, dissolved, cut or \ncrushed.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/011210s053lbl.pdf"
  },
  {
    "id": "106",
    "name": "Biaxin Xl",
    "genericName": "Biaxin Xl",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "BIAXIN ® XL should be swallowed whole and not chewed, broken, or crushed.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/50662s036,50697s003,50698s019,50775s007ltr.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "BIAXIN ® XL should be swallowed whole and not chewed, broken, or crushed.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/50662s036,50697s003,50698s019,50775s007ltr.pdf"
  },
  {
    "id": "107",
    "name": "Clarithromycin Er",
    "genericName": "Clarithromycin Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "BIAXIN ® XL should be swallowed whole and not chewed, broken, or crushed.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/50662s036,50697s003,50698s019,50775s007ltr.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "BIAXIN ® XL should be swallowed whole and not chewed, broken, or crushed.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/50662s036,50697s003,50698s019,50775s007ltr.pdf"
  },
  {
    "id": "108",
    "name": "Biltricide",
    "genericName": "Biltricide",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "must be swallowed whole and not",
        "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process"
      }
    ],
    "form": "Tablet",
    "alteration": "must be swallowed whole and not",
    "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process"
  },
  {
    "id": "109",
    "name": "Binosto",
    "genericName": "Binosto",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Effervescent Tablet",
        "alteration": "chewed, cut, or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202344s015lbl.pdf"
      }
    ],
    "form": "effervescent tablet",
    "alteration": "chewed, cut, or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202344s015lbl.pdf"
  },
  {
    "id": "110",
    "name": "Bisacodyl",
    "genericName": "Bisacodyl",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Enteric Coated Tablet",
        "alteration": "Swallow the Whole tablet",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b4e052c0-d849-4327-a191-6d71d862886f"
      }
    ],
    "form": "Enteric Coated Tablet",
    "alteration": "Swallow the Whole tablet",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b4e052c0-d849-4327-a191-6d71d862886f"
  },
  {
    "id": "111",
    "name": "Ibandronate Sodium",
    "genericName": "Ibandronate Sodium",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow whole tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021455s021lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow whole tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021455s021lbl.pdf"
  },
  {
    "id": "112",
    "name": "Boniva",
    "genericName": "Boniva",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow whole tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021455s021lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow whole tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021455s021lbl.pdf"
  },
  {
    "id": "113",
    "name": "Doxylamine And Pyridoxine",
    "genericName": "Doxylamine And Pyridoxine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow tablets whole. Do not crush, chew, or split BONJESTA tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209661s008lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow tablets whole. Do not crush, chew, or split BONJESTA tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209661s008lbl.pdf"
  },
  {
    "id": "114",
    "name": "Bonjesta(Doxylamine And Pyridoxine)",
    "genericName": "Bonjesta(Doxylamine And Pyridoxine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow tablets whole. Do not crush, chew, or split BONJESTA tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209661s008lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow tablets whole. Do not crush, chew, or split BONJESTA tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209661s008lbl.pdf"
  },
  {
    "id": "115",
    "name": "Bosulif",
    "genericName": "Bosulif",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow tablets whole. Do not cut, crush, break or chew tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/203341s026lbl.pdf"
      },
      {
        "form": "Capsule",
        "alteration": "Capsules may be swallowed whole. For patients who are unable to swallow a whole capsule(s), each capsule can be opened and the contents mixed with applesauce or yogurt",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217729s001lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/203341s026lbl.pdf"
  },
  {
    "id": "116",
    "name": "Brincidofovir",
    "genericName": "Brincidofovir",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow Brincidofovir tablets whole. Do not crush or divide Brincidofovir tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214460s000,214461s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow Brincidofovir tablets whole. Do not crush or divide Brincidofovir tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214460s000,214461s000lbl.pdf"
  },
  {
    "id": "117",
    "name": "Tembexa",
    "genericName": "Tembexa",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow TEMBEXA tablets whole. Do not crush or divide TEMBEXA tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214460s001,214461s001lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow TEMBEXA tablets whole. Do not crush or divide TEMBEXA tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214460s001,214461s001lbl.pdf"
  },
  {
    "id": "118",
    "name": "Brenzavvy",
    "genericName": "Brenzavvy",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "must be swallowed whole and not",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214373s001lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "must be swallowed whole and not",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214373s001lbl.pdf"
  },
  {
    "id": "119",
    "name": "Brivaracetam",
    "genericName": "Brivaracetam",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "chewed, cut, or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205836s014,205837s011,205838s011lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "chewed, cut, or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205836s014,205837s011,205838s011lbl.pdf"
  },
  {
    "id": "120",
    "name": "Briviact",
    "genericName": "Briviact",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "BRIVIACT tablets should be swallowed whole with liquid. BRIVIACT tablets should not be chewed or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205836s014,205837s011,205838s011lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "BRIVIACT tablets should be swallowed whole with liquid. BRIVIACT tablets should not be chewed or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205836s014,205837s011,205838s011lbl.pdf"
  },
  {
    "id": "121",
    "name": "Brukinsa",
    "genericName": "Brukinsa",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Advise patients not to open, break, or chew capsules",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/213217s000lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Advise patients not to open, break, or chew capsules",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/213217s000lbl.pdf"
  },
  {
    "id": "122",
    "name": "Buprenorphine And Naloxone Sublingual)",
    "genericName": "Buprenorphine And Naloxone Sublingual)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Sublingual Tablet",
        "alteration": "SUBOXONE sublingual tablets must be administered whole. Do not cut, chew, or swallow SUBOXONE sublingual tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020733s031s032lbl.pdf"
      }
    ],
    "form": "Sublingual Tablet",
    "alteration": "SUBOXONE sublingual tablets must be administered whole. Do not cut, chew, or swallow SUBOXONE sublingual tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020733s031s032lbl.pdf"
  },
  {
    "id": "123",
    "name": "Suboxone",
    "genericName": "Suboxone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Sublingual Tablet",
        "alteration": "SUBOXONE sublingual tablets must be administered whole. Do not cut, chew, or swallow SUBOXONE sublingual tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020733s031s032lbl.pdf"
      }
    ],
    "form": "Sublingual Tablet",
    "alteration": "SUBOXONE sublingual tablets must be administered whole. Do not cut, chew, or swallow SUBOXONE sublingual tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020733s031s032lbl.pdf"
  },
  {
    "id": "124",
    "name": "Buproban",
    "genericName": "Buproban",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "swallow Bupropion XL Tablets whole so that the release rate is not altered. Do not chew, divide, or crush tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21515_wellbutrin_lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "swallow Bupropion XL Tablets whole so that the release rate is not altered. Do not chew, divide, or crush tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21515_wellbutrin_lbl.pdf"
  },
  {
    "id": "125",
    "name": "Bylvay(Odevixibat)",
    "genericName": "Bylvay(Odevixibat)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Do not crush or chew capsules",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215498s006lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Do not crush or chew capsules",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215498s006lbl.pdf"
  },
  {
    "id": "126",
    "name": "Cabometylx",
    "genericName": "Cabometylx",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow CABOMETYX tablets whole. Do not crush CABOMETYX tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208692s016lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow CABOMETYX tablets whole. Do not crush CABOMETYX tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208692s016lbl.pdf"
  },
  {
    "id": "127",
    "name": "Verapamil",
    "genericName": "Verapamil",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not chew, crush tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019152Orig1s045lbl.pdf"
      }
    ],
    "form": "Extended Relased Tablet",
    "alteration": "Do not chew, crush tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019152Orig1s045lbl.pdf"
  },
  {
    "id": "128",
    "name": "Calan Sr",
    "genericName": "Calan Sr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not chew, crush tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019152Orig1s045lbl.pdf"
      }
    ],
    "form": "Extended Relased Tablet",
    "alteration": "Do not chew, crush tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019152Orig1s045lbl.pdf"
  },
  {
    "id": "129",
    "name": "Calquence Capsule",
    "genericName": "Calquence Capsule",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Advise patients to swallow capsule whole with water. Advise patients not to open, break or chew the capsules",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210259s010lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Advise patients to swallow capsule whole with water. Advise patients not to open, break or chew the capsules",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210259s010lbl.pdf"
  },
  {
    "id": "130",
    "name": "Calquece Tablet",
    "genericName": "Calquece Tablet",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Advise patients to swallow tablet whole with water. Advise patients not to chew, crush, dissolve, or cut the tablets",
        "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216387"
      }
    ],
    "form": "Tablet",
    "alteration": "Advise patients to swallow tablet whole with water. Advise patients not to chew, crush, dissolve, or cut the tablets",
    "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216387"
  },
  {
    "id": "131",
    "name": "Campral",
    "genericName": "Campral",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Tablet",
        "alteration": "Do not chew, crush tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021431s015lbl.pdf"
      }
    ],
    "form": "Delayed released tablet",
    "alteration": "Do not chew, crush tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021431s015lbl.pdf"
  },
  {
    "id": "132",
    "name": "Acamprosate Sodium",
    "genericName": "Acamprosate Sodium",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Tablet",
        "alteration": "Do not chew, crush tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021431s015lbl.pdf"
      }
    ],
    "form": "Delayed Released Tablet",
    "alteration": "Do not chew, crush tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021431s015lbl.pdf"
  },
  {
    "id": "133",
    "name": "Caprelsa (Vandetanib)",
    "genericName": "Caprelsa (Vandetanib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not crush CAPRELSA tablets. The tablets can be dispersed in 2 ounces of water by stirring for approximately 10 minutes (will not completely dissolve",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022405s023lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not crush CAPRELSA tablets. The tablets can be dispersed in 2 ounces of water by stirring for approximately 10 minutes (will not completely dissolve",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022405s023lbl.pdf"
  },
  {
    "id": "134",
    "name": "Carbaglu(Carglumic Acid)",
    "genericName": "Carbaglu(Carglumic Acid)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Disperse CARBAGLU tablets in water. Do not swallow whole or crush",
        "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022562"
      }
    ],
    "form": "Extended Relased Tablet",
    "alteration": "Disperse CARBAGLU tablets in water. Do not swallow whole or crush",
    "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022562"
  },
  {
    "id": "135",
    "name": "Carbamazepine Er",
    "genericName": "Carbamazepine Er",
    "category": "Medication",
    "description": "Available in 3 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "The Carbatrol capsules may be opened and the beads sprinkled over food, such as a teaspoon of applesauce or other similar food products if this method of administration is preferred. Carbatrol capsules or their contents should not be crushed or chewed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020712s038lbl.pdf"
      },
      {
        "form": "Extended Released Capsule",
        "alteration": "Swallow  capsules whole or open and sprinkle the beads over food, such as a teaspoon of applesauce. Do not crush or chew EQUETRO capsules or the beads inside the capsule. EQUETRO can be taken with or without meals.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/021710lbl.pdf"
      },
      {
        "form": "Extended Released Tablet",
        "alteration": "Tegretol-XR tablets must be swallowed whole and never crushed or chewed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016608s121_018927s60_020234s054lbl.pdf"
      }
    ],
    "form": "Extended released capsule",
    "alteration": "Multiple forms available (3 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020712s038lbl.pdf"
  },
  {
    "id": "136",
    "name": "Carbatrol (Carbamazepine)",
    "genericName": "Carbatrol (Carbamazepine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "The Carbatrol capsules may be opened and the beads sprinkled over food, such as a teaspoon of applesauce or other similar food products if this method of administration is preferred. Carbatrol capsules or their contents should not be crushed or chewed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020712s038lbl.pdf"
      }
    ],
    "form": "Extended released capsule",
    "alteration": "The Carbatrol capsules may be opened and the beads sprinkled over food, such as a teaspoon of applesauce or other similar food products if this method of administration is preferred. Carbatrol capsules or their contents should not be crushed or chewed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020712s038lbl.pdf"
  },
  {
    "id": "137",
    "name": "Diltiazem Cd",
    "genericName": "Diltiazem Cd",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Take as whole capsule",
        "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020062"
      }
    ],
    "form": "Extended Released Capsule",
    "alteration": "Take as whole capsule",
    "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020062"
  },
  {
    "id": "138",
    "name": "Cardizem Cd",
    "genericName": "Cardizem Cd",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Take as whole capsule",
        "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020062"
      }
    ],
    "form": "Extended Released Capsule",
    "alteration": "Take as whole capsule",
    "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020062"
  },
  {
    "id": "139",
    "name": "Diltiazem La",
    "genericName": "Diltiazem La",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Tablet should be swallowed whole and not chewed or crushed.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021392025s028lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Tablet should be swallowed whole and not chewed or crushed.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021392025s028lbl.pdf"
  },
  {
    "id": "140",
    "name": "Cardizem La",
    "genericName": "Cardizem La",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Tablet should be swallowed whole and not chewed or crushed.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021392025s028lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Tablet should be swallowed whole and not chewed or crushed.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021392025s028lbl.pdf"
  },
  {
    "id": "141",
    "name": "Diltiazem Er",
    "genericName": "Diltiazem Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Tablets should be swallowed whole. Patients should not chew, divide, cut or crush tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021269lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Tablets should be swallowed whole. Patients should not chew, divide, cut or crush tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021269lbl.pdf"
  },
  {
    "id": "142",
    "name": "Cardura Xl",
    "genericName": "Cardura Xl",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Tablets should be swallowed whole. Patients should not chew, divide, cut or crush tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021269lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Tablets should be swallowed whole. Patients should not chew, divide, cut or crush tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021269lbl.pdf"
  },
  {
    "id": "143",
    "name": "Cardura",
    "genericName": "Cardura",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019668Orig1s032lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019668Orig1s032lbl.pdf"
  },
  {
    "id": "144",
    "name": "Doxazosin",
    "genericName": "Doxazosin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019668Orig1s032lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019668Orig1s032lbl.pdf"
  },
  {
    "id": "145",
    "name": "Casodex (Bicalutamide)",
    "genericName": "Casodex (Bicalutamide)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020498s028lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020498s028lbl.pdf"
  },
  {
    "id": "146",
    "name": "Cefaclor",
    "genericName": "Cefaclor",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2f61354e-bcb0-41aa-955f-51eabc11387b"
      }
    ],
    "form": "Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2f61354e-bcb0-41aa-955f-51eabc11387b"
  },
  {
    "id": "147",
    "name": "Cefaclor Er",
    "genericName": "Cefaclor Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "The extended-release tablets should not be cut, crushed, or chewed.",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0878bdc2-0410-4938-9890-96523aa81c2f"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "The extended-release tablets should not be cut, crushed, or chewed.",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0878bdc2-0410-4938-9890-96523aa81c2f"
  },
  {
    "id": "148",
    "name": "Ceftin",
    "genericName": "Ceftin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Taste. Use suspense for children",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050605s052,050672s038lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Taste. Use suspense for children",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050605s052,050672s038lbl.pdf"
  },
  {
    "id": "149",
    "name": "Cefuroxime",
    "genericName": "Cefuroxime",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Taste. Use suspense for children",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050605s052,050672s038lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Taste. Use suspense for children",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050605s052,050672s038lbl.pdf"
  },
  {
    "id": "150",
    "name": "Cellcept Capsule",
    "genericName": "Cellcept Capsule",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "CELLCEPT capsule should not be opened",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/50723s054lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "CELLCEPT capsule should not be opened",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/50723s054lbl.pdf"
  },
  {
    "id": "151",
    "name": "Cellcept  Tablet",
    "genericName": "Cellcept  Tablet",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "CELLCEPT tablets should not be crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/50723s054lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "CELLCEPT tablets should not be crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/50723s054lbl.pdf"
  },
  {
    "id": "152",
    "name": "Mycophenolate Mofetil",
    "genericName": "Mycophenolate Mofetil",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Tablet should not be crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/065413s000lbl.pdf"
      },
      {
        "form": "Capsule",
        "alteration": "Capsule should not be opened",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/065413s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/065413s000lbl.pdf"
  },
  {
    "id": "153",
    "name": "Cerdelga (Eliglustat)",
    "genericName": "Cerdelga (Eliglustat)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow capsules whole, preferably with water, and do not crush, dissolve, or open the capsules",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205494s003lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow capsules whole, preferably with water, and do not crush, dissolve, or open the capsules",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205494s003lbl.pdf"
  },
  {
    "id": "154",
    "name": "Cesamet (Nabilone)",
    "genericName": "Cesamet (Nabilone)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "must be swallowed whole and not",
        "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process"
      }
    ],
    "form": "Capsule",
    "alteration": "must be swallowed whole and not",
    "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process"
  },
  {
    "id": "155",
    "name": "Cholbam (Cholic Acid)",
    "genericName": "Cholbam (Cholic Acid)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "chewed, cut, or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205750s003lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "chewed, cut, or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205750s003lbl.pdf"
  },
  {
    "id": "156",
    "name": "Cibinqo(Abrocitinib)",
    "genericName": "Cibinqo(Abrocitinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Disintegrating Tablet",
        "alteration": "Swallow CIBINQO tablets whole with water. Do not crush, split, or chew CIBINQO tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213871s004lblcorrected.pdf"
      }
    ],
    "form": "Disintergrating Tablet",
    "alteration": "Swallow CIBINQO tablets whole with water. Do not crush, split, or chew CIBINQO tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213871s004lblcorrected.pdf"
  },
  {
    "id": "157",
    "name": "Cipro Xr",
    "genericName": "Cipro Xr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow the CIPRO XR tablet whole. DO NOT SPLIT, CRUSH, OR CHEW THE TABLET",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21554_ciproXR_lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow the CIPRO XR tablet whole. DO NOT SPLIT, CRUSH, OR CHEW THE TABLET",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21554_ciproXR_lbl.pdf"
  },
  {
    "id": "158",
    "name": "Claravis",
    "genericName": "Claravis",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow \nyour Myorisan capsules whole with a full glass of liquid. Do not chew or suck on the \ncapsule. Myorisan can hurt the tube that connects your mouth to your stomach (esophagus) if it \nis not swallowed whole.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/anda/2012/076485Orig1s003.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow \nyour Myorisan capsules whole with a full glass of liquid. Do not chew or suck on the \ncapsule. Myorisan can hurt the tube that connects your mouth to your stomach (esophagus) if it \nis not swallowed whole.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/anda/2012/076485Orig1s003.pdf"
  },
  {
    "id": "159",
    "name": "Claritin-D 12 Hour",
    "genericName": "Claritin-D 12 Hour",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not divide, cursh, chew or dissolve tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19670s019,20470s022lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Do not divide, cursh, chew or dissolve tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19670s019,20470s022lbl.pdf"
  },
  {
    "id": "160",
    "name": "Claritin-D 24 Hour",
    "genericName": "Claritin-D 24 Hour",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not divide, cursh, chew or dissolve tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19670s019,20470s022lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Do not divide, cursh, chew or dissolve tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19670s019,20470s022lbl.pdf"
  },
  {
    "id": "161",
    "name": "Docusate Sodium",
    "genericName": "Docusate Sodium",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Take as whole capsule",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=30d23151-3cd8-4a15-a1da-46aa4be8fb79"
      }
    ],
    "form": "Capsule",
    "alteration": "Take as whole capsule",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=30d23151-3cd8-4a15-a1da-46aa4be8fb79"
  },
  {
    "id": "162",
    "name": "Colace",
    "genericName": "Colace",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Take as whole capsule",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=30d23151-3cd8-4a15-a1da-46aa4be8fb79"
      }
    ],
    "form": "Capsule",
    "alteration": "Take as whole capsule",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=30d23151-3cd8-4a15-a1da-46aa4be8fb79"
  },
  {
    "id": "163",
    "name": "Colazal (Balsalazide)",
    "genericName": "Colazal (Balsalazide)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow COLAZAL capsules whole. Do not cut, break, crush or chew the capsules. For patients who cannot swallow intact capsules, COLAZAL may also be administered by opening the capsule \nand sprinkling the capsule contents on applesauce",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020610s026lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow COLAZAL capsules whole. Do not cut, break, crush or chew the capsules. For patients who cannot swallow intact capsules, COLAZAL may also be administered by opening the capsule \nand sprinkling the capsule contents on applesauce",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020610s026lbl.pdf"
  },
  {
    "id": "164",
    "name": "Colestipol Hydrochloride",
    "genericName": "Colestipol Hydrochloride",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow each tablet whole. Do not cut, crush, or chew the tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/20222Orig1s006correctedlbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow each tablet whole. Do not cut, crush, or chew the tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/20222Orig1s006correctedlbl.pdf"
  },
  {
    "id": "165",
    "name": "Colestid",
    "genericName": "Colestid",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow each tablet whole. Do not cut, crush, or chew the tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/20222Orig1s006correctedlbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow each tablet whole. Do not cut, crush, or chew the tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/20222Orig1s006correctedlbl.pdf"
  },
  {
    "id": "166",
    "name": "Cometriq (Cabozantinib)",
    "genericName": "Cometriq (Cabozantinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow COMETRIQ capsules whole. Do not open COMETRIQ capsules",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203756s011lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow COMETRIQ capsules whole. Do not open COMETRIQ capsules",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203756s011lbl.pdf"
  },
  {
    "id": "167",
    "name": "Methylphenidate Er",
    "genericName": "Methylphenidate Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Must be swallowed whole and never crushed or chewed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021121s049lbl.pdf"
      }
    ],
    "form": "Extended released Tablet",
    "alteration": "Must be swallowed whole and never crushed or chewed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021121s049lbl.pdf"
  },
  {
    "id": "168",
    "name": "Dexmethylhpenidate",
    "genericName": "Dexmethylhpenidate",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021278s028s031lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021278s028s031lbl.pdf"
  },
  {
    "id": "169",
    "name": "Focalin",
    "genericName": "Focalin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021278s028s031lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021278s028s031lbl.pdf"
  },
  {
    "id": "170",
    "name": "Focalin Xr ( Dexmethylphenidate)",
    "genericName": "Focalin Xr ( Dexmethylphenidate)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "may be taken whole or the capsule may be opened and the entire contents sprinkled onto applesauce.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021802s038s041lbl.pdf"
      }
    ],
    "form": "Extended released capsule",
    "alteration": "may be taken whole or the capsule may be opened and the entire contents sprinkled onto applesauce.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021802s038s041lbl.pdf"
  },
  {
    "id": "171",
    "name": "Ritalin",
    "genericName": "Ritalin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/010187s094lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/010187s094lbl.pdf"
  },
  {
    "id": "172",
    "name": "Ritalin La",
    "genericName": "Ritalin La",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Capsules may be swallowed whole or opened and the entire contents sprinkled on applesauce. Should not be crushed, chewed, or divided",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021284s042s046lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Capsules may be swallowed whole or opened and the entire contents sprinkled on applesauce. Should not be crushed, chewed, or divided",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021284s042s046lbl.pdf"
  },
  {
    "id": "173",
    "name": "Ritalin-Sr",
    "genericName": "Ritalin-Sr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Must be swallowed whole and never crushed or chewed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/010187s091,018029s059lbl.pdf"
      }
    ],
    "form": "Extended Released tablet",
    "alteration": "Must be swallowed whole and never crushed or chewed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/010187s091,018029s059lbl.pdf"
  },
  {
    "id": "174",
    "name": "Metadate Cd",
    "genericName": "Metadate Cd",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Swallow the capsule whole.  The capsules and the capsule contents must not be crushed or chewed.Alternatively, open the capsule and sprinkle the contents onto a small amount \n(tablespoon) of applesauce and administer immediately",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021259s034lbl.pdf"
      }
    ],
    "form": "Extended released capsule",
    "alteration": "Swallow the capsule whole.  The capsules and the capsule contents must not be crushed or chewed.Alternatively, open the capsule and sprinkle the contents onto a small amount \n(tablespoon) of applesauce and administer immediately",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021259s034lbl.pdf"
  },
  {
    "id": "175",
    "name": "Concerta",
    "genericName": "Concerta",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "CONCERTA should not be chewed or crushed. Swallow as a whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021121s049lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "CONCERTA should not be chewed or crushed. Swallow as a whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021121s049lbl.pdf"
  },
  {
    "id": "176",
    "name": "Naltrexone And Bupropion",
    "genericName": "Naltrexone And Bupropion",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "The tablets should not be cut, chewed, or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/200063s022lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "The tablets should not be cut, chewed, or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/200063s022lbl.pdf"
  },
  {
    "id": "177",
    "name": "Contrave",
    "genericName": "Contrave",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "The tablets should not be cut, chewed, or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/200063s022lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "The tablets should not be cut, chewed, or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/200063s022lbl.pdf"
  },
  {
    "id": "178",
    "name": "Conzip (Tramadol)",
    "genericName": "Conzip (Tramadol)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "swallow CONZIP capsules whole, and to take it with liquid. Breaking, chewing, \nsplitting, or dissolving CONZIP capsules will result in uncontrolled delivery of tramadol and can lead to \noverdose or death",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022370s025lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "swallow CONZIP capsules whole, and to take it with liquid. Breaking, chewing, \nsplitting, or dissolving CONZIP capsules will result in uncontrolled delivery of tramadol and can lead to \noverdose or death",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022370s025lbl.pdf"
  },
  {
    "id": "179",
    "name": "Copiktra(Duvelisib)",
    "genericName": "Copiktra(Duvelisib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "The capsules should be swallowed whole. \nAdvise patients not to open, break, or chew the capsules",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/211155s007lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "The capsules should be swallowed whole. \nAdvise patients not to open, break, or chew the capsules",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/211155s007lbl.pdf"
  },
  {
    "id": "180",
    "name": "Carvedilol",
    "genericName": "Carvedilol",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020297Orig1s039correctedlbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020297Orig1s039correctedlbl.pdf"
  },
  {
    "id": "181",
    "name": "Coreg",
    "genericName": "Coreg",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020297Orig1s039correctedlbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020297Orig1s039correctedlbl.pdf"
  },
  {
    "id": "182",
    "name": "Carvedilol Er",
    "genericName": "Carvedilol Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Carvedilol Phosphate extended-release capsules should be swallowed whole. Carvedilol \nPhosphate extended-release capsules and/or their contents should not be crushed, chewed, or \ntaken in divided doses. The capsules may be carefully opened and the beads sprinkled over a spoonful of applesauce",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022012s024lbl.pdf"
      }
    ],
    "form": "Extended Released Capsule",
    "alteration": "Carvedilol Phosphate extended-release capsules should be swallowed whole. Carvedilol \nPhosphate extended-release capsules and/or their contents should not be crushed, chewed, or \ntaken in divided doses. The capsules may be carefully opened and the beads sprinkled over a spoonful of applesauce",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022012s024lbl.pdf"
  },
  {
    "id": "183",
    "name": "Coreg Cr",
    "genericName": "Coreg Cr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Carvedilol Phosphate extended-release capsules should be swallowed whole. Carvedilol \nPhosphate extended-release capsules and/or their contents should not be crushed, chewed, or \ntaken in divided doses. The capsules may be carefully opened and the beads sprinkled over a spoonful of applesauce",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022012s024lbl.pdf"
      }
    ],
    "form": "Extended Released Capsule",
    "alteration": "Carvedilol Phosphate extended-release capsules should be swallowed whole. Carvedilol \nPhosphate extended-release capsules and/or their contents should not be crushed, chewed, or \ntaken in divided doses. The capsules may be carefully opened and the beads sprinkled over a spoonful of applesauce",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022012s024lbl.pdf"
  },
  {
    "id": "184",
    "name": "Cotellic (Cobimetinib)",
    "genericName": "Cotellic (Cobimetinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "In clinical trial, tablet was administered whole, do not chew, cut or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206192s006lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "In clinical trial, tablet was administered whole, do not chew, cut or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206192s006lbl.pdf"
  },
  {
    "id": "185",
    "name": "Cotempla Xr-Odt (Methylphenidate)",
    "genericName": "Cotempla Xr-Odt (Methylphenidate)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Disintegrating Tablet",
        "alteration": "Place the whole tablet on the tongue and allow it to disintegrate without chewing or \ncrushing.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205489s012lbl.pdf"
      }
    ],
    "form": "Disintergrating Tablet",
    "alteration": "Place the whole tablet on the tongue and allow it to disintegrate without chewing or \ncrushing.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205489s012lbl.pdf"
  },
  {
    "id": "186",
    "name": "Creon (Pancrelipase)",
    "genericName": "Creon (Pancrelipase)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "CREON capsules and capsule contents \n59 should not be crushed or chewed. Capsules should be swallowed whole. \n60 For patients who are unable to swallow intact capsules, the capsules may be carefully opened and the \n61 contents added to a small amount of acidic soft food with a pH of 4 or less",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020725s000lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "CREON capsules and capsule contents \n59 should not be crushed or chewed. Capsules should be swallowed whole. \n60 For patients who are unable to swallow intact capsules, the capsules may be carefully opened and the \n61 contents added to a small amount of acidic soft food with a pH of 4 or less",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020725s000lbl.pdf"
  },
  {
    "id": "187",
    "name": "Cresemba (Isavuconazium)",
    "genericName": "Cresemba (Isavuconazium)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "swallow CRESEMBA capsules whole. Do not chew, crush, dissolve, or open the capsules.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/207500s016,207501s016lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "swallow CRESEMBA capsules whole. Do not chew, crush, dissolve, or open the capsules.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/207500s016,207501s016lbl.pdf"
  },
  {
    "id": "188",
    "name": "Crixivan(Indinavir)",
    "genericName": "Crixivan(Indinavir)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "May be opened and mixed with fruit puree",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020685s078lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "May be opened and mixed with fruit puree",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020685s078lbl.pdf"
  },
  {
    "id": "189",
    "name": "Cyclophosphamide",
    "genericName": "Cyclophosphamide",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Cyclophosphamide Capsules should be swallowed whole. The capsules should not be opened, chewed, or crushed.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203856s003lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Cyclophosphamide Capsules should be swallowed whole. The capsules should not be opened, chewed, or crushed.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203856s003lbl.pdf"
  },
  {
    "id": "190",
    "name": "Duloxetine",
    "genericName": "Duloxetine",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Swallow whole. Do not chew or crush, and do not open the \ndelayed-release capsule and sprinkle its contents on food or mix with liquids because these actions might affect the \nenteric coating",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021427s055s057lbl.pdf"
      },
      {
        "form": "Capsule",
        "alteration": "Administer CYMBALTA orally (with or without meals) and swallow whole. Do not chew or crush, and do not open the delayed-release capsule and sprinkle its contents on food or mix with liquids because these actions might affect the enteric coating",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021427s055s057lbl.pdf"
      }
    ],
    "form": "Delayed released capsule",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021427s055s057lbl.pdf"
  },
  {
    "id": "191",
    "name": "Cymbalta",
    "genericName": "Cymbalta",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Swallow whole. Do not chew or crush, and do not open the \ndelayed-release capsule and sprinkle its contents on food or mix with liquids because these actions might affect the \nenteric coating",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021427s055s057lbl.pdf"
      },
      {
        "form": "Capsule",
        "alteration": "Administer CYMBALTA orally (with or without meals) and swallow whole. Do not chew or crush, and do not open the delayed-release capsule and sprinkle its contents on food or mix with liquids because these actions might affect the enteric coating",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021427s055s057lbl.pdf"
      }
    ],
    "form": "Delayed released capsule",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021427s055s057lbl.pdf"
  },
  {
    "id": "192",
    "name": "Dartisla-Odt (Glycopyrilate)",
    "genericName": "Dartisla-Odt (Glycopyrilate)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not break or cut the tablet. Immediately place the tablet on the tongue, allow it to disintegrate, and swallow without water",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215019s001lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not break or cut the tablet. Immediately place the tablet on the tongue, allow it to disintegrate, and swallow without water",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215019s001lbl.pdf"
  },
  {
    "id": "193",
    "name": "Daurismo (Glasdegib)",
    "genericName": "Daurismo (Glasdegib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not split or crush DAURISMO tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210656s005lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not split or crush DAURISMO tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210656s005lbl.pdf"
  },
  {
    "id": "194",
    "name": "Delzicol (Mesalamine)",
    "genericName": "Delzicol (Mesalamine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Swallow the capsules whole; do not cut, break, crush or chew.  For patients who are unable to swallow the capsules, the capsules can be opened and the inner tablets swallowed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204412s017lbl.pdf"
      }
    ],
    "form": "Extended Released Capsule",
    "alteration": "Swallow the capsules whole; do not cut, break, crush or chew.  For patients who are unable to swallow the capsules, the capsules can be opened and the inner tablets swallowed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204412s017lbl.pdf"
  },
  {
    "id": "195",
    "name": "Valproic Acid",
    "genericName": "Valproic Acid",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Depakene capsules should be swallowed whole \nwithout chewing to avoid local irritation of the mouth and throat.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018081s071,018082s054lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Depakene capsules should be swallowed whole \nwithout chewing to avoid local irritation of the mouth and throat.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018081s071,018082s054lbl.pdf"
  },
  {
    "id": "196",
    "name": "Depakene",
    "genericName": "Depakene",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Depakene capsules should be swallowed whole \nwithout chewing to avoid local irritation of the mouth and throat.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018081s071,018082s054lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Depakene capsules should be swallowed whole \nwithout chewing to avoid local irritation of the mouth and throat.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018081s071,018082s054lbl.pdf"
  },
  {
    "id": "197",
    "name": "Depakote",
    "genericName": "Depakote",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Depakote tablets should be swallowed whole and should not be crushed or chewed.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/018723s070lbl.pdf"
      }
    ],
    "form": "Delayed Released Capsule",
    "alteration": "Depakote tablets should be swallowed whole and should not be crushed or chewed.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/018723s070lbl.pdf"
  },
  {
    "id": "198",
    "name": "Divalproex Er",
    "genericName": "Divalproex Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "tablets should be swallowed whole and should not be crushed or chewed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20782_depakote_lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "tablets should be swallowed whole and should not be crushed or chewed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20782_depakote_lbl.pdf"
  },
  {
    "id": "199",
    "name": "Depalote Er",
    "genericName": "Depalote Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "tablets should be swallowed whole and should not be crushed or chewed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20782_depakote_lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "tablets should be swallowed whole and should not be crushed or chewed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20782_depakote_lbl.pdf"
  },
  {
    "id": "200",
    "name": "Depakote Sprinkles (Divalproex)",
    "genericName": "Depakote Sprinkles (Divalproex)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Depakote Sprinkle Capsules may be swallowed whole or the contents \nmay be sprinkled on soft food. The drug/food mixture should be \nswallowed immediately (avoid chewing)",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019680s035lbl.pdf"
      }
    ],
    "form": "Delayed released capsule",
    "alteration": "Depakote Sprinkle Capsules may be swallowed whole or the contents \nmay be sprinkled on soft food. The drug/food mixture should be \nswallowed immediately (avoid chewing)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019680s035lbl.pdf"
  },
  {
    "id": "201",
    "name": "Detrol",
    "genericName": "Detrol",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "No alteration information was provided by manufacature",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020771s028lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "No alteration information was provided by manufacature",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020771s028lbl.pdf"
  },
  {
    "id": "202",
    "name": "Detrol La (Tolterodine)",
    "genericName": "Detrol La (Tolterodine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "swallowed whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021228s023lbl.pdf"
      }
    ],
    "form": "Extended Released Capsule",
    "alteration": "swallowed whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021228s023lbl.pdf"
  },
  {
    "id": "203",
    "name": "Dexedrine Spansule",
    "genericName": "Dexedrine Spansule",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "swallowed whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017078s055lbl.pdf"
      }
    ],
    "form": "Extended Released Capsule",
    "alteration": "swallowed whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017078s055lbl.pdf"
  },
  {
    "id": "204",
    "name": "Dexlansoprazole",
    "genericName": "Dexlansoprazole",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Swallow whole; do not chew.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022287s037lbl.pdf"
      }
    ],
    "form": "Delayed released capsule",
    "alteration": "Swallow whole; do not chew.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022287s037lbl.pdf"
  },
  {
    "id": "205",
    "name": "Dexilant",
    "genericName": "Dexilant",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Swallow whole; do not chew.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022287s037lbl.pdf"
      },
      {
        "form": "Tablet",
        "alteration": "Swallow whole; do not chew",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022287s038lbl.pdf"
      }
    ],
    "form": "Delayed released capsule",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022287s037lbl.pdf"
  },
  {
    "id": "206",
    "name": "Diacomit (Stiripentol)",
    "genericName": "Diacomit (Stiripentol)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Capsules must be swallowed whole with a glass of water during a meal. \nCapsules should not be broken or opened.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206709s003,207223s003lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Capsules must be swallowed whole with a glass of water during a meal. \nCapsules should not be broken or opened.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206709s003,207223s003lbl.pdf"
  },
  {
    "id": "207",
    "name": "Acetazolamide",
    "genericName": "Acetazolamide",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "swallowed whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/012945s048lbl.pdf"
      }
    ],
    "form": "Extended Released Capsule",
    "alteration": "swallowed whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/012945s048lbl.pdf"
  },
  {
    "id": "208",
    "name": "Diamox Sequels",
    "genericName": "Diamox Sequels",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "swallowed whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/012945s048lbl.pdf"
      }
    ],
    "form": "Extended Released Capsule",
    "alteration": "swallowed whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/012945s048lbl.pdf"
  },
  {
    "id": "209",
    "name": "Dibenzyline (Phenoxybenzamine)",
    "genericName": "Dibenzyline (Phenoxybenzamine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Hazardous substance",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/008708s025lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Hazardous substance",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/008708s025lbl.pdf"
  },
  {
    "id": "210",
    "name": "Diclegis (Doxylamine And Pyridoxine)",
    "genericName": "Diclegis (Doxylamine And Pyridoxine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Tablet",
        "alteration": "Swallow tablets whole. Do not crush, chew, or split DICLEGIS tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021876s016lbl.pdf"
      }
    ],
    "form": "Delayed released tablet",
    "alteration": "Swallow tablets whole. Do not crush, chew, or split DICLEGIS tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021876s016lbl.pdf"
  },
  {
    "id": "211",
    "name": "Diflunisal",
    "genericName": "Diflunisal",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Tablets should be swallowed whole, not crushed or chewed",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2043bab8-87c9-45ce-88c7-383f0d4c4b64"
      }
    ],
    "form": "Tablet",
    "alteration": "Tablets should be swallowed whole, not crushed or chewed",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2043bab8-87c9-45ce-88c7-383f0d4c4b64"
  },
  {
    "id": "212",
    "name": "Phenytoin",
    "genericName": "Phenytoin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/084349s088lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/084349s088lbl.pdf"
  },
  {
    "id": "213",
    "name": "Dilantin",
    "genericName": "Dilantin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/084349s088lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/084349s088lbl.pdf"
  },
  {
    "id": "214",
    "name": "Isosorbide Dinitrate",
    "genericName": "Isosorbide Dinitrate",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019790s011lbl.pdf"
      },
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b166eb5b-bad8-4663-9c05-1c43539dab2c"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019790s011lbl.pdf"
  },
  {
    "id": "215",
    "name": "Dilatrate-Sr",
    "genericName": "Dilatrate-Sr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019790s011lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019790s011lbl.pdf"
  },
  {
    "id": "216",
    "name": "Diltiazem",
    "genericName": "Diltiazem",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020062s048lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020062s048lbl.pdf"
  },
  {
    "id": "217",
    "name": "Dilt-Xr",
    "genericName": "Dilt-Xr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020062s048lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020062s048lbl.pdf"
  },
  {
    "id": "218",
    "name": "Ditropan",
    "genericName": "Ditropan",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/017577s038lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/017577s038lbl.pdf"
  },
  {
    "id": "219",
    "name": "Ditropan Xl",
    "genericName": "Ditropan Xl",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "should not chew, divide, or crush tablets. Swallow whole tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20897lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "should not chew, divide, or crush tablets. Swallow whole tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20897lbl.pdf"
  },
  {
    "id": "220",
    "name": "Doryx Mpc",
    "genericName": "Doryx Mpc",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Tablet",
        "alteration": "Do not chew or crush tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/050795s037lbl.pdf"
      }
    ],
    "form": "Delayed Released Tablet",
    "alteration": "Do not chew or crush tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/050795s037lbl.pdf"
  },
  {
    "id": "221",
    "name": "Drisdol (Ergocalciferol)",
    "genericName": "Drisdol (Ergocalciferol)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Liquid-Filled Capsule",
        "alteration": "Swallow whole; do not chew.",
        "reference": ""
      }
    ],
    "form": "Liquid Filled Capsule",
    "alteration": "Swallow whole; do not chew.",
    "reference": ""
  },
  {
    "id": "222",
    "name": "Drizalma Sprinkle (Duloxetine)",
    "genericName": "Drizalma Sprinkle (Duloxetine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "DRIZALMA Sprinkle may be: swallowed whole (do not crush or chew capsule); opened and sprinkled over applesauce; or administered via nasogastric tube",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212516s000lbl.pdf"
      }
    ],
    "form": "Delayed released capsule",
    "alteration": "DRIZALMA Sprinkle may be: swallowed whole (do not crush or chew capsule); opened and sprinkled over applesauce; or administered via nasogastric tube",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212516s000lbl.pdf"
  },
  {
    "id": "223",
    "name": "Droxia",
    "genericName": "Droxia",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow DROXIA capsules whole. Do NOT open, break, or chew capsules because DROXIA is \na cytotoxic drug.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016295s058lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow DROXIA capsules whole. Do NOT open, break, or chew capsules because DROXIA is \na cytotoxic drug.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016295s058lbl.pdf"
  },
  {
    "id": "224",
    "name": "Hydroxyurea",
    "genericName": "Hydroxyurea",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow DROXIA capsules whole. Do NOT open, break, or chew capsules because DROXIA is \na cytotoxic drug.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016295s058lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow DROXIA capsules whole. Do NOT open, break, or chew capsules because DROXIA is \na cytotoxic drug.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016295s058lbl.pdf"
  },
  {
    "id": "225",
    "name": "Duavee (Estrogens [Conjugated/Equine) And Bazedoxifene)",
    "genericName": "Duavee (Estrogens [Conjugated/Equine) And Bazedoxifene)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Tablets should be swallowed whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022247Orig1s001lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Tablets should be swallowed whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022247Orig1s001lbl.pdf"
  },
  {
    "id": "226",
    "name": "Duexis (Ibuprofen And Famotidine)",
    "genericName": "Duexis (Ibuprofen And Famotidine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "DUEXIS tablets should be swallowed whole, and should not be cut to supply a lower dose. Do not chew, divide, or crush \ntablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022519s014lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "DUEXIS tablets should be swallowed whole, and should not be cut to supply a lower dose. Do not chew, divide, or crush \ntablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022519s014lbl.pdf"
  },
  {
    "id": "227",
    "name": "Dulcolax (Bisacodyl)",
    "genericName": "Dulcolax (Bisacodyl)",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Liquid-Filled Capsule",
        "alteration": "Swallow whole; do not chew.",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=919375cd-7646-4958-9e2b-cec2e1b2bd49"
      },
      {
        "form": "Enteric Coated Tablet",
        "alteration": "Swallow whole; do not chew.",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d285651b-7ccc-4ae5-a862-7a38dffefa28"
      }
    ],
    "form": "Liquid Filled Capsule",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=919375cd-7646-4958-9e2b-cec2e1b2bd49"
  },
  {
    "id": "228",
    "name": "Durlaza (Aspirin)",
    "genericName": "Durlaza (Aspirin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Enteric Coated Tablet",
        "alteration": "Swallow whole; do not chew.",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d285651b-7ccc-4ae5-a862-7a38dffefa28"
      }
    ],
    "form": "Enteric Coated Tablet",
    "alteration": "Swallow whole; do not chew.",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d285651b-7ccc-4ae5-a862-7a38dffefa28"
  },
  {
    "id": "229",
    "name": "Ec- Naprosyn (Naproxen)",
    "genericName": "Ec- Naprosyn (Naproxen)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Enteric Coated Tablet",
        "alteration": "Delayed release, enteric coated tablet",
        "reference": ""
      }
    ],
    "form": "Enteric Coated Tablet",
    "alteration": "Delayed release, enteric coated tablet",
    "reference": ""
  },
  {
    "id": "230",
    "name": "E.E.S (Erythromycin)",
    "genericName": "E.E.S (Erythromycin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Enteric Coated Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": ""
      }
    ],
    "form": "Enteric Coated Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": ""
  },
  {
    "id": "231",
    "name": "Effer-K (Potassium Bicarbonate And Potassium Citrate)",
    "genericName": "Effer-K (Potassium Bicarbonate And Potassium Citrate)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Effervescent Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": ""
      }
    ],
    "form": "Effervescent Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": ""
  },
  {
    "id": "232",
    "name": "Levetiracetam Er",
    "genericName": "Levetiracetam Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Should be taken whole; do not split or cut tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204417s009lbl.pdf"
      }
    ],
    "form": "Extended released tablet",
    "alteration": "Should be taken whole; do not split or cut tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204417s009lbl.pdf"
  },
  {
    "id": "233",
    "name": "Elepsia Xr",
    "genericName": "Elepsia Xr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "ELEPSIA XR should be taken whole; do not split or cut tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204417s009lbl.pdf"
      }
    ],
    "form": "Extended released Tablet",
    "alteration": "ELEPSIA XR should be taken whole; do not split or cut tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204417s009lbl.pdf"
  },
  {
    "id": "234",
    "name": "Keppra",
    "genericName": "Keppra",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "KEPPRA tablets should be swallowed whole. KEPPRA tablets should not be chewed or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021035s115,021505s053lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "KEPPRA tablets should be swallowed whole. KEPPRA tablets should not be chewed or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021035s115,021505s053lbl.pdf"
  },
  {
    "id": "235",
    "name": "Levetiracetam",
    "genericName": "Levetiracetam",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "KEPPRA tablets should be swallowed whole. KEPPRA tablets should not be chewed or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021035s115,021505s053lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "KEPPRA tablets should be swallowed whole. KEPPRA tablets should not be chewed or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021035s115,021505s053lbl.pdf"
  },
  {
    "id": "236",
    "name": "Embeda (Morphine And Naltrexone)",
    "genericName": "Embeda (Morphine And Naltrexone)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Instruct patients to swallow EMBEDA capsules whole [see Patient Counseling Information (17)]. Crushing, chewing, or dissolving \nEMBEDA capsules will result in uncontrolled delivery of morphine and can lead to overdose or death",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022321s030lbl.pdf"
      }
    ],
    "form": "Entended released Capsule",
    "alteration": "Instruct patients to swallow EMBEDA capsules whole [see Patient Counseling Information (17)]. Crushing, chewing, or dissolving \nEMBEDA capsules will result in uncontrolled delivery of morphine and can lead to overdose or death",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022321s030lbl.pdf"
  },
  {
    "id": "237",
    "name": "Emend",
    "genericName": "Emend",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow capsules whole.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021549s030,207865s003lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow capsules whole.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021549s030,207865s003lbl.pdf"
  },
  {
    "id": "238",
    "name": "Aprepitant",
    "genericName": "Aprepitant",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow capsules whole.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021549s030,207865s003lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow capsules whole.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021549s030,207865s003lbl.pdf"
  },
  {
    "id": "239",
    "name": "Enablex (Darifenacin)",
    "genericName": "Enablex (Darifenacin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "should be swallowed whole and not chewed, divided or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021513s017lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "should be swallowed whole and not chewed, divided or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021513s017lbl.pdf"
  },
  {
    "id": "240",
    "name": "Entocort Ec",
    "genericName": "Entocort Ec",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Swallow ENTOCORT EC delayed-release capsules whole. Do not chew or crush. For patients unable to swallow an intact capsule, ENTOCORT EC delayed-release capsules \ncan be opened and administered as follows: Place one tablespoonful of applesauce into a clean container (e.g., empty bowl). The \napplesauce used should not be hot and should be soft enough to be swallowed without \nchewing.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021324s027lbl.pdf"
      },
      {
        "form": "Delayed Released Capsule",
        "alteration": "Swallow ENTOCORT EC delayed-release capsules whole. Do not chew or crush. • For patients unable to swallow an intact capsule, ENTOCORT EC delayed-release capsules can be opened",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021324s027lbl.pdf"
      }
    ],
    "form": "Delayed released capsule",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021324s027lbl.pdf"
  },
  {
    "id": "241",
    "name": "Budesonide",
    "genericName": "Budesonide",
    "category": "Medication",
    "description": "Available in 3 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Swallow ENTOCORT EC delayed-release capsules whole. Do not chew or crush. For patients unable to swallow an intact capsule, ENTOCORT EC delayed-release capsules \ncan be opened and administered as follows: Place one tablespoonful of applesauce into a clean container (e.g., empty bowl). The \napplesauce used should not be hot and should be soft enough to be swallowed without \nchewing.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021324s027lbl.pdf"
      },
      {
        "form": "Extended Released Capsule",
        "alteration": "Swallow whole. Do not chew or crush.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/211929s011lbl.pdf"
      },
      {
        "form": "Delayed Released Capsule",
        "alteration": "Swallow whole. Do not open, crush or chew",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215935s005lbl.pdf"
      }
    ],
    "form": "Delayed released capsule",
    "alteration": "Multiple forms available (3 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021324s027lbl.pdf"
  },
  {
    "id": "242",
    "name": "Epclusa (Sofosbuvir And Velpatasvir)",
    "genericName": "Epclusa (Sofosbuvir And Velpatasvir)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Pharmacokinetic amorphous solid dispersion technology maybe affected",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Pharmacokinetic amorphous solid dispersion technology maybe affected",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf"
  },
  {
    "id": "243",
    "name": "Equetro",
    "genericName": "Equetro",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Swallow EQUETRO capsules whole or open and sprinkle the beads over food, such as a teaspoon of applesauce. Do not crush or chew EQUETRO capsules or the beads inside the capsule. EQUETRO can be taken with or without meals.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/021710lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Swallow EQUETRO capsules whole or open and sprinkle the beads over food, such as a teaspoon of applesauce. Do not crush or chew EQUETRO capsules or the beads inside the capsule. EQUETRO can be taken with or without meals.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/021710lbl.pdf"
  },
  {
    "id": "244",
    "name": "Ergomar (Ergotamine)",
    "genericName": "Ergomar (Ergotamine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Sublingual Tablet",
        "alteration": "",
        "reference": ""
      }
    ],
    "form": "Sublingual Tablet",
    "alteration": "",
    "reference": ""
  },
  {
    "id": "245",
    "name": "Erivedge (Vismodegib)",
    "genericName": "Erivedge (Vismodegib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Swallow capsules whole. Do not open or crush capsules.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203388s017lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Swallow capsules whole. Do not open or crush capsules.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203388s017lbl.pdf"
  },
  {
    "id": "246",
    "name": "Erleada (Apalutamide)",
    "genericName": "Erleada (Apalutamide)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow tablets whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210951s016lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow tablets whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210951s016lbl.pdf"
  },
  {
    "id": "247",
    "name": "Eryc (Erythromycin)",
    "genericName": "Eryc (Erythromycin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Enteric coated capsule",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050536s026lbl.pdf"
      }
    ],
    "form": "Delayed released capsule",
    "alteration": "Enteric coated capsule",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050536s026lbl.pdf"
  },
  {
    "id": "248",
    "name": "Ery-Tab (Erythromycin)",
    "genericName": "Ery-Tab (Erythromycin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Tablet",
        "alteration": "Delayed release and enteric coated tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/062298s068lbl.pdf"
      }
    ],
    "form": "Delayed Released Tablet",
    "alteration": "Delayed release and enteric coated tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/062298s068lbl.pdf"
  },
  {
    "id": "249",
    "name": "Erythromycin Base",
    "genericName": "Erythromycin Base",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Enteric Coated Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": ""
      }
    ],
    "form": "Enteric Coated Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": ""
  },
  {
    "id": "250",
    "name": "Erythromycin Delayed Release",
    "genericName": "Erythromycin Delayed Release",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Enteric-coated pellets",
        "reference": ""
      }
    ],
    "form": "Delayed released capsule",
    "alteration": "Enteric-coated pellets",
    "reference": ""
  },
  {
    "id": "251",
    "name": "Erythromycin Ethylsuccinate",
    "genericName": "Erythromycin Ethylsuccinate",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Taste",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "Taste",
    "reference": ""
  },
  {
    "id": "252",
    "name": "Erythromycin Stearate",
    "genericName": "Erythromycin Stearate",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Enteric Coated Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": ""
      }
    ],
    "form": "Enteric Coated Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": ""
  },
  {
    "id": "253",
    "name": "Etoposide",
    "genericName": "Etoposide",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Hazardous substance",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/75-635_Etoposide.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Hazardous substance",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/75-635_Etoposide.pdf"
  },
  {
    "id": "254",
    "name": "Evekeo Odt (Amphetamine)",
    "genericName": "Evekeo Odt (Amphetamine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Disintegrating Tablet",
        "alteration": "Sublingal form",
        "reference": ""
      }
    ],
    "form": "Disintergrating Tablet",
    "alteration": "Sublingal form",
    "reference": ""
  },
  {
    "id": "255",
    "name": "Evista (Raloxifene)",
    "genericName": "Evista (Raloxifene)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Taste, Teratogenic potential, hazardous substance",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020815s034lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Taste, Teratogenic potential, hazardous substance",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020815s034lbl.pdf"
  },
  {
    "id": "256",
    "name": "Exalgo (Hydromorphone)",
    "genericName": "Exalgo (Hydromorphone)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "ER : breaking,chewing, crushingm or dissolving before ingestion or injecting increases the risk of over dose",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021217s025lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "ER : breaking,chewing, crushingm or dissolving before ingestion or injecting increases the risk of over dose",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021217s025lbl.pdf"
  },
  {
    "id": "257",
    "name": "Exelon (Rivastigmine)",
    "genericName": "Exelon (Rivastigmine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Canadian manufacture recommendation",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20823lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Canadian manufacture recommendation",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20823lbl.pdf"
  },
  {
    "id": "258",
    "name": "Exjade (Deferasirox)",
    "genericName": "Exjade (Deferasirox)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "EXJADE should be taken once daily on an empty stomach at least 30 minutes before food, preferably \nat the same time each day. Tablets should not be chewed or swallowed whole. EXJADE should not \nbe taken with aluminum-containing antacid products. Doses (mg/kg) should be calculated to the \nnearest whole tablet. Tablets should be completely dispersed by stirring in water, orange juice, or apple \njuice until a fine suspension is obtained. Doses of < 1 g should be dispersed in 3.5 ounces of liquid \nand doses of > 1 g in 7.0 ounces of liquid. After swallowing the suspension, any residue should be \nresuspended in a small volume of liquid and swallowed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021882lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "EXJADE should be taken once daily on an empty stomach at least 30 minutes before food, preferably \nat the same time each day. Tablets should not be chewed or swallowed whole. EXJADE should not \nbe taken with aluminum-containing antacid products. Doses (mg/kg) should be calculated to the \nnearest whole tablet. Tablets should be completely dispersed by stirring in water, orange juice, or apple \njuice until a fine suspension is obtained. Doses of < 1 g should be dispersed in 3.5 ounces of liquid \nand doses of > 1 g in 7.0 ounces of liquid. After swallowing the suspension, any residue should be \nresuspended in a small volume of liquid and swallowed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021882lbl.pdf"
  },
  {
    "id": "259",
    "name": "Exkivity (Mobocertinib)",
    "genericName": "Exkivity (Mobocertinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow EXKIVITY capsules whole. Do not open, chew, or dissolve the contents of the capsules",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215310s003lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow EXKIVITY capsules whole. Do not open, chew, or dissolve the contents of the capsules",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215310s003lbl.pdf"
  },
  {
    "id": "260",
    "name": "Rilutek",
    "genericName": "Rilutek",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020599s019lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020599s019lbl.pdf"
  },
  {
    "id": "261",
    "name": "Riluzole",
    "genericName": "Riluzole",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020599s019lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020599s019lbl.pdf"
  },
  {
    "id": "262",
    "name": "Exservan ( Riluzole)",
    "genericName": "Exservan ( Riluzole)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Sublingual Film",
        "alteration": "film, sublingual form",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212640s001lbl.pdf"
      }
    ],
    "form": "Film, Sublingual film",
    "alteration": "film, sublingual form",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212640s001lbl.pdf"
  },
  {
    "id": "263",
    "name": "Ezallor Sprinkle (Rosuvastatin)",
    "genericName": "Ezallor Sprinkle (Rosuvastatin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow the capsules whole. Do not crush or chew",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208647s015lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow the capsules whole. Do not crush or chew",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208647s015lbl.pdf"
  },
  {
    "id": "264",
    "name": "Fareston (Toremifene)",
    "genericName": "Fareston (Toremifene)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Hazardouse substance",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020497s018lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Hazardouse substance",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020497s018lbl.pdf"
  },
  {
    "id": "265",
    "name": "Farydak (Panobinostat)",
    "genericName": "Farydak (Panobinostat)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "FARYDAK capsules should be swallowed whole with a cup of water. Do not open, crush, or chew the capsules",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "FARYDAK capsules should be swallowed whole with a cup of water. Do not open, crush, or chew the capsules",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf"
  },
  {
    "id": "266",
    "name": "Feldene (Piroxicam)",
    "genericName": "Feldene (Piroxicam)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Mucous membrane irritant",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018147s053lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Mucous membrane irritant",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018147s053lbl.pdf"
  },
  {
    "id": "267",
    "name": "Plendil",
    "genericName": "Plendil",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "PLENDIL should be swallowed whole and not crushed or chewed.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019834s025lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "PLENDIL should be swallowed whole and not crushed or chewed.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019834s025lbl.pdf"
  },
  {
    "id": "268",
    "name": "Felodipine",
    "genericName": "Felodipine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Felodipine  should be swallowed \nwhole and not crushed or chewed.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019834s025lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Felodipine  should be swallowed \nwhole and not crushed or chewed.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019834s025lbl.pdf"
  },
  {
    "id": "269",
    "name": "Fentanyl",
    "genericName": "Fentanyl",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Lozenge",
        "alteration": "Slow release, lillipop delivery system requres the patient to slowly dissolve in mouth",
        "reference": ""
      }
    ],
    "form": "Lozenge",
    "alteration": "Slow release, lillipop delivery system requres the patient to slowly dissolve in mouth",
    "reference": ""
  },
  {
    "id": "270",
    "name": "Fentora (Fentanyl)",
    "genericName": "Fentora (Fentanyl)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Buccal Tablet",
        "alteration": "Place entire tablet in buccal cavity or under the tongue; tablet is not to be \nsplit, crushed, sucked, chewed, or swallowed whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021947s043lbl.pdf"
      }
    ],
    "form": "Bucca Tablet",
    "alteration": "Place entire tablet in buccal cavity or under the tongue; tablet is not to be \nsplit, crushed, sucked, chewed, or swallowed whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021947s043lbl.pdf"
  },
  {
    "id": "271",
    "name": "Ferrous Sulfate",
    "genericName": "Ferrous Sulfate",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": ""
      }
    ],
    "form": "Delayed Released Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": ""
  },
  {
    "id": "272",
    "name": "Fetzima (Levomilnacipran)",
    "genericName": "Fetzima (Levomilnacipran)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Swallow FETZIMA whole; do not open, chew, or crush the capsule",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204168s012lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Swallow FETZIMA whole; do not open, chew, or crush the capsule",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204168s012lbl.pdf"
  },
  {
    "id": "273",
    "name": "Fexinidazole",
    "genericName": "Fexinidazole",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not break or crush tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214429s003s004lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not break or crush tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214429s003s004lbl.pdf"
  },
  {
    "id": "274",
    "name": "Fenofibric Acid",
    "genericName": "Fenofibric Acid",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Advise patients to swallow FIBRICOR tablets whole. Do not crush, break, dissolve, or chew tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022418s020lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Advise patients to swallow FIBRICOR tablets whole. Do not crush, break, dissolve, or chew tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022418s020lbl.pdf"
  },
  {
    "id": "275",
    "name": "Fibricor (Fenofibric Acid)",
    "genericName": "Fibricor (Fenofibric Acid)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Advise patients to swallow FIBRICOR tablets whole. Do not crush, break, dissolve, or chew tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022418s020lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Advise patients to swallow FIBRICOR tablets whole. Do not crush, break, dissolve, or chew tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022418s020lbl.pdf"
  },
  {
    "id": "276",
    "name": "Fleet Laxative (Bisacodyl)",
    "genericName": "Fleet Laxative (Bisacodyl)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Enteric Coated Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": ""
      }
    ],
    "form": "Enteric Coated Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": ""
  },
  {
    "id": "277",
    "name": "Tamsulosin",
    "genericName": "Tamsulosin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Tamsulosin capsules should not be crushed, chewed or opened.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020579s033lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Tamsulosin capsules should not be crushed, chewed or opened.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020579s033lbl.pdf"
  },
  {
    "id": "278",
    "name": "Flomax",
    "genericName": "Flomax",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "FLOMAX capsules should not be crushed, chewed or opened.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020579s033lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "FLOMAX capsules should not be crushed, chewed or opened.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020579s033lbl.pdf"
  },
  {
    "id": "279",
    "name": "Fluoxetine",
    "genericName": "Fluoxetine",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/018936s76,20101s35,20974s8,21235s7,21520s12,21427s11lbl.pdf"
      },
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018936%20s112lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/018936s76,20101s35,20974s8,21235s7,21520s12,21427s11lbl.pdf"
  },
  {
    "id": "280",
    "name": "Prozac",
    "genericName": "Prozac",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018936%20s112lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018936%20s112lbl.pdf"
  },
  {
    "id": "281",
    "name": "Luvox Cr",
    "genericName": "Luvox Cr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Capsules should not be crushed or chewed.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022033lbl.pdf"
      }
    ],
    "form": "Extended Released Capsule",
    "alteration": "Capsules should not be crushed or chewed.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022033lbl.pdf"
  },
  {
    "id": "282",
    "name": "Fluvoxamine",
    "genericName": "Fluvoxamine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021519s026lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021519s026lbl.pdf"
  },
  {
    "id": "283",
    "name": "Fluvoxamine Er",
    "genericName": "Fluvoxamine Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Capsules should not be crushed or chewed.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022033lbl.pdf"
      }
    ],
    "form": "Extended Released Capsule",
    "alteration": "Capsules should not be crushed or chewed.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022033lbl.pdf"
  },
  {
    "id": "284",
    "name": "Forfivo Xl (Bupropion)",
    "genericName": "Forfivo Xl (Bupropion)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Swallow the tablet whole. Do not chew, divide, or crush",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022497s000lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Swallow the tablet whole. Do not chew, divide, or crush",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022497s000lbl.pdf"
  },
  {
    "id": "285",
    "name": "Fortamet (Metformin)",
    "genericName": "Fortamet (Metformin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Swallow FORTAMET tablets whole and never crush, cut or chew",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021574s017lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Swallow FORTAMET tablets whole and never crush, cut or chew",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021574s017lbl.pdf"
  },
  {
    "id": "286",
    "name": "Alendronate Sodium",
    "genericName": "Alendronate Sodium",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Mucous membrane irritant",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021575s017lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Mucous membrane irritant",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021575s017lbl.pdf"
  },
  {
    "id": "287",
    "name": "Fosamax",
    "genericName": "Fosamax",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Mucous membrane irritant",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021575s017lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Mucous membrane irritant",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021575s017lbl.pdf"
  },
  {
    "id": "288",
    "name": "Fosamax Plus D ( Alendronate And Cholecalciferol)",
    "genericName": "Fosamax Plus D ( Alendronate And Cholecalciferol)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Mucous membrane irritant",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212904s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Mucous membrane irritant",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212904s000lbl.pdf"
  },
  {
    "id": "289",
    "name": "Fotivda (Tivozanib)",
    "genericName": "Fotivda (Tivozanib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow the FOTIVDA capsule whole with a glass of water. Do not open the capsule.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212904s000lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow the FOTIVDA capsule whole with a glass of water. Do not open the capsule.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212904s000lbl.pdf"
  },
  {
    "id": "290",
    "name": "Galafold (Migalastat)",
    "genericName": "Galafold (Migalastat)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow capsule whole. Do not cut, crush, or chew the capsule.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208623s009lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow capsule whole. Do not cut, crush, or chew the capsule.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208623s009lbl.pdf"
  },
  {
    "id": "291",
    "name": "Galzin (Zin Acetate)",
    "genericName": "Galzin (Zin Acetate)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Manufacture recommendation, Possible gastric irritation",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020458s009lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Manufacture recommendation, Possible gastric irritation",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020458s009lbl.pdf"
  },
  {
    "id": "292",
    "name": "Sandiummne",
    "genericName": "Sandiummne",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Teratogenic potential, Hazardous Substance",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/050573s044,050574s057,050625s061lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Teratogenic potential, Hazardous Substance",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/050573s044,050574s057,050625s061lbl.pdf"
  },
  {
    "id": "293",
    "name": "Cyclosporine",
    "genericName": "Cyclosporine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Teratogenic potential, Hazardous Substance",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/050573s044,050574s057,050625s061lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Teratogenic potential, Hazardous Substance",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/050573s044,050574s057,050625s061lbl.pdf"
  },
  {
    "id": "294",
    "name": "Gengraf (Cyclosporine)",
    "genericName": "Gengraf (Cyclosporine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Teratogenic potential, Hazardous Substance",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/050573s044,050574s057,050625s061lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Teratogenic potential, Hazardous Substance",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/050573s044,050574s057,050625s061lbl.pdf"
  },
  {
    "id": "295",
    "name": "Ziprazidone",
    "genericName": "Ziprazidone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow capsules whole, do not open, crush, or chew the capsules.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020825s065,020919s053lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow capsules whole, do not open, crush, or chew the capsules.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020825s065,020919s053lbl.pdf"
  },
  {
    "id": "296",
    "name": "Geodon (Ziprazidone)",
    "genericName": "Geodon (Ziprazidone)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow capsules whole, do not open, crush, or chew the capsules.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020825s065,020919s053lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow capsules whole, do not open, crush, or chew the capsules.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020825s065,020919s053lbl.pdf"
  },
  {
    "id": "297",
    "name": "Giotrif (Afatinib)",
    "genericName": "Giotrif (Afatinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Canadian manufacture recommendation, hazrdous substance",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "Canadian manufacture recommendation, hazrdous substance",
    "reference": ""
  },
  {
    "id": "298",
    "name": "Gleevec (Imatinib)",
    "genericName": "Gleevec (Imatinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Gleevec can be  dissolved in water or apple juice for patients having difficulty swallowing",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021588s062lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Gleevec can be  dissolved in water or apple juice for patients having difficulty swallowing",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021588s062lbl.pdf"
  },
  {
    "id": "299",
    "name": "Gleostine (Lomustine)",
    "genericName": "Gleostine (Lomustine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Manufacture recommendation, Hazardous substance. Do not break Gleostine capsules; avoid exposure to broken capsules",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017588s043lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Manufacture recommendation, Hazardous substance. Do not break Gleostine capsules; avoid exposure to broken capsules",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017588s043lbl.pdf"
  },
  {
    "id": "300",
    "name": "Glipizide Xl",
    "genericName": "Glipizide Xl",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow the Glipizide XL whole. Do not break, crush, dissolve, chew, or cut the tablet in half",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020329s032lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow the Glipizide XL whole. Do not break, crush, dissolve, chew, or cut the tablet in half",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020329s032lbl.pdf"
  },
  {
    "id": "301",
    "name": "Glucotrol Xl (Glipizide)",
    "genericName": "Glucotrol Xl (Glipizide)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow the GLUCOTROL XL whole. Do not break, crush, dissolve, chew, or cut the tablet in half",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020329s032lbl.pdf"
      }
    ],
    "form": "Extended Released Tabllet",
    "alteration": "Swallow the GLUCOTROL XL whole. Do not break, crush, dissolve, chew, or cut the tablet in half",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020329s032lbl.pdf"
  },
  {
    "id": "302",
    "name": "Glipizide",
    "genericName": "Glipizide",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017783s026lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017783s026lbl.pdf"
  },
  {
    "id": "303",
    "name": "Glucotrol",
    "genericName": "Glucotrol",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017783s026lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017783s026lbl.pdf"
  },
  {
    "id": "304",
    "name": "Metformin Er",
    "genericName": "Metformin Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow GLUMETZA tablets whole and never crush, cut or chew.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021748s025lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow GLUMETZA tablets whole and never crush, cut or chew.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021748s025lbl.pdf"
  },
  {
    "id": "305",
    "name": "Glumetza (Metformin)",
    "genericName": "Glumetza (Metformin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow GLUMETZA tablets whole and never crush, cut or chew.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021748s025lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow GLUMETZA tablets whole and never crush, cut or chew.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021748s025lbl.pdf"
  },
  {
    "id": "306",
    "name": "Gocovri  (Amantadine)",
    "genericName": "Gocovri  (Amantadine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "GOCOVRI should be swallowed whole. Do not crush, chew or divide capsules. If needed, \nGOCOVRI may be administered by carefully opening and sprinkling the entire contents on a \nsmall amount (teaspoonful) of soft food, such as applesauce",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208944s009lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "GOCOVRI should be swallowed whole. Do not crush, chew or divide capsules. If needed, \nGOCOVRI may be administered by carefully opening and sprinkling the entire contents on a \nsmall amount (teaspoonful) of soft food, such as applesauce",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208944s009lbl.pdf"
  },
  {
    "id": "307",
    "name": "Gralise (Gabapentin)",
    "genericName": "Gralise (Gabapentin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "GRALISE tablets should be swallowed whole. Do not split, crush, or chew the tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022544s031lbl.pdf"
      }
    ],
    "form": "Extended Released tablet",
    "alteration": "GRALISE tablets should be swallowed whole. Do not split, crush, or chew the tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022544s031lbl.pdf"
  },
  {
    "id": "308",
    "name": "Guaifenesin And Pseudoephedrine",
    "genericName": "Guaifenesin And Pseudoephedrine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Slow release tablet",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "Slow release tablet",
    "reference": ""
  },
  {
    "id": "309",
    "name": "Halfprin (Aspirin)",
    "genericName": "Halfprin (Aspirin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Enteric Coated Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": ""
      }
    ],
    "form": "Enteric Coated Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": ""
  },
  {
    "id": "310",
    "name": "Harvoni Pellets",
    "genericName": "Harvoni Pellets",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Pellets",
        "alteration": "Do not chew HARVONI pellets. If HARVONI pellets are administered with food, sprinkle the pellets on one or more spoonfuls of non-acidic soft food at or below room temperature. Do not chew pellets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/205834s036,212477s006lbl.pdf"
      }
    ],
    "form": "Pellet",
    "alteration": "Do not chew HARVONI pellets. If HARVONI pellets are administered with food, sprinkle the pellets on one or more spoonfuls of non-acidic soft food at or below room temperature. Do not chew pellets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/205834s036,212477s006lbl.pdf"
  },
  {
    "id": "311",
    "name": "Harvoni (Ledipasvir And Sofosbuvir)",
    "genericName": "Harvoni (Ledipasvir And Sofosbuvir)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Pharmacokinetic and amorphous solid dispersion technology maybe affected",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/205834s036,212477s006lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Pharmacokinetic and amorphous solid dispersion technology maybe affected",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/205834s036,212477s006lbl.pdf"
  },
  {
    "id": "312",
    "name": "Hetlioz (Tasimelteon)",
    "genericName": "Hetlioz (Tasimelteon)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "To swallow the capsule whole.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205677s006lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "To swallow the capsule whole.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205677s006lbl.pdf"
  },
  {
    "id": "313",
    "name": "Holkira Pak (Ombitasvir, Paritaprevir, Ritonavir And Dasabuvir)",
    "genericName": "Holkira Pak (Ombitasvir, Paritaprevir, Ritonavir And Dasabuvir)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Canadian manufacture recommendation",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "Canadian manufacture recommendation",
    "reference": ""
  },
  {
    "id": "314",
    "name": "Horizant (Gabapentin)",
    "genericName": "Horizant (Gabapentin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Tablets should be swallowed whole and should not be cut, crushed, or chewed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022399s014lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Tablets should be swallowed whole and should not be cut, crushed, or chewed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022399s014lbl.pdf"
  },
  {
    "id": "315",
    "name": "Hycamtin (Topotecan)",
    "genericName": "Hycamtin (Topotecan)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow capsules whole. Do not chew, crush, or divide the capsules.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020981s008lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow capsules whole. Do not chew, crush, or divide the capsules.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020981s008lbl.pdf"
  },
  {
    "id": "316",
    "name": "Hydrea (Hydroxyurea)",
    "genericName": "Hydrea (Hydroxyurea)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow DROXIA capsules whole. Do NOT open, break, or chew capsules because DROXIA is \na cytotoxic drug.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016295s058lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow DROXIA capsules whole. Do NOT open, break, or chew capsules because DROXIA is \na cytotoxic drug.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016295s058lbl.pdf"
  },
  {
    "id": "317",
    "name": "Hydromorph Contin (Hydromorphone",
    "genericName": "Hydromorph Contin (Hydromorphone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "must be swallowed whole and not",
        "reference": ""
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "must be swallowed whole and not",
    "reference": ""
  },
  {
    "id": "318",
    "name": "Hydromorphone Er",
    "genericName": "Hydromorphone Er",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Instruct patients to swallow tablets intact, and not to cut, break, chew, crush, or dissolve the tablets (risk of potentially fatal overdose).",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021217s025lbl.pdf"
      },
      {
        "form": "Tablet",
        "alteration": "Instruct patients to swallow  tablets intact, and not to cut, break, chew, crush, or dissolve the tablets (risk of potentially fatal overdose)",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021217s025lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021217s025lbl.pdf"
  },
  {
    "id": "319",
    "name": "Hydrocodone Bitartrate Er",
    "genericName": "Hydrocodone Bitartrate Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "ER , tablet disruption may cause a potentially fatal overdose",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206627s015lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "ER , tablet disruption may cause a potentially fatal overdose",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206627s015lbl.pdf"
  },
  {
    "id": "320",
    "name": "Hysingla Er (Hydrocodone)",
    "genericName": "Hysingla Er (Hydrocodone)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "ER , tablet disruption may cause a potentially fatal overdose",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206627s015lbl.pdf"
      }
    ],
    "form": "Extended Releaesd Tablet",
    "alteration": "ER , tablet disruption may cause a potentially fatal overdose",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206627s015lbl.pdf"
  },
  {
    "id": "321",
    "name": "Ibrance (Palbociclib)",
    "genericName": "Ibrance (Palbociclib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "IBRANCE capsules should be swallowed whole (do not chew, crush, or open them prior to swallowing)",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/207103s021,212436s009lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "IBRANCE capsules should be swallowed whole (do not chew, crush, or open them prior to swallowing)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/207103s021,212436s009lbl.pdf"
  },
  {
    "id": "322",
    "name": "Ibsrela (Tenapanor)",
    "genericName": "Ibsrela (Tenapanor)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Canadian Manufac ture recommendation",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211801s014lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Canadian Manufac ture recommendation",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211801s014lbl.pdf"
  },
  {
    "id": "323",
    "name": "Iclusig (Ponatinib)",
    "genericName": "Iclusig (Ponatinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Manufacture recommendation. Swallow tablets whole. Do not crush, break, cut or chew tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/203469s037lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Manufacture recommendation. Swallow tablets whole. Do not crush, break, cut or chew tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/203469s037lbl.pdf"
  },
  {
    "id": "324",
    "name": "Idhifa (Enasidenib)",
    "genericName": "Idhifa (Enasidenib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Advise patients not to chew, split, or crush the tablets but swallow whole with a cup of water",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209606s007lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Advise patients not to chew, split, or crush the tablets but swallow whole with a cup of water",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209606s007lbl.pdf"
  },
  {
    "id": "325",
    "name": "Imbruvica (Ibrutinib)",
    "genericName": "Imbruvica (Ibrutinib)",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not open, break, or chew the capsules. Do not cut, crush, or chew the tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/205552s043,210563s019,217003s004lbl.pdf"
      },
      {
        "form": "Capsule",
        "alteration": "Do not open, break, or chew the capsules. Do not cut, crush, or chew the tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/205552s043,210563s019,217003s004lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/205552s043,210563s019,217003s004lbl.pdf"
  },
  {
    "id": "326",
    "name": "Imdur",
    "genericName": "Imdur",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Tablet should not be chewed or crushed and should be swallow whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/075155Orig1s034lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Tablet should not be chewed or crushed and should be swallow whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/075155Orig1s034lbl.pdf"
  },
  {
    "id": "327",
    "name": "Sumatriptan",
    "genericName": "Sumatriptan",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Take Sumatriptan tablets whole with water or other liquids",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020132s030lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Take Sumatriptan tablets whole with water or other liquids",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020132s030lbl.pdf"
  },
  {
    "id": "328",
    "name": "Imitrex (Sumatriptan)",
    "genericName": "Imitrex (Sumatriptan)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Take IMITREX tablets whole with water or other liquids",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020132s030lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Take IMITREX tablets whole with water or other liquids",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020132s030lbl.pdf"
  },
  {
    "id": "329",
    "name": "Impavido (Miltefosine)",
    "genericName": "Impavido (Miltefosine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "swallow the capsule whole and not to chew it or break it apart",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204684s007s008lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "swallow the capsule whole and not to chew it or break it apart",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204684s007s008lbl.pdf"
  },
  {
    "id": "330",
    "name": "Propranolol Er",
    "genericName": "Propranolol Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "swallow the capsule whole and not to chew it or break it apart",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018553Orig1s048s052lbl.pdf"
      }
    ],
    "form": "Extended Released Capsule",
    "alteration": "swallow the capsule whole and not to chew it or break it apart",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018553Orig1s048s052lbl.pdf"
  },
  {
    "id": "331",
    "name": "Inderal La",
    "genericName": "Inderal La",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "swallow the capsule whole and not to chew it or break it apart",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018553Orig1s048s052lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "swallow the capsule whole and not to chew it or break it apart",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018553Orig1s048s052lbl.pdf"
  },
  {
    "id": "332",
    "name": "Indomethacin Er",
    "genericName": "Indomethacin Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "must be swallowed whole and not",
        "reference": ""
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "must be swallowed whole and not",
    "reference": ""
  },
  {
    "id": "333",
    "name": "Inlyta (Axitinib)",
    "genericName": "Inlyta (Axitinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "chewed, cut, or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202324s016lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "chewed, cut, or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202324s016lbl.pdf"
  },
  {
    "id": "334",
    "name": "Innopran Xl (Propranolol)",
    "genericName": "Innopran Xl (Propranolol)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "must be swallowed whole and not",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021438s032lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "must be swallowed whole and not",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021438s032lbl.pdf"
  },
  {
    "id": "335",
    "name": "Inqovi (Decitabine And Cedazuridine)",
    "genericName": "Inqovi (Decitabine And Cedazuridine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "chewed, cut, or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212576s003lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "chewed, cut, or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212576s003lbl.pdf"
  },
  {
    "id": "336",
    "name": "Intelence( Etravirine)",
    "genericName": "Intelence( Etravirine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "swallow the INTELENCE tablet(s) whole with liquid such as water. Patients \nwho are unable to swallow the INTELENCE tablet(s) whole may disperse the tablet(s) in water.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022187s025lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "swallow the INTELENCE tablet(s) whole with liquid such as water. Patients \nwho are unable to swallow the INTELENCE tablet(s) whole may disperse the tablet(s) in water.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022187s025lbl.pdf"
  },
  {
    "id": "337",
    "name": "Intermezzo (Zolpidem)",
    "genericName": "Intermezzo (Zolpidem)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Sublingual Tablet",
        "alteration": "NTERMEZZO should be placed under the tongue and allowed to disintegrate completely before swallowing. The tablet should not be swallowed whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022328s008lbl.pdf"
      }
    ],
    "form": "Sublingual Tablet",
    "alteration": "NTERMEZZO should be placed under the tongue and allowed to disintegrate completely before swallowing. The tablet should not be swallowed whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022328s008lbl.pdf"
  },
  {
    "id": "338",
    "name": "Intuniv",
    "genericName": "Intuniv",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not crush, chew or break tablets before swallowing",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022037s019lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Do not crush, chew or break tablets before swallowing",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022037s019lbl.pdf"
  },
  {
    "id": "339",
    "name": "Guafanecine Er",
    "genericName": "Guafanecine Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not crush, chew or break tablets before swallowing",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022037s019lbl.pdf"
      }
    ],
    "form": "Extended Released Tablat",
    "alteration": "Do not crush, chew or break tablets before swallowing",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022037s019lbl.pdf"
  },
  {
    "id": "340",
    "name": "Invirase (Saquinavir)",
    "genericName": "Invirase (Saquinavir)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020628s047,021785s023lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020628s047,021785s023lbl.pdf"
  },
  {
    "id": "341",
    "name": "Invokamet Xr (Canagliflozin And Metformin)",
    "genericName": "Invokamet Xr (Canagliflozin And Metformin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow whole. Never crush, cut, or chew",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204353s045,205879s022lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow whole. Never crush, cut, or chew",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204353s045,205879s022lbl.pdf"
  },
  {
    "id": "342",
    "name": "Invokana (Canagliflozin)",
    "genericName": "Invokana (Canagliflozin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Canadian manufacture recommendation",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "Canadian manufacture recommendation",
    "reference": ""
  },
  {
    "id": "343",
    "name": "Iressa (Gefitinib)",
    "genericName": "Iressa (Gefitinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Immerse IRESSA tablets in 4 to 8 ounces of water by dropping the tablet in water, and stir for approximately 15 minutes. \nImmediately drink the liquid or administer through a naso-gastric tube. Rinse the container with 4 to 8 ounces of water \nand immediately drink or administer through the naso-gastric tube.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206995s004lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Immerse IRESSA tablets in 4 to 8 ounces of water by dropping the tablet in water, and stir for approximately 15 minutes. \nImmediately drink the liquid or administer through a naso-gastric tube. Rinse the container with 4 to 8 ounces of water \nand immediately drink or administer through the naso-gastric tube.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206995s004lbl.pdf"
  },
  {
    "id": "344",
    "name": "Isoptin Sr (Verapamil)",
    "genericName": "Isoptin Sr (Verapamil)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "ER tablet, Pharmacokinetic amorphous solid dispersion technology may be affected",
        "reference": ""
      }
    ],
    "form": "Extneded Released Tablet",
    "alteration": "ER tablet, Pharmacokinetic amorphous solid dispersion technology may be affected",
    "reference": ""
  },
  {
    "id": "345",
    "name": "Isosorbide Dinitrate Er",
    "genericName": "Isosorbide Dinitrate Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Tablet should not be chewed or crushed and should be swallow whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/075155Orig1s034lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Tablet should not be chewed or crushed and should be swallow whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/075155Orig1s034lbl.pdf"
  },
  {
    "id": "346",
    "name": "Isorosorbide Mononitrate Er",
    "genericName": "Isorosorbide Mononitrate Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Tablet should not be chewed or crushed and should be swallow whole",
        "reference": ""
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Tablet should not be chewed or crushed and should be swallow whole",
    "reference": ""
  },
  {
    "id": "347",
    "name": "Isradipine",
    "genericName": "Isradipine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Slow release",
        "reference": ""
      }
    ],
    "form": "Capsule",
    "alteration": "Slow release",
    "reference": ""
  },
  {
    "id": "348",
    "name": "Jakavi (Ruxolitinib)",
    "genericName": "Jakavi (Ruxolitinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow the tablets whole. Do not chew, break, or crush tablets",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow the tablets whole. Do not chew, break, or crush tablets",
    "reference": ""
  },
  {
    "id": "349",
    "name": "Jalyn (Dutasteride And Tamsulosin)",
    "genericName": "Jalyn (Dutasteride And Tamsulosin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow capsule whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022460Orig1s011lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow capsule whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022460Orig1s011lbl.pdf"
  },
  {
    "id": "350",
    "name": "Janumet Xr (Sitagliptin And Metformin)",
    "genericName": "Janumet Xr (Sitagliptin And Metformin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not split, crush or chew JANUMET XR tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202270s026lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Do not split, crush or chew JANUMET XR tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202270s026lbl.pdf"
  },
  {
    "id": "351",
    "name": "Jaypirca (Pirtobrutinib)",
    "genericName": "Jaypirca (Pirtobrutinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow whole  with water, with or without food. Do not cut, crush, or chew tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216059s002lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow whole  with water, with or without food. Do not cut, crush, or chew tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216059s002lbl.pdf"
  },
  {
    "id": "352",
    "name": "Jentadueto Xr (Linagliptin And Metformin)",
    "genericName": "Jentadueto Xr (Linagliptin And Metformin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow whole; do not split, crush, dissolve, or chew",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201281s035,208026s024lbl.pdf#page=24"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow whole; do not split, crush, dissolve, or chew",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201281s035,208026s024lbl.pdf#page=24"
  },
  {
    "id": "353",
    "name": "Jornay Pm (Methylphenidate)",
    "genericName": "Jornay Pm (Methylphenidate)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Capsules may be swallowed whole or opened and the entire contents sprinkled onto applesauce",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209311s010lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Capsules may be swallowed whole or opened and the entire contents sprinkled onto applesauce",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209311s010lbl.pdf"
  },
  {
    "id": "354",
    "name": "Juxtapid (Lomitapide)",
    "genericName": "Juxtapid (Lomitapide)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "swallow JUXTAPID\ncapsules whole. Capsules should not be opened, crushed, dissolved, or chewed.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203858s019lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "swallow JUXTAPID\ncapsules whole. Capsules should not be opened, crushed, dissolved, or chewed.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203858s019lbl.pdf"
  },
  {
    "id": "355",
    "name": "Kadian (Morphine)",
    "genericName": "Kadian (Morphine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "ER. Do not give via NG tubes. May add contents to applesauce without crushing. Capsule disruption may cause a potentially fatal overdose",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020616s025lbl.pdf"
      }
    ],
    "form": "Extended Released Capsule",
    "alteration": "ER. Do not give via NG tubes. May add contents to applesauce without crushing. Capsule disruption may cause a potentially fatal overdose",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020616s025lbl.pdf"
  },
  {
    "id": "356",
    "name": "Kaletra (Lopinavir And Ritonavir)",
    "genericName": "Kaletra (Lopinavir And Ritonavir)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Film coated . Pharmacokinetic amorphous solid dispersion technology maybe affected. Pregnant women or women who may become pregnant should not handle crushed or broken tablets. Active ingredients surrounded by wax matrix to prevent health care exposure",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021226s049lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Film coated . Pharmacokinetic amorphous solid dispersion technology maybe affected. Pregnant women or women who may become pregnant should not handle crushed or broken tablets. Active ingredients surrounded by wax matrix to prevent health care exposure",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021226s049lbl.pdf"
  },
  {
    "id": "357",
    "name": "Kalydeco (Ivacaftor)",
    "genericName": "Kalydeco (Ivacaftor)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Pharmacokinetic amorphous sollid dispersion technology maybe affected",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203188lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Pharmacokinetic amorphous sollid dispersion technology maybe affected",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203188lbl.pdf"
  },
  {
    "id": "358",
    "name": "Kapsargo Sprinkle (Metoprolol)",
    "genericName": "Kapsargo Sprinkle (Metoprolol)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "",
        "reference": ""
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "",
    "reference": ""
  },
  {
    "id": "359",
    "name": "Clonidine Er",
    "genericName": "Clonidine Er",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not crush, chew or break tablet before swallowing.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022331s021lbl.pdf"
      },
      {
        "form": "Tablet",
        "alteration": "Do not crush, chew or break tablet before swallowing",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022331s021lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022331s021lbl.pdf"
  },
  {
    "id": "360",
    "name": "Kapvay (Clonidine)",
    "genericName": "Kapvay (Clonidine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not crush, chew or break tablet before swallowing.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022331s021lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Do not crush, chew or break tablet before swallowing.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022331s021lbl.pdf"
  },
  {
    "id": "361",
    "name": "Kazano (Alogliptin And Metformin)",
    "genericName": "Kazano (Alogliptin And Metformin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "KAZANO tablets must \n15 not be split before swallowing.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203414s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "KAZANO tablets must \n15 not be split before swallowing.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203414s000lbl.pdf"
  },
  {
    "id": "362",
    "name": "K-Dur (Potassium Chloride)",
    "genericName": "K-Dur (Potassium Chloride)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Slow release",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "Slow release",
    "reference": ""
  },
  {
    "id": "363",
    "name": "Keppra Xr (Levetiracetam)",
    "genericName": "Keppra Xr (Levetiracetam)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow the tablets whole. Do not chew, break, or crush tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022285lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow the tablets whole. Do not chew, break, or crush tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022285lbl.pdf"
  },
  {
    "id": "364",
    "name": "Ketoprofen Er",
    "genericName": "Ketoprofen Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow the tablets whole. Do not chew, break, or crush tablets",
        "reference": ""
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow the tablets whole. Do not chew, break, or crush tablets",
    "reference": ""
  },
  {
    "id": "365",
    "name": "Khedezla (Desvenlafaxin)",
    "genericName": "Khedezla (Desvenlafaxin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Take tablets whole: Do not divide, crush, chew, or dissolve",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204683s000lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Take tablets whole: Do not divide, crush, chew, or dissolve",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204683s000lbl.pdf"
  },
  {
    "id": "366",
    "name": "Kisqali (Ribociclib)",
    "genericName": "Kisqali (Ribociclib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "KISQALI tablets should be swallowed whole (tablets should not be \nchewed, crushed or split prior to swallowing). No tablet should be ingested if it is broken, cracked, or otherwise not intact.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209092s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "KISQALI tablets should be swallowed whole (tablets should not be \nchewed, crushed or split prior to swallowing). No tablet should be ingested if it is broken, cracked, or otherwise not intact.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209092s000lbl.pdf"
  },
  {
    "id": "367",
    "name": "Kisqali Femara Co-Pack (Ribociclib And Letrozole)",
    "genericName": "Kisqali Femara Co-Pack (Ribociclib And Letrozole)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "KISQALI tablets should be swallowed whole (tablets should not be \nchewed, crushed or split prior to swallowing). No tablet should be ingested if it is broken, cracked, or otherwise not intact.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209935s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "KISQALI tablets should be swallowed whole (tablets should not be \nchewed, crushed or split prior to swallowing). No tablet should be ingested if it is broken, cracked, or otherwise not intact.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209935s000lbl.pdf"
  },
  {
    "id": "368",
    "name": "Potassium Chloride",
    "genericName": "Potassium Chloride",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Patients having difficulty swallowing whole tablets may try one of the following. Break the tablet in half, and take each half separately with a glass of water. Place the whole tablet(s) in approximately 1 /2 glass of water.",
        "reference": ""
      },
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": ""
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Multiple forms available (2 forms)",
    "reference": ""
  },
  {
    "id": "369",
    "name": "Klor-Con (Potassium Chloride)",
    "genericName": "Klor-Con (Potassium Chloride)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow tablets whole without crushing, chewing or sucking",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019123s036lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow tablets whole without crushing, chewing or sucking",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019123s036lbl.pdf"
  },
  {
    "id": "370",
    "name": "Klor-Con M (Potassium Chloride)",
    "genericName": "Klor-Con M (Potassium Chloride)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Slow release, some strengths are scored . To make liquid, place tablet in 120ml of water. Disperse 2 minutes, stir",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "Slow release, some strengths are scored . To make liquid, place tablet in 120ml of water. Disperse 2 minutes, stir",
    "reference": ""
  },
  {
    "id": "371",
    "name": "Klor-Con Sprinkle",
    "genericName": "Klor-Con Sprinkle",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "",
        "reference": ""
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "",
    "reference": ""
  },
  {
    "id": "372",
    "name": "K-Lyte/Cl (Potassium Bicarbonate And Potassium Chloride)",
    "genericName": "K-Lyte/Cl (Potassium Bicarbonate And Potassium Chloride)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Effervescent Tablet",
        "alteration": "",
        "reference": ""
      }
    ],
    "form": "Effervescent Tablet",
    "alteration": "",
    "reference": ""
  },
  {
    "id": "373",
    "name": "Kombiglyze Xr (Saxagliptin And Metformin)",
    "genericName": "Kombiglyze Xr (Saxagliptin And Metformin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow whole. Never crush, cut, or chew",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/200678s000lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow whole. Never crush, cut, or chew",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/200678s000lbl.pdf"
  },
  {
    "id": "374",
    "name": "Korlym (Mifepristone)",
    "genericName": "Korlym (Mifepristone)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow KORLYM whole. Do not split, crush or chew KORLYM tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202107s008lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow KORLYM whole. Do not split, crush or chew KORLYM tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202107s008lbl.pdf"
  },
  {
    "id": "375",
    "name": "Koselugo (Selumetinib)",
    "genericName": "Koselugo (Selumetinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow KOSELUGO capsules whole with water. Do not chew, dissolve or open capsule.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/213756s004lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow KOSELUGO capsules whole with water. Do not chew, dissolve or open capsule.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/213756s004lbl.pdf"
  },
  {
    "id": "376",
    "name": "Krazati (Adagrasib)",
    "genericName": "Krazati (Adagrasib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow tablets whole with or without food",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216340s005lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow tablets whole with or without food",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216340s005lbl.pdf"
  },
  {
    "id": "377",
    "name": "Krintafel (Tafenoquine)",
    "genericName": "Krintafel (Tafenoquine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow tablets whole. Do not break, crush, or chew the tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210795s001lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow tablets whole. Do not break, crush, or chew the tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210795s001lbl.pdf"
  },
  {
    "id": "378",
    "name": "K-Tab (Potassium Chloride)",
    "genericName": "K-Tab (Potassium Chloride)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow tablets whole without crushing, chewing or sucking.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018279Orig1s037lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow tablets whole without crushing, chewing or sucking.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018279Orig1s037lbl.pdf"
  },
  {
    "id": "379",
    "name": "Lamotrigine Er",
    "genericName": "Lamotrigine Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Tablets must be swallowed whole and must not be chewed, crushed, or divided.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022115s031s032lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Tablets must be swallowed whole and must not be chewed, crushed, or divided.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022115s031s032lbl.pdf"
  },
  {
    "id": "380",
    "name": "Lamictal Xr (Lanitrigine)",
    "genericName": "Lamictal Xr (Lanitrigine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Tablets must be swallowed whole and must not be chewed, crushed, or divided.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022115s031s032lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Tablets must be swallowed whole and must not be chewed, crushed, or divided.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022115s031s032lbl.pdf"
  },
  {
    "id": "381",
    "name": "Lurasidone",
    "genericName": "Lurasidone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/200603s041lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/200603s041lbl.pdf"
  },
  {
    "id": "382",
    "name": "Latuda (Lurasidone)",
    "genericName": "Latuda (Lurasidone)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/200603s041lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/200603s041lbl.pdf"
  },
  {
    "id": "383",
    "name": "Lenvima (Lenvatinib)",
    "genericName": "Lenvima (Lenvatinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow LENVIMA capsules whole at the same time each day with or without food \n[see Clinical Pharmacology (12.3)]. Do not crush or chew the LENVIMA capsules. Can compound into suspension.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/206947s032lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow LENVIMA capsules whole at the same time each day with or without food \n[see Clinical Pharmacology (12.3)]. Do not crush or chew the LENVIMA capsules. Can compound into suspension.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/206947s032lbl.pdf"
  },
  {
    "id": "384",
    "name": "Fluvastatin",
    "genericName": "Fluvastatin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020261s052,021192s026lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020261s052,021192s026lbl.pdf"
  },
  {
    "id": "385",
    "name": "Lescol",
    "genericName": "Lescol",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020261s052,021192s026lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020261s052,021192s026lbl.pdf"
  },
  {
    "id": "386",
    "name": "Lescol Xl (Fluvastatin)",
    "genericName": "Lescol Xl (Fluvastatin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not break, crush or chew LESCOL XL tablets prior to administration",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021192s029lbl.pdf"
      }
    ],
    "form": "Extended Released tablet",
    "alteration": "Do not break, crush or chew LESCOL XL tablets prior to administration",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021192s029lbl.pdf"
  },
  {
    "id": "387",
    "name": "Letairis (Ambrisentan)",
    "genericName": "Letairis (Ambrisentan)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not split, crush, or chew tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022081s041lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not split, crush, or chew tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022081s041lbl.pdf"
  },
  {
    "id": "388",
    "name": "Leukeran (Chlorambucil)",
    "genericName": "Leukeran (Chlorambucil)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Hazardous Substance",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/010669s032lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Hazardous Substance",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/010669s032lbl.pdf"
  },
  {
    "id": "389",
    "name": "Levbid (Hyoscyamine)",
    "genericName": "Levbid (Hyoscyamine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": ""
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": ""
  },
  {
    "id": "390",
    "name": "Linaclotide",
    "genericName": "Linaclotide",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Do not crush or chew LINZESS capsule or capsule contents",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202811s021lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Do not crush or chew LINZESS capsule or capsule contents",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202811s021lbl.pdf"
  },
  {
    "id": "391",
    "name": "Linzess (Linaclotide)",
    "genericName": "Linzess (Linaclotide)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Do not crush or chew LINZESS capsule or capsule contents",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202811s021lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Do not crush or chew LINZESS capsule or capsule contents",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202811s021lbl.pdf"
  },
  {
    "id": "392",
    "name": "Lipidil Ez (Fenofibrate)",
    "genericName": "Lipidil Ez (Fenofibrate)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Film-coated, Manufacturer recommendation",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/19304-S005_Tricor_prntlbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Film-coated, Manufacturer recommendation",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/19304-S005_Tricor_prntlbl.pdf"
  },
  {
    "id": "393",
    "name": "Lipitor (Atorvastatin)",
    "genericName": "Lipitor (Atorvastatin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020702s081lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020702s081lbl.pdf"
  },
  {
    "id": "394",
    "name": "Lithium Carbonate Er",
    "genericName": "Lithium Carbonate Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Tablets must be swallowed whole and never chewed or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018027s069lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Tablets must be swallowed whole and never chewed or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018027s069lbl.pdf"
  },
  {
    "id": "395",
    "name": "Lithobid (Lithium)",
    "genericName": "Lithobid (Lithium)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "LITHOBID® Extended-Release Tablets must be swallowed whole and never chewed or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018027s069lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "LITHOBID® Extended-Release Tablets must be swallowed whole and never chewed or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018027s069lbl.pdf"
  },
  {
    "id": "396",
    "name": "Lonsurf (Trifluridine And Tipiracil)",
    "genericName": "Lonsurf (Trifluridine And Tipiracil)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Instruct patients to swallow LONSURF tablets whole.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207981s012lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Instruct patients to swallow LONSURF tablets whole.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207981s012lbl.pdf"
  },
  {
    "id": "397",
    "name": "Lorbrena (Lorlatinib)",
    "genericName": "Lorbrena (Lorlatinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow tablets whole. Do not chew, crush or split tablets. Do not ingest if tablets are broken, cracked, or \notherwise not intact.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210868s004lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow tablets whole. Do not chew, crush or split tablets. Do not ingest if tablets are broken, cracked, or \notherwise not intact.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210868s004lbl.pdf"
  },
  {
    "id": "398",
    "name": "Lovaza (Omega-3 Fatty Acids)",
    "genericName": "Lovaza (Omega-3 Fatty Acids)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Patients should be advised to swallow LOVAZA capsules whole. Do not \nbreak open, crush, dissolve, or chew LOVAZA",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021654s044lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Patients should be advised to swallow LOVAZA capsules whole. Do not \nbreak open, crush, dissolve, or chew LOVAZA",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021654s044lbl.pdf"
  },
  {
    "id": "399",
    "name": "Lumakras (Sotorasib)",
    "genericName": "Lumakras (Sotorasib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow tablets whole with or without food",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/214665Orig1s009correctedlbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow tablets whole with or without food",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/214665Orig1s009correctedlbl.pdf"
  },
  {
    "id": "400",
    "name": "Lupkynis (Voclosporin)",
    "genericName": "Lupkynis (Voclosporin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "LUPKYNIS must be swallowed whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/213716s004lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "LUPKYNIS must be swallowed whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/213716s004lbl.pdf"
  },
  {
    "id": "401",
    "name": "Lybalvi (Olanzapine And Samidorphan)",
    "genericName": "Lybalvi (Olanzapine And Samidorphan)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not divide tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/213378s008lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not divide tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/213378s008lbl.pdf"
  },
  {
    "id": "402",
    "name": "Lynparza (Olaparib)",
    "genericName": "Lynparza (Olaparib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow Lynparza capsules whole. Do not chew, dissolve, or open the capsules",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206162s011lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow Lynparza capsules whole. Do not chew, dissolve, or open the capsules",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206162s011lbl.pdf"
  },
  {
    "id": "403",
    "name": "Pregabalin",
    "genericName": "Pregabalin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021446s046,022488s022lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021446s046,022488s022lbl.pdf"
  },
  {
    "id": "404",
    "name": "Lyrica",
    "genericName": "Lyrica",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021446s046,022488s022lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021446s046,022488s022lbl.pdf"
  },
  {
    "id": "405",
    "name": "Lyrica Cr (Pregabalin)",
    "genericName": "Lyrica Cr (Pregabalin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "It should be swallowed whole and should not be split, crushed, or chewed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209501s010lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "It should be swallowed whole and should not be split, crushed, or chewed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209501s010lbl.pdf"
  },
  {
    "id": "406",
    "name": "Lytgobi (Futibatinib)",
    "genericName": "Lytgobi (Futibatinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow tablets whole. Do not crush, chew, split, or dissolve tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214801s002lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow tablets whole. Do not crush, chew, split, or dissolve tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214801s002lbl.pdf"
  },
  {
    "id": "407",
    "name": "Macrobid (Nitrofurantoin)",
    "genericName": "Macrobid (Nitrofurantoin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020064Orig1s029lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020064Orig1s029lbl.pdf"
  },
  {
    "id": "408",
    "name": "Mag-Tab Sr (Magnesium L-Lactate)",
    "genericName": "Mag-Tab Sr (Magnesium L-Lactate)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow tablets whole. Do not crush, chew, split, or dissolve tablets.",
        "reference": ""
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow tablets whole. Do not crush, chew, split, or dissolve tablets.",
    "reference": ""
  },
  {
    "id": "409",
    "name": "Matulane (Procarbazine)",
    "genericName": "Matulane (Procarbazine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Hazardous Substance",
        "reference": ""
      }
    ],
    "form": "Capsule",
    "alteration": "Hazardous Substance",
    "reference": ""
  },
  {
    "id": "410",
    "name": "Mavenclad (Cladribine)",
    "genericName": "Mavenclad (Cladribine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "MAVENCLAD is a cytotoxic drug.  MAVENCLAD tablets are taken orally, with water, and swallowed whole without chewing.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022561s011lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "MAVENCLAD is a cytotoxic drug.  MAVENCLAD tablets are taken orally, with water, and swallowed whole without chewing.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022561s011lbl.pdf"
  },
  {
    "id": "411",
    "name": "Mavyret",
    "genericName": "Mavyret",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Pellets",
        "alteration": "The oral pellets should be taken together, with food, once daily. In addition, the oral pellets for the total daily dose should be sprinkled on a small amount of soft food with a low water content that will stick to a spoon and should be swallowed without chewing",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209394s019,215110s005lbl.pdf"
      }
    ],
    "form": "Pellets",
    "alteration": "The oral pellets should be taken together, with food, once daily. In addition, the oral pellets for the total daily dose should be sprinkled on a small amount of soft food with a low water content that will stick to a spoon and should be swallowed without chewing",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209394s019,215110s005lbl.pdf"
  },
  {
    "id": "412",
    "name": "Mavyret (Glecaprevir And Pibrentasvir)",
    "genericName": "Mavyret (Glecaprevir And Pibrentasvir)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Pharmacokinetic amorphous solid dispersion technology maybe affected",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209394s019,215110s005lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Pharmacokinetic amorphous solid dispersion technology maybe affected",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209394s019,215110s005lbl.pdf"
  },
  {
    "id": "413",
    "name": "Mayzent (Siponimod)",
    "genericName": "Mayzent (Siponimod)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not split, crush, or chew MAYZENT tablets; take tablets whole.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209884s019lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not split, crush, or chew MAYZENT tablets; take tablets whole.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209884s019lbl.pdf"
  },
  {
    "id": "414",
    "name": "Mestinon Er (Pyridostigmine)",
    "genericName": "Mestinon Er (Pyridostigmine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "must be swallowed whole and not",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/15193s18lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "must be swallowed whole and not",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/15193s18lbl.pdf"
  },
  {
    "id": "415",
    "name": "Metadate Cd (Methylphenidate)",
    "genericName": "Metadate Cd (Methylphenidate)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "chewed, cut, or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021259s034lbl.pdf"
      }
    ],
    "form": "Extended Released Capsule",
    "alteration": "chewed, cut, or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021259s034lbl.pdf"
  },
  {
    "id": "416",
    "name": "Metadate Er (Methylphenidate)",
    "genericName": "Metadate Er (Methylphenidate)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Discontinue medication",
        "reference": ""
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Discontinue medication",
    "reference": ""
  },
  {
    "id": "417",
    "name": "Methylin Er (Methylphenidate)",
    "genericName": "Methylin Er (Methylphenidate)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Extended released Tablet. Do not alter tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/75-629_Mythylphenidate%20Hydrochloride.pdf"
      }
    ],
    "form": "Extended Released tablet",
    "alteration": "Extended released Tablet. Do not alter tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/75-629_Mythylphenidate%20Hydrochloride.pdf"
  },
  {
    "id": "418",
    "name": "Methylphenidate Er Tablet",
    "genericName": "Methylphenidate Er Tablet",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Extended released Tablet. Do not alter tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/75-629_Mythylphenidate%20Hydrochloride.pdf"
      }
    ],
    "form": "Extended Released tablet",
    "alteration": "Extended released Tablet. Do not alter tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/75-629_Mythylphenidate%20Hydrochloride.pdf"
  },
  {
    "id": "419",
    "name": "Micro-K (Potassium Chloride)",
    "genericName": "Micro-K (Potassium Chloride)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Patients who have difficulty swallowing capsules may sprinkle the contents of the capsule onto a spoonful of soft food. The soft food, such as applesauce or pudding, should be swallowed immediately without chewing and followed with a glass of water or juice to ensure complete swallowing of the microcapsules. Do not added to hot foods. Any microcapsule/food mixture should be used immediately and not stored for future use.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018238s046lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Patients who have difficulty swallowing capsules may sprinkle the contents of the capsule onto a spoonful of soft food. The soft food, such as applesauce or pudding, should be swallowed immediately without chewing and followed with a glass of water or juice to ensure complete swallowing of the microcapsules. Do not added to hot foods. Any microcapsule/food mixture should be used immediately and not stored for future use.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018238s046lbl.pdf"
  },
  {
    "id": "420",
    "name": "Minocin (Minocycline)",
    "genericName": "Minocin (Minocycline)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Mucous membrane irritant, slow release",
        "reference": ""
      }
    ],
    "form": "Capsule",
    "alteration": "Mucous membrane irritant, slow release",
    "reference": ""
  },
  {
    "id": "421",
    "name": "Minolira (Minocycline)",
    "genericName": "Minolira (Minocycline)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not chew or crush tablet.",
        "reference": ""
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Do not chew or crush tablet.",
    "reference": ""
  },
  {
    "id": "422",
    "name": "Pramipexole",
    "genericName": "Pramipexole",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020667s044lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020667s044lbl.pdf"
  },
  {
    "id": "423",
    "name": "Mirapex",
    "genericName": "Mirapex",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020667s044lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020667s044lbl.pdf"
  },
  {
    "id": "424",
    "name": "Pramipexole Er",
    "genericName": "Pramipexole Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Tablets must be swallowed whole and must not be chewed, crushed, or divided",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022421s023lbl.pdf"
      }
    ],
    "form": "Extended released Tablet",
    "alteration": "Tablets must be swallowed whole and must not be chewed, crushed, or divided",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022421s023lbl.pdf"
  },
  {
    "id": "425",
    "name": "Mirapex Er (Pramipexole)",
    "genericName": "Mirapex Er (Pramipexole)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Tablets must be swallowed whole and must not be chewed, crushed, or divided",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022421s023lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Tablets must be swallowed whole and must not be chewed, crushed, or divided",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022421s023lbl.pdf"
  },
  {
    "id": "426",
    "name": "Morphabond (Morphine)",
    "genericName": "Morphabond (Morphine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "ER, tablet disruption may cause a potentially fatal overdose",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206544lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "ER, tablet disruption may cause a potentially fatal overdose",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206544lbl.pdf"
  },
  {
    "id": "427",
    "name": "Morphine Sulfate Extended Release",
    "genericName": "Morphine Sulfate Extended Release",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "ER, tablet disruption may cause a potentially fatal overdose",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206544lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "ER, tablet disruption may cause a potentially fatal overdose",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206544lbl.pdf"
  },
  {
    "id": "428",
    "name": "Motrin (Ibuprofen)",
    "genericName": "Motrin (Ibuprofen)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Taste. Manufacture does not have recommendation",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/017463s105lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Taste. Manufacture does not have recommendation",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/017463s105lbl.pdf"
  },
  {
    "id": "429",
    "name": "Amoxicillin Er Tablet",
    "genericName": "Amoxicillin Er Tablet",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not chew or crush tablet.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/050813s010lbl.pdf"
      }
    ],
    "form": "Extended Release Tablet",
    "alteration": "Do not chew or crush tablet.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/050813s010lbl.pdf"
  },
  {
    "id": "430",
    "name": "Moxatag (Amoxicillin)",
    "genericName": "Moxatag (Amoxicillin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not chew or crush tablet.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/050813s010lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Do not chew or crush tablet.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/050813s010lbl.pdf"
  },
  {
    "id": "431",
    "name": "Ms Contin (Morphine)",
    "genericName": "Ms Contin (Morphine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "ER, tablet disruption may cause a potentially fatal overdose",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019516s058lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "ER, tablet disruption may cause a potentially fatal overdose",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019516s058lbl.pdf"
  },
  {
    "id": "432",
    "name": "Mucinex (Guaifenesin)",
    "genericName": "Mucinex (Guaifenesin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not crush chew tablet. Take as a whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021282Orig1s055lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not crush chew tablet. Take as a whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021282Orig1s055lbl.pdf"
  },
  {
    "id": "433",
    "name": "Mucinex Dm (Guaifenesin)",
    "genericName": "Mucinex Dm (Guaifenesin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not crush chew tablet. Take as a whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021282Orig1s055lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not crush chew tablet. Take as a whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021282Orig1s055lbl.pdf"
  },
  {
    "id": "434",
    "name": "Multaq (Dronedadrone)",
    "genericName": "Multaq (Dronedadrone)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Hazardous substance. Take as a whole tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022425s028s030lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Hazardous substance. Take as a whole tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022425s028s030lbl.pdf"
  },
  {
    "id": "435",
    "name": "Mycapssa (Octreotide)",
    "genericName": "Mycapssa (Octreotide)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Swallow MYCAPSSA capsules whole. Do not crush or chew the capsules",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/208232s006lbl.pdf"
      }
    ],
    "form": "Delayed Released Capsule",
    "alteration": "Swallow MYCAPSSA capsules whole. Do not crush or chew the capsules",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/208232s006lbl.pdf"
  },
  {
    "id": "436",
    "name": "Mydayis (Dextroamphetamine And Amphetamine)",
    "genericName": "Mydayis (Dextroamphetamine And Amphetamine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Swallow MYDAYIS capsules whole, or • Open capsule and sprinkle the entire contents over a spoonful of applesauce. The sprinkled applesauce should be consumed immediately; it should not be stored. Patients should take the sprinkled applesauce in its entirety without chewing.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022063s005lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Swallow MYDAYIS capsules whole, or • Open capsule and sprinkle the entire contents over a spoonful of applesauce. The sprinkled applesauce should be consumed immediately; it should not be stored. Patients should take the sprinkled applesauce in its entirety without chewing.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022063s005lbl.pdf"
  },
  {
    "id": "437",
    "name": "Myfortic (Mycophenolate)",
    "genericName": "Myfortic (Mycophenolate)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Tablet",
        "alteration": "Do not crush, chew, or cut tablet prior to ingestion.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/050791s040lbl.pdf"
      }
    ],
    "form": "Delayed Released Tablet",
    "alteration": "Do not crush, chew, or cut tablet prior to ingestion.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/050791s040lbl.pdf"
  },
  {
    "id": "438",
    "name": "Myorisan (Isotretinoin)",
    "genericName": "Myorisan (Isotretinoin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Mucous membrane irritant, teratogenic potential",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/anda/2012/076485Orig1s003.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Mucous membrane irritant, teratogenic potential",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/anda/2012/076485Orig1s003.pdf"
  },
  {
    "id": "439",
    "name": "Mirabegron",
    "genericName": "Mirabegron",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow whole with water, do not chew, divide or crush",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202611s000lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow whole with water, do not chew, divide or crush",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202611s000lbl.pdf"
  },
  {
    "id": "440",
    "name": "Myrbertriq (Mirabegron)",
    "genericName": "Myrbertriq (Mirabegron)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow whole with water, do not chew, divide or crush",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202611s000lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow whole with water, do not chew, divide or crush",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202611s000lbl.pdf"
  },
  {
    "id": "441",
    "name": "Mytesi (Crofelemer)",
    "genericName": "Mytesi (Crofelemer)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Tablet",
        "alteration": "FULYZAQ tablets should not be crushed or chewed. Tablets should be swallowed whole.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202292s000lbl.pdf"
      }
    ],
    "form": "Delayed Released Tablet",
    "alteration": "FULYZAQ tablets should not be crushed or chewed. Tablets should be swallowed whole.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202292s000lbl.pdf"
  },
  {
    "id": "442",
    "name": "Memantine",
    "genericName": "Memantine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021487s025lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021487s025lbl.pdf"
  },
  {
    "id": "443",
    "name": "Namenda",
    "genericName": "Namenda",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021487s025lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021487s025lbl.pdf"
  },
  {
    "id": "444",
    "name": "Memantine Er Capsule",
    "genericName": "Memantine Er Capsule",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "NAMENDA XR capsules can be taken intact or may be opened, sprinkled on applesauce, and thereby swallowed. when opened and sprinkled on applesauce, as described above, NAMENDA XR\nshould be swallowed whole. NAMENDA XR capsules should not be divided, chewed, or\ncrushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022525s015lbl.pdf"
      }
    ],
    "form": "Extended Released Capsule",
    "alteration": "NAMENDA XR capsules can be taken intact or may be opened, sprinkled on applesauce, and thereby swallowed. when opened and sprinkled on applesauce, as described above, NAMENDA XR\nshould be swallowed whole. NAMENDA XR capsules should not be divided, chewed, or\ncrushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022525s015lbl.pdf"
  },
  {
    "id": "445",
    "name": "Nameda Xr (Memantine)",
    "genericName": "Nameda Xr (Memantine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "NAMENDA XR capsules can be taken intact or may be opened, sprinkled on applesauce, and thereby swallowed. when opened and sprinkled on applesauce, as described above, NAMENDA XR\nshould be swallowed whole. NAMENDA XR capsules should not be divided, chewed, or\ncrushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022525s015lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "NAMENDA XR capsules can be taken intact or may be opened, sprinkled on applesauce, and thereby swallowed. when opened and sprinkled on applesauce, as described above, NAMENDA XR\nshould be swallowed whole. NAMENDA XR capsules should not be divided, chewed, or\ncrushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022525s015lbl.pdf"
  },
  {
    "id": "446",
    "name": "Namzaric (Memantine And Donepezil)",
    "genericName": "Namzaric (Memantine And Donepezil)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "NAMZARIC can be taken with or without food, whole or sprinkled on \napplesauce; do not divide, chew, or crush",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206439s003lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "NAMZARIC can be taken with or without food, whole or sprinkled on \napplesauce; do not divide, chew, or crush",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206439s003lbl.pdf"
  },
  {
    "id": "447",
    "name": "Naprelan (Naproxen)",
    "genericName": "Naprelan (Naproxen)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Extended released Tablet. Do not alter tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020353s041lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Extended released Tablet. Do not alter tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020353s041lbl.pdf"
  },
  {
    "id": "448",
    "name": "Neoral (Cyclosporine)",
    "genericName": "Neoral (Cyclosporine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Teratogenic potential, hazardous substance",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/050715s041,050716s041,050735s003,050736s001,050737s003,050738s001lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Teratogenic potential, hazardous substance",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/050715s041,050716s041,050735s003,050736s001,050737s003,050738s001lbl.pdf"
  },
  {
    "id": "449",
    "name": "Nerlynx (Neratinib)",
    "genericName": "Nerlynx (Neratinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "NERLYNX tablets should be \nswallowed whole (tablets should not be chewed, crushed, or split prior to swallowing).",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208051s009lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "NERLYNX tablets should be \nswallowed whole (tablets should not be chewed, crushed, or split prior to swallowing).",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208051s009lbl.pdf"
  },
  {
    "id": "450",
    "name": "Alogliptin",
    "genericName": "Alogliptin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Film Coated Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022271s013lbl.pdf"
      }
    ],
    "form": "Film-coated Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022271s013lbl.pdf"
  },
  {
    "id": "451",
    "name": "Nesina (Alogliptin)",
    "genericName": "Nesina (Alogliptin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Film Coated Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022271s013lbl.pdf"
      }
    ],
    "form": "Film-Coated Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022271s013lbl.pdf"
  },
  {
    "id": "452",
    "name": "Neurotin (Gabapentin)",
    "genericName": "Neurotin (Gabapentin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "NEURONTIN capsules should be swallowed whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020235s079,020882s060,021129s059lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "NEURONTIN capsules should be swallowed whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020235s079,020882s060,021129s059lbl.pdf"
  },
  {
    "id": "453",
    "name": "Gabapentin",
    "genericName": "Gabapentin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "NEURONTIN capsules should be swallowed whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020235s079,020882s060,021129s059lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "NEURONTIN capsules should be swallowed whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020235s079,020882s060,021129s059lbl.pdf"
  },
  {
    "id": "454",
    "name": "Esomeprazole",
    "genericName": "Esomeprazole",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Swallow NEXIUM delayed-release capsules whole; do not chew or crush the capsules.For patients who have difficulty swallowing capsules, NEXIUM delayed-release capsules can be opened, and \nthe contents sprinkled on applesauce.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021153s060,021957s027,022101s024lbl.pdf"
      }
    ],
    "form": "Delayed Released Capsule",
    "alteration": "Swallow NEXIUM delayed-release capsules whole; do not chew or crush the capsules.For patients who have difficulty swallowing capsules, NEXIUM delayed-release capsules can be opened, and \nthe contents sprinkled on applesauce.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021153s060,021957s027,022101s024lbl.pdf"
  },
  {
    "id": "455",
    "name": "Nexium (Esomeprazole)",
    "genericName": "Nexium (Esomeprazole)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Swallow NEXIUM delayed-release capsules whole; do not chew or crush the capsules.For patients who have difficulty swallowing capsules, NEXIUM delayed-release capsules can be opened, and \nthe contents sprinkled on applesauce.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021153s060,021957s027,022101s024lbl.pdf"
      }
    ],
    "form": "Delayed Released Capsule",
    "alteration": "Swallow NEXIUM delayed-release capsules whole; do not chew or crush the capsules.For patients who have difficulty swallowing capsules, NEXIUM delayed-release capsules can be opened, and \nthe contents sprinkled on applesauce.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021153s060,021957s027,022101s024lbl.pdf"
  },
  {
    "id": "456",
    "name": "Niacin",
    "genericName": "Niacin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Niacin tablets should not be broken, crushed or chewed, but should be swallowed whole.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020381s055lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Niacin tablets should not be broken, crushed or chewed, but should be swallowed whole.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020381s055lbl.pdf"
  },
  {
    "id": "457",
    "name": "Niaspan (Niacin)",
    "genericName": "Niaspan (Niacin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "NIASPAN tablets should not be broken, crushed or chewed, but should be swallowed whole.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020381s055lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "NIASPAN tablets should not be broken, crushed or chewed, but should be swallowed whole.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020381s055lbl.pdf"
  },
  {
    "id": "458",
    "name": "Nimotop (Nimodipine)",
    "genericName": "Nimotop (Nimodipine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/018869s014lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/018869s014lbl.pdf"
  },
  {
    "id": "459",
    "name": "Ninlaro (Ixazomib)",
    "genericName": "Ninlaro (Ixazomib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "The whole capsule should be swallowed with water. The capsule should not \nbe crushed, chewed or opened",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/208462s017lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "The whole capsule should be swallowed with water. The capsule should not \nbe crushed, chewed or opened",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/208462s017lbl.pdf"
  },
  {
    "id": "460",
    "name": "Nitroglycerin",
    "genericName": "Nitroglycerin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Sublingual Tablet",
        "alteration": "Allow tablet to dissolve under the tongue without swallowing",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021134s010lbl.pdf"
      }
    ],
    "form": "Sublingual Tablet",
    "alteration": "Allow tablet to dissolve under the tongue without swallowing",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021134s010lbl.pdf"
  },
  {
    "id": "461",
    "name": "Nitrostat (Nitrogylcerin)",
    "genericName": "Nitrostat (Nitrogylcerin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Sublingual Tablet",
        "alteration": "Allow tablet to dissolve under the tongue without swallowing",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021134s010lbl.pdf"
      }
    ],
    "form": "Sublingual Tablet",
    "alteration": "Allow tablet to dissolve under the tongue without swallowing",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021134s010lbl.pdf"
  },
  {
    "id": "462",
    "name": "Desmopressin",
    "genericName": "Desmopressin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021795s006lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021795s006lbl.pdf"
  },
  {
    "id": "463",
    "name": "Nocdurna (Desmopressin)",
    "genericName": "Nocdurna (Desmopressin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Sublingual Tablet",
        "alteration": "Keep the tablet under the tongue until it has fully dissolved.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022517s000lbl.pdf"
      }
    ],
    "form": "Sublingual Tablet",
    "alteration": "Keep the tablet under the tongue until it has fully dissolved.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022517s000lbl.pdf"
  },
  {
    "id": "464",
    "name": "Norpace Cr (Disopyramide)",
    "genericName": "Norpace Cr (Disopyramide)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Take as a whole",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e2aa1642-d262-4520-bc6a-9fd3ad795677"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Take as a whole",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e2aa1642-d262-4520-bc6a-9fd3ad795677"
  },
  {
    "id": "465",
    "name": "Disopyramide Phosphate",
    "genericName": "Disopyramide Phosphate",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Take as a whole",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e2aa1642-d262-4520-bc6a-9fd3ad795677"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Take as a whole",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e2aa1642-d262-4520-bc6a-9fd3ad795677"
  },
  {
    "id": "466",
    "name": "Droxidopa",
    "genericName": "Droxidopa",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Take Droxidopa capsule whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203202s007lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Take Droxidopa capsule whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203202s007lbl.pdf"
  },
  {
    "id": "467",
    "name": "Northera (Droxidopa)",
    "genericName": "Northera (Droxidopa)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Take NORTHERA capsule whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203202s007lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Take NORTHERA capsule whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203202s007lbl.pdf"
  },
  {
    "id": "468",
    "name": "Norvir (Ritonavir)",
    "genericName": "Norvir (Ritonavir)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Decreased bioavailability of drug, Pharamcokinetic amorphous solid dispersion technology may be affected",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "Decreased bioavailability of drug, Pharamcokinetic amorphous solid dispersion technology may be affected",
    "reference": ""
  },
  {
    "id": "469",
    "name": "Noxafil (Posaconazole)",
    "genericName": "Noxafil (Posaconazole)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Tablet",
        "alteration": "Swallow tablets whole. Do not divide, crush, or chew",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022003s033,205053s017,205596s020,214770s008lbl.pdf"
      }
    ],
    "form": "Delayed Released Tablet",
    "alteration": "Swallow tablets whole. Do not divide, crush, or chew",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022003s033,205053s017,205596s020,214770s008lbl.pdf"
  },
  {
    "id": "470",
    "name": "Nubeqa (Darolutamide)",
    "genericName": "Nubeqa (Darolutamide)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "must be swallowed whole and not",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/212099s008lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "must be swallowed whole and not",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/212099s008lbl.pdf"
  },
  {
    "id": "471",
    "name": "Nucynta Er (Tapentadol)",
    "genericName": "Nucynta Er (Tapentadol)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "chewed, cut, or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/200533s029lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "chewed, cut, or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/200533s029lbl.pdf"
  },
  {
    "id": "472",
    "name": "Nurtec Odt(Timegepant)",
    "genericName": "Nurtec Odt(Timegepant)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Disintegrating Tablet",
        "alteration": "Orally disintegrating",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/212728s028lbl.pdf"
      }
    ],
    "form": "Disintergrating Tablet",
    "alteration": "Orally disintegrating",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/212728s028lbl.pdf"
  },
  {
    "id": "473",
    "name": "Ofev (Nintedanib)",
    "genericName": "Ofev (Nintedanib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Do not chew or crush OFEV capsules",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205832s000lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Do not chew or crush OFEV capsules",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205832s000lbl.pdf"
  },
  {
    "id": "474",
    "name": "Oleptro (Trazodone)",
    "genericName": "Oleptro (Trazodone)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Tablets should be swallowed whole or broken in half along the score line, and should not be chewed or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022411s008lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Tablets should be swallowed whole or broken in half along the score line, and should not be chewed or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022411s008lbl.pdf"
  },
  {
    "id": "475",
    "name": "Omtryg (Omega-3-Fatty Acids)",
    "genericName": "Omtryg (Omega-3-Fatty Acids)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow OMTRYG capsules whole. Do not break open, crush, \ndissolve or chew OMTRYG capsules",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204977s010lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow OMTRYG capsules whole. Do not break open, crush, \ndissolve or chew OMTRYG capsules",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204977s010lbl.pdf"
  },
  {
    "id": "476",
    "name": "Onglyza (Saxagliptin)",
    "genericName": "Onglyza (Saxagliptin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not cut, crush,  or chew ONGLYZA tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022350s026lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not cut, crush,  or chew ONGLYZA tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022350s026lbl.pdf"
  },
  {
    "id": "477",
    "name": "Onureg (Azacitidine)",
    "genericName": "Onureg (Azacitidine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not split, crush, or chew ONUREG tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/214120s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not split, crush, or chew ONUREG tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/214120s000lbl.pdf"
  },
  {
    "id": "478",
    "name": "Opana Er (Oxymorphone)",
    "genericName": "Opana Er (Oxymorphone)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Extended release, tablet disruption may cause a potentially fatal",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021610s031lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Extended release, tablet disruption may cause a potentially fatal",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021610s031lbl.pdf"
  },
  {
    "id": "479",
    "name": "Opsumit (Macitentan)",
    "genericName": "Opsumit (Macitentan)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Teratogenic potential, Hazardous substance",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204410s031lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Teratogenic potential, Hazardous substance",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204410s031lbl.pdf"
  },
  {
    "id": "480",
    "name": "Opsynvi (Macitentan And Tadalafil)",
    "genericName": "Opsynvi (Macitentan And Tadalafil)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "film coated , Teratogenic potential, hazardous substances. Swallow the tablets whole, with water. \nDo not cut, crush, or chew tablets. I",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218490s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "film coated , Teratogenic potential, hazardous substances. Swallow the tablets whole, with water. \nDo not cut, crush, or chew tablets. I",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218490s000lbl.pdf"
  },
  {
    "id": "481",
    "name": "Oracea (Doxycycline)",
    "genericName": "Oracea (Doxycycline)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "dministration of adequate amounts of fluid along with the capsules is recommended to wash down the capsule to reduce the risk of esophageal irritation and ulceration",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/050805s020lbl.pdf"
      }
    ],
    "form": "Delayed Released Capsule",
    "alteration": "dministration of adequate amounts of fluid along with the capsules is recommended to wash down the capsule to reduce the risk of esophageal irritation and ulceration",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/050805s020lbl.pdf"
  },
  {
    "id": "482",
    "name": "Orapred Odt (Prednisolone)",
    "genericName": "Orapred Odt (Prednisolone)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Disintegrating Tablet",
        "alteration": "Orally disintegrating, Do not break, cut, split, or sue partial tablet. May swallow wole or allow tablet to dissolve on tongue",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021959s014lbl.pdf"
      }
    ],
    "form": "Disintergrating Tablet",
    "alteration": "Orally disintegrating, Do not break, cut, split, or sue partial tablet. May swallow wole or allow tablet to dissolve on tongue",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021959s014lbl.pdf"
  },
  {
    "id": "483",
    "name": "Oravig (Miconazole)",
    "genericName": "Oravig (Miconazole)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Buccal Tablet",
        "alteration": "Buccal tablet. ORAVIG should not be crushed, chewed or swallowed.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022404lbl.pdf"
      }
    ],
    "form": "Buccal Tablet",
    "alteration": "Buccal tablet. ORAVIG should not be crushed, chewed or swallowed.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022404lbl.pdf"
  },
  {
    "id": "484",
    "name": "Orenitram (Treprostinil)",
    "genericName": "Orenitram (Treprostinil)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow tablets whole; use only intact tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203496Orig1s000lbl_edt.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow tablets whole; use only intact tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203496Orig1s000lbl_edt.pdf"
  },
  {
    "id": "485",
    "name": "Orgovyx (Relugolix)",
    "genericName": "Orgovyx (Relugolix)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Instruct patients to swallow tablets whole and not to crush or chew tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214621s006lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Instruct patients to swallow tablets whole and not to crush or chew tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214621s006lbl.pdf"
  },
  {
    "id": "486",
    "name": "Orkambi( Lumacaftor And Ivacaftor)",
    "genericName": "Orkambi( Lumacaftor And Ivacaftor)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Pharmacokinetic amorphous solid dispersion technology may be affected",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/206038s018,211358s006lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Pharmacokinetic amorphous solid dispersion technology may be affected",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/206038s018,211358s006lbl.pdf"
  },
  {
    "id": "487",
    "name": "Orphenadrine Citrate Er",
    "genericName": "Orphenadrine Citrate Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Extended released Tablet. Do not alter tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/012157s028lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Extended released Tablet. Do not alter tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/012157s028lbl.pdf"
  },
  {
    "id": "488",
    "name": "Ortikos (Budesonide)",
    "genericName": "Ortikos (Budesonide)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Swallow whole. Do not chew or crush.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/211929s011lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Swallow whole. Do not chew or crush.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/211929s011lbl.pdf"
  },
  {
    "id": "489",
    "name": "Oseni (Alogliptin And Piogl",
    "genericName": "Oseni (Alogliptin And Piogl",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow whole. Do not chew or crush.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022426s016lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow whole. Do not chew or crush.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022426s016lbl.pdf"
  },
  {
    "id": "490",
    "name": "Oserdu ( Elacestrant)",
    "genericName": "Oserdu ( Elacestrant)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "must be swallowed whole and not",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "must be swallowed whole and not",
    "reference": ""
  },
  {
    "id": "491",
    "name": "Osmolex Er (Amantadine )",
    "genericName": "Osmolex Er (Amantadine )",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "chewed, cut, or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209410s009lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "chewed, cut, or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209410s009lbl.pdf"
  },
  {
    "id": "492",
    "name": "Amantadine Er",
    "genericName": "Amantadine Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow tablets whole; do not chew, crush, or divide",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209410s009lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow tablets whole; do not chew, crush, or divide",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209410s009lbl.pdf"
  },
  {
    "id": "493",
    "name": "Otezla (Apremilast)",
    "genericName": "Otezla (Apremilast)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow tablets whole. Do not crush, split, or chew.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/205437s014lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow tablets whole. Do not crush, split, or chew.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/205437s014lbl.pdf"
  },
  {
    "id": "494",
    "name": "Apremilast",
    "genericName": "Apremilast",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow tablets whole. Do not crush, split, or chew.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/205437s014lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow tablets whole. Do not crush, split, or chew.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/205437s014lbl.pdf"
  },
  {
    "id": "495",
    "name": "Oxaydo (Oxycodone)",
    "genericName": "Oxaydo (Oxycodone)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "OXAYDO must be swallowed whole. OXAYDO is not amenable to crushing and dissolution. Do not administer OXAYDO via \nnasogastric, gastric or other feeding tubes as it may cause obstruction of feeding tubes.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202080s014lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "OXAYDO must be swallowed whole. OXAYDO is not amenable to crushing and dissolution. Do not administer OXAYDO via \nnasogastric, gastric or other feeding tubes as it may cause obstruction of feeding tubes.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202080s014lbl.pdf"
  },
  {
    "id": "496",
    "name": "Oxbryta (Voxelotor)",
    "genericName": "Oxbryta (Voxelotor)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "tablet swallowed whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213137s012,216157s003lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "tablet swallowed whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213137s012,216157s003lbl.pdf"
  },
  {
    "id": "497",
    "name": "Oxcarbazepine Er",
    "genericName": "Oxcarbazepine Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow Oxtellar XR tablets whole. Do not cut, crush, or chew the tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202810s020lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow Oxtellar XR tablets whole. Do not cut, crush, or chew the tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202810s020lbl.pdf"
  },
  {
    "id": "498",
    "name": "Oxtellar Xr (Oxcarbazepine)",
    "genericName": "Oxtellar Xr (Oxcarbazepine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow Oxtellar XR tablets whole. Do not cut, crush, or chew the tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202810s020lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow Oxtellar XR tablets whole. Do not cut, crush, or chew the tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202810s020lbl.pdf"
  },
  {
    "id": "499",
    "name": "Oxycodone Er",
    "genericName": "Oxycodone Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Extended release, surrounded by wax matrix. Tablet disruption may cause a potential fatal overdose",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020553s059lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Extended release, surrounded by wax matrix. Tablet disruption may cause a potential fatal overdose",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020553s059lbl.pdf"
  },
  {
    "id": "500",
    "name": "Oxycontin",
    "genericName": "Oxycontin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Extended release, surrounded by wax matrix. Tablet disruption may cause a potential fatal overdose",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020553s059lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Extended release, surrounded by wax matrix. Tablet disruption may cause a potential fatal overdose",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020553s059lbl.pdf"
  },
  {
    "id": "501",
    "name": "Oxy-Ir",
    "genericName": "Oxy-Ir",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Canadian manufacture recommendation not to crush",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "Canadian manufacture recommendation not to crush",
    "reference": ""
  },
  {
    "id": "502",
    "name": "Oxymorphone Er",
    "genericName": "Oxymorphone Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "o swallow OPANA ER tablets whole. Crushing, chewing, or dissolving OPANA ER tablets will result in uncontrolled delivery of oxymorphone and can lead to overdose or death",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021610s031lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "o swallow OPANA ER tablets whole. Crushing, chewing, or dissolving OPANA ER tablets will result in uncontrolled delivery of oxymorphone and can lead to overdose or death",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021610s031lbl.pdf"
  },
  {
    "id": "503",
    "name": "Pancreaze (Pancrelipase)",
    "genericName": "Pancreaze (Pancrelipase)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow capsules whole. For patients unable to swallow intact capsule(s), \nthe capsule contents may be sprinkled on soft acidic food (e.g., \napplesauce). \n• Do not crush or chew PANCREAZE capsules or capsule contents.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022523s019lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow capsules whole. For patients unable to swallow intact capsule(s), \nthe capsule contents may be sprinkled on soft acidic food (e.g., \napplesauce). \n• Do not crush or chew PANCREAZE capsules or capsule contents.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022523s019lbl.pdf"
  },
  {
    "id": "504",
    "name": "Paxil (Paroxetine)",
    "genericName": "Paxil (Paroxetine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Film-coated",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020031s083,020710s051lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Film-coated",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020031s083,020710s051lbl.pdf"
  },
  {
    "id": "505",
    "name": "Pemazyre (Pemigatinib)",
    "genericName": "Pemazyre (Pemigatinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow tablet whole, with or without food",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213736s002lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow tablet whole, with or without food",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213736s002lbl.pdf"
  },
  {
    "id": "506",
    "name": "Pentasa",
    "genericName": "Pentasa",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Swallow capsules whole; do not crush or chew. Alternatively, the capsule(s) may be opened and the contents \nsprinkled onto applesauce or yogurt",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020049s041lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Swallow capsules whole; do not crush or chew. Alternatively, the capsule(s) may be opened and the contents \nsprinkled onto applesauce or yogurt",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020049s041lbl.pdf"
  },
  {
    "id": "507",
    "name": "Pertzye (Pancrelipase)",
    "genericName": "Pertzye (Pancrelipase)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Slow release, Enteric coated content",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022175s010lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Slow release, Enteric coated content",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022175s010lbl.pdf"
  },
  {
    "id": "508",
    "name": "Pexeva (Paroxetine)",
    "genericName": "Pexeva (Paroxetine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Film-coated tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021299s035s038lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Film-coated tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021299s035s038lbl.pdf"
  },
  {
    "id": "509",
    "name": "Phenytek (Phenytoin)",
    "genericName": "Phenytek (Phenytoin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Extended release, manufacture recommendation",
        "reference": ""
      }
    ],
    "form": "Extended Released Capsule",
    "alteration": "Extended release, manufacture recommendation",
    "reference": ""
  },
  {
    "id": "510",
    "name": "Piqray(Alpelisib)",
    "genericName": "Piqray(Alpelisib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow PIQRAY tablets whole (tablets should not be chewed, crushed or split prior to swallowing). No tablet should be \ningested if it is broken, cracked, or otherwise not intact.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/212526s009lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow PIQRAY tablets whole (tablets should not be chewed, crushed or split prior to swallowing). No tablet should be \ningested if it is broken, cracked, or otherwise not intact.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/212526s009lbl.pdf"
  },
  {
    "id": "511",
    "name": "Plaquenil (Hydroxychloroquine)",
    "genericName": "Plaquenil (Hydroxychloroquine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not crush or divide the tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/009768s054lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not crush or divide the tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/009768s054lbl.pdf"
  },
  {
    "id": "512",
    "name": "Hydroxychloroquine",
    "genericName": "Hydroxychloroquine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not crush or divide the tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/009768s054lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not crush or divide the tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/009768s054lbl.pdf"
  },
  {
    "id": "513",
    "name": "Plendil (Felodipine)",
    "genericName": "Plendil (Felodipine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "PLENDIL should be swallowed whole and not crushed or chewed.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019834s025lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "PLENDIL should be swallowed whole and not crushed or chewed.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019834s025lbl.pdf"
  },
  {
    "id": "514",
    "name": "Pomalyst (Pomalidomide)",
    "genericName": "Pomalyst (Pomalidomide)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "not to break, chew or open the capsules.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204026lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "not to break, chew or open the capsules.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204026lbl.pdf"
  },
  {
    "id": "515",
    "name": "Ponvory (Ponesimod)",
    "genericName": "Ponvory (Ponesimod)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow PONVORY tablets whole.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213498s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow PONVORY tablets whole.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213498s000lbl.pdf"
  },
  {
    "id": "516",
    "name": "Pradaxa (Dabigatran)",
    "genericName": "Pradaxa (Dabigatran)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Bioavailability increases by 75% when the pellets are taken without the capsule shell",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022512s000lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Bioavailability increases by 75% when the pellets are taken without the capsule shell",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022512s000lbl.pdf"
  },
  {
    "id": "517",
    "name": "Pretomanid",
    "genericName": "Pretomanid",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow Pretomanid Tablets whole with water",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212862s004lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow Pretomanid Tablets whole with water",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212862s004lbl.pdf"
  },
  {
    "id": "518",
    "name": "Prevacid (Lanzoprazole)",
    "genericName": "Prevacid (Lanzoprazole)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Should be swallowed whole.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020406s095,021428s042lbl.pdf"
      }
    ],
    "form": "Delayed Released Capsule",
    "alteration": "Should be swallowed whole.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020406s095,021428s042lbl.pdf"
  },
  {
    "id": "519",
    "name": "Lanzoprazole",
    "genericName": "Lanzoprazole",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Should be swallowed whole.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020406s095,021428s042lbl.pdf"
      }
    ],
    "form": "Delayed Released Capsule",
    "alteration": "Should be swallowed whole.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020406s095,021428s042lbl.pdf"
  },
  {
    "id": "520",
    "name": "Prevacid Solutab (Lansoprazole)",
    "genericName": "Prevacid Solutab (Lansoprazole)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Disintegrating Tablet",
        "alteration": "Orally disintegrating. Do not swallow. Dissolve in water only and dispense via dosing syringe or NG tube",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020406s095,021428s042lbl.pdf"
      }
    ],
    "form": "Disintergrating Tablet",
    "alteration": "Orally disintegrating. Do not swallow. Dissolve in water only and dispense via dosing syringe or NG tube",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020406s095,021428s042lbl.pdf"
  },
  {
    "id": "521",
    "name": "Prevpac (Lansoprazole, Amoxicillin, And Clarithromycin)",
    "genericName": "Prevpac (Lansoprazole, Amoxicillin, And Clarithromycin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Manufacture recommendation",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050757s022lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Manufacture recommendation",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050757s022lbl.pdf"
  },
  {
    "id": "522",
    "name": "Prevymis (Letermovir)",
    "genericName": "Prevymis (Letermovir)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow tablets whole.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209939s015,209940s015,219104s001lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow tablets whole.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209939s015,209940s015,219104s001lbl.pdf"
  },
  {
    "id": "523",
    "name": "Prevymis Oral Pellets",
    "genericName": "Prevymis Oral Pellets",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Oral Pellets",
        "alteration": "EVYMIS Oral Pellets - Administer orally mixed with soft food or via nasogastric tube (NG tube) or gastric tube (G tube) - Do not crush or chew.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209939s015,209940s015,219104s001lbl.pdf"
      }
    ],
    "form": "Oral pellets",
    "alteration": "EVYMIS Oral Pellets - Administer orally mixed with soft food or via nasogastric tube (NG tube) or gastric tube (G tube) - Do not crush or chew.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209939s015,209940s015,219104s001lbl.pdf"
  },
  {
    "id": "524",
    "name": "Omeprazole",
    "genericName": "Omeprazole",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow PRILOSEC delayed-release capsules whole; do not chew.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019810s102,022056s019lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow PRILOSEC delayed-release capsules whole; do not chew.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019810s102,022056s019lbl.pdf"
  },
  {
    "id": "525",
    "name": "Prilosec (Omerpazole)",
    "genericName": "Prilosec (Omerpazole)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Swallow PRILOSEC delayed-release capsules whole; do not chew.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019810s102,022056s019lbl.pdf"
      }
    ],
    "form": "Delayed Released Capsule",
    "alteration": "Swallow PRILOSEC delayed-release capsules whole; do not chew.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019810s102,022056s019lbl.pdf"
  },
  {
    "id": "526",
    "name": "Prilosec Otc (Omeprazole)",
    "genericName": "Prilosec Otc (Omeprazole)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Tablet",
        "alteration": "Extended released Tablet. Do not alter tablet",
        "reference": ""
      }
    ],
    "form": "Delayed Released Tablet",
    "alteration": "Extended released Tablet. Do not alter tablet",
    "reference": ""
  },
  {
    "id": "527",
    "name": "Desvenlafaxine",
    "genericName": "Desvenlafaxine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Take tablets whole; do not divide, crush, chew, or dissolve",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021992s051lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Take tablets whole; do not divide, crush, chew, or dissolve",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021992s051lbl.pdf"
  },
  {
    "id": "528",
    "name": "Pristiq (Desvenlafaxine)",
    "genericName": "Pristiq (Desvenlafaxine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Take tablets whole; do not divide, crush, chew, or dissolve",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021992s051lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Take tablets whole; do not divide, crush, chew, or dissolve",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021992s051lbl.pdf"
  },
  {
    "id": "529",
    "name": "Procardia (Nifedipine)",
    "genericName": "Procardia (Nifedipine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Pharmacokinetics may be altered if not taken whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018482s051lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Pharmacokinetics may be altered if not taken whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018482s051lbl.pdf"
  },
  {
    "id": "530",
    "name": "Procardia Xl (Nifedipine)",
    "genericName": "Procardia Xl (Nifedipine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Tablets should be swallowed whole and should not be bitten or divided",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019684s033lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Tablets should be swallowed whole and should not be bitten or divided",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019684s033lbl.pdf"
  },
  {
    "id": "531",
    "name": "Nifedipine Er",
    "genericName": "Nifedipine Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Tablets should be swallowed whole and should not be bitten or divided",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019684s033lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Tablets should be swallowed whole and should not be bitten or divided",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019684s033lbl.pdf"
  },
  {
    "id": "532",
    "name": "Procysbi (Cysteamine)",
    "genericName": "Procysbi (Cysteamine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Swallow whole; do not crush or chew capsules or capsule contents. For patients who cannot swallow the capsules or with gastrostomy tubes, \nsee the full prescribing information on how to prepare and administer the \ncapsules and oral granules",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203389s027,213491s002lbl.pdf"
      }
    ],
    "form": "Delayed Released Capsule",
    "alteration": "Swallow whole; do not crush or chew capsules or capsule contents. For patients who cannot swallow the capsules or with gastrostomy tubes, \nsee the full prescribing information on how to prepare and administer the \ncapsules and oral granules",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203389s027,213491s002lbl.pdf"
  },
  {
    "id": "533",
    "name": "Prograf (Tacrolimus)",
    "genericName": "Prograf (Tacrolimus)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Do not open or crush PROGRAF capsules",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/050708s055,010115s007lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Do not open or crush PROGRAF capsules",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/050708s055,010115s007lbl.pdf"
  },
  {
    "id": "534",
    "name": "Promacta (Eltrombopag)",
    "genericName": "Promacta (Eltrombopag)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not split, chew, or crush tablets and mix with food or liquids",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022291s041,207027s020lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not split, chew, or crush tablets and mix with food or liquids",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022291s041,207027s020lbl.pdf"
  },
  {
    "id": "535",
    "name": "Finasteride",
    "genericName": "Finasteride",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Women who are, or may become pregnant should not handle crushed or broken tablets due to teratogenic potenital, Hazardous substance",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020788s030lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Women who are, or may become pregnant should not handle crushed or broken tablets due to teratogenic potenital, Hazardous substance",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020788s030lbl.pdf"
  },
  {
    "id": "536",
    "name": "Propecia",
    "genericName": "Propecia",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Women who are, or may become pregnant should not handle crushed or broken tablets due to teratogenic potenital, Hazardous substance",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020788s030lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Women who are, or may become pregnant should not handle crushed or broken tablets due to teratogenic potenital, Hazardous substance",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020788s030lbl.pdf"
  },
  {
    "id": "537",
    "name": "Proscar",
    "genericName": "Proscar",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Women who are, or may become pregnant should not handle crushed or broken tablets due to teratogenic potenital, Hazardous substance",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020180s049lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Women who are, or may become pregnant should not handle crushed or broken tablets due to teratogenic potenital, Hazardous substance",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020180s049lbl.pdf"
  },
  {
    "id": "538",
    "name": "Pantoprazole",
    "genericName": "Pantoprazole",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "PROTONIX Delayed-Release Tablets should be swallowed whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020987s045lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "PROTONIX Delayed-Release Tablets should be swallowed whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020987s045lbl.pdf"
  },
  {
    "id": "539",
    "name": "Protonix (Pantoprazole",
    "genericName": "Protonix (Pantoprazole",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "PROTONIX Delayed-Release Tablets should be swallowed whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020987s045lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "PROTONIX Delayed-Release Tablets should be swallowed whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020987s045lbl.pdf"
  },
  {
    "id": "540",
    "name": "Mercatopurine",
    "genericName": "Mercatopurine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Teratogenic potential, hazardous substance . Do not administer to patients who are unable to swallow tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/009053s044lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Teratogenic potential, hazardous substance . Do not administer to patients who are unable to swallow tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/009053s044lbl.pdf"
  },
  {
    "id": "541",
    "name": "Purinethol (Mercaptopurine)",
    "genericName": "Purinethol (Mercaptopurine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Teratogenic potential, hazardous substance . Do not administer to patients who are unable to swallow tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/009053s044lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Teratogenic potential, hazardous substance . Do not administer to patients who are unable to swallow tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/009053s044lbl.pdf"
  },
  {
    "id": "542",
    "name": "Pylera ( Bismuth Subcitrate, Metronidazole, And Tetracycline)",
    "genericName": "Pylera ( Bismuth Subcitrate, Metronidazole, And Tetracycline)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "swallow the PYLERA capsules whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/050786s029lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "swallow the PYLERA capsules whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/050786s029lbl.pdf"
  },
  {
    "id": "543",
    "name": "Pyrukynd (Mitapivat)",
    "genericName": "Pyrukynd (Mitapivat)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "PYRUKYND is taken with or without food and swallowed whole. Do not split, crush, chew, or\ndissolve the tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/216196s004lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "PYRUKYND is taken with or without food and swallowed whole. Do not split, crush, chew, or\ndissolve the tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/216196s004lbl.pdf"
  },
  {
    "id": "544",
    "name": "Pytest (Carbon 14 Urea)",
    "genericName": "Pytest (Carbon 14 Urea)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "must be swallowed whole and not",
        "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020617"
      }
    ],
    "form": "Capsule",
    "alteration": "must be swallowed whole and not",
    "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020617"
  },
  {
    "id": "545",
    "name": "Qelbree (Viloxazine)",
    "genericName": "Qelbree (Viloxazine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "chewed, cut, or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211964s000lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "chewed, cut, or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211964s000lbl.pdf"
  },
  {
    "id": "546",
    "name": "Qinlock (Ripretinib)",
    "genericName": "Qinlock (Ripretinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "swallow tablets whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/213973s010lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "swallow tablets whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/213973s010lbl.pdf"
  },
  {
    "id": "547",
    "name": "Qtern (Dapagliflozin And Saxagliptin)",
    "genericName": "Qtern (Dapagliflozin And Saxagliptin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow tablet whole. Do not crush, cut or chew",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209091s008lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow tablet whole. Do not crush, cut or chew",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209091s008lbl.pdf"
  },
  {
    "id": "548",
    "name": "Qternmet Xr (Dapagliflozin, Saxagliptin And Meformin)",
    "genericName": "Qternmet Xr (Dapagliflozin, Saxagliptin And Meformin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow tablet whole. Do not crush, cut or chew",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210874s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow tablet whole. Do not crush, cut or chew",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210874s000lbl.pdf"
  },
  {
    "id": "549",
    "name": "Qudexy Xr (Topiramate)",
    "genericName": "Qudexy Xr (Topiramate)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "QUDEXY XR capsules may be swallowed whole or may be administered by carefully opening the capsule and sprinkling the entire contents on a small amount (teaspoon) of soft food. This drug/food mixture should be swallowed immediately and not chewed or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/205122s017lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "QUDEXY XR capsules may be swallowed whole or may be administered by carefully opening the capsule and sprinkling the entire contents on a small amount (teaspoon) of soft food. This drug/food mixture should be swallowed immediately and not chewed or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/205122s017lbl.pdf"
  },
  {
    "id": "550",
    "name": "Quinidine Er",
    "genericName": "Quinidine Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Extended released Tablet. Do not alter tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/12796s49lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Extended released Tablet. Do not alter tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/12796s49lbl.pdf"
  },
  {
    "id": "551",
    "name": "Ranolazine",
    "genericName": "Ranolazine",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow  RANEXA tablets whole; do not crush, break, or chew.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021526s035lbl.pdf"
      },
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow RANEXA tablets whole; do not crush, break, or chew.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021526s035lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021526s035lbl.pdf"
  },
  {
    "id": "552",
    "name": "Ranexa (Ranolazine)",
    "genericName": "Ranexa (Ranolazine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow  RANEXA tablets whole; do not crush, break, or chew.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021526s035lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow  RANEXA tablets whole; do not crush, break, or chew.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021526s035lbl.pdf"
  },
  {
    "id": "553",
    "name": "Rapamune (Sirolimus)",
    "genericName": "Rapamune (Sirolimus)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Tablets should not be crushed, chewed or split",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021083s069s070,021110s087s088lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Tablets should not be crushed, chewed or split",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021083s069s070,021110s087s088lbl.pdf"
  },
  {
    "id": "554",
    "name": "Rayaldee (Calcifediol)",
    "genericName": "Rayaldee (Calcifediol)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "swallow RAYALDEE capsules whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/208010Orig1s013lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "swallow RAYALDEE capsules whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/208010Orig1s013lbl.pdf"
  },
  {
    "id": "555",
    "name": "Rayos",
    "genericName": "Rayos",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Tablet",
        "alteration": "RAYOS should be swallowed whole and not broken, divided, or chewed.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202020s013lbl.pdf"
      },
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3400d26a-41cb-40e4-99b4-780e1e0ec561"
      }
    ],
    "form": "Delayed Released Tablet",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202020s013lbl.pdf"
  },
  {
    "id": "556",
    "name": "Mirtazapine Soltab",
    "genericName": "Mirtazapine Soltab",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Disintegrating Tablet",
        "alteration": "The whole tablet should be placed on the tongue and allowed to disintegrate without chewing or \ncrushing. Do not attempt to split the tablet. \n The tablet will disintegrate in saliva so that it can be swallowed.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020415s038,021208s028lbl.pdf"
      }
    ],
    "form": "Disintergrating Tablet",
    "alteration": "The whole tablet should be placed on the tongue and allowed to disintegrate without chewing or \ncrushing. Do not attempt to split the tablet. \n The tablet will disintegrate in saliva so that it can be swallowed.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020415s038,021208s028lbl.pdf"
  },
  {
    "id": "557",
    "name": "Remeron Soltab (Mirtazapine )",
    "genericName": "Remeron Soltab (Mirtazapine )",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Disintegrating Tablet",
        "alteration": "The whole tablet should be placed on the tongue and allowed to disintegrate without chewing or \ncrushing. Do not attempt to split the tablet. \n The tablet will disintegrate in saliva so that it can be swallowed.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020415s038,021208s028lbl.pdf"
      }
    ],
    "form": "Disintergrating Tablet",
    "alteration": "The whole tablet should be placed on the tongue and allowed to disintegrate without chewing or \ncrushing. Do not attempt to split the tablet. \n The tablet will disintegrate in saliva so that it can be swallowed.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020415s038,021208s028lbl.pdf"
  },
  {
    "id": "558",
    "name": "Mirtazapine",
    "genericName": "Mirtazapine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020415s038,021208s028lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020415s038,021208s028lbl.pdf"
  },
  {
    "id": "559",
    "name": "Renagel (Sevelamer)",
    "genericName": "Renagel (Sevelamer)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Manufacture recommendation, expand in liquid if broken/crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20926lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Manufacture recommendation, expand in liquid if broken/crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20926lbl.pdf"
  },
  {
    "id": "560",
    "name": "Renvela (Sevelamer)",
    "genericName": "Renvela (Sevelamer)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Manufacture reocmmendation, expand in liquid if broken or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022127s011lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Manufacture reocmmendation, expand in liquid if broken or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022127s011lbl.pdf"
  },
  {
    "id": "561",
    "name": "Ropinirole",
    "genericName": "Ropinirole",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020658Orig1s037lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020658Orig1s037lbl.pdf"
  },
  {
    "id": "562",
    "name": "Ropinirole Er",
    "genericName": "Ropinirole Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Tablets must be swallowed whole and must not be chewed, crushed, or divided.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022008lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Tablets must be swallowed whole and must not be chewed, crushed, or divided.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022008lbl.pdf"
  },
  {
    "id": "563",
    "name": "Requip Xl (Ropinirole)",
    "genericName": "Requip Xl (Ropinirole)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Tablets must be swallowed whole and must not be chewed, crushed, or divided.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022008lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Tablets must be swallowed whole and must not be chewed, crushed, or divided.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022008lbl.pdf"
  },
  {
    "id": "564",
    "name": "Rescriptor (Delavirdine)",
    "genericName": "Rescriptor (Delavirdine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "The 100-mg RESCRIPTOR Tablets may be dispersed in water prior to consumption. To \n552 prepare a dispersion, add four 100-mg RESCRIPTOR Tablets to at least 3 ounces of water, allow \n553 to stand for a few minutes, and then stir until a uniform dispersion occurs (see CLINICAL \n554 PHARMACOLOGY: Pharmacokinetics: Absorption and Bioavailability). The dispersion should \n555 be consumed promptly. The glass should be rinsed with water and the rinse swallowed to insure \n556 the entire dose is consumed. The 200-mg tablets should be taken as intact tablets, because \n557 they are not readily dispersed in water. Note: The 200-mg tablets are approximately one-third",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020705s018lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "The 100-mg RESCRIPTOR Tablets may be dispersed in water prior to consumption. To \n552 prepare a dispersion, add four 100-mg RESCRIPTOR Tablets to at least 3 ounces of water, allow \n553 to stand for a few minutes, and then stir until a uniform dispersion occurs (see CLINICAL \n554 PHARMACOLOGY: Pharmacokinetics: Absorption and Bioavailability). The dispersion should \n555 be consumed promptly. The glass should be rinsed with water and the rinse swallowed to insure \n556 the entire dose is consumed. The 200-mg tablets should be taken as intact tablets, because \n557 they are not readily dispersed in water. Note: The 200-mg tablets are approximately one-third",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020705s018lbl.pdf"
  },
  {
    "id": "565",
    "name": "Retevmo (Selpercatinib)",
    "genericName": "Retevmo (Selpercatinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow the capsules whole. Do not crush or chew the capsules.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213246s000lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow the capsules whole. Do not crush or chew the capsules.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213246s000lbl.pdf"
  },
  {
    "id": "566",
    "name": "Lenalidomide",
    "genericName": "Lenalidomide",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "swallow REVLIMID capsules whole with \nwater and not to open, break, or chew them. Manufacture recommendation,, teratogenic potential, hazardous substance",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021880s067lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "swallow REVLIMID capsules whole with \nwater and not to open, break, or chew them. Manufacture recommendation,, teratogenic potential, hazardous substance",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021880s067lbl.pdf"
  },
  {
    "id": "567",
    "name": "Revlimid (Lenalidomide)",
    "genericName": "Revlimid (Lenalidomide)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "swallow REVLIMID capsules whole with \nwater and not to open, break, or chew them. Manufacture recommendation,, teratogenic potential, hazardous substance",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021880s067lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "swallow REVLIMID capsules whole with \nwater and not to open, break, or chew them. Manufacture recommendation,, teratogenic potential, hazardous substance",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021880s067lbl.pdf"
  },
  {
    "id": "568",
    "name": "Reyataz (Atazanavir)",
    "genericName": "Reyataz (Atazanavir)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow the capsules whole. Do not open the capsules.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21567_reyataz_lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow the capsules whole. Do not open the capsules.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21567_reyataz_lbl.pdf"
  },
  {
    "id": "569",
    "name": "Reywow (Lasmiditan)",
    "genericName": "Reywow (Lasmiditan)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Film-coated, Manufacturer recommendation",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "Film-coated, Manufacturer recommendation",
    "reference": ""
  },
  {
    "id": "570",
    "name": "Rezlidhia (Olutasidenib)",
    "genericName": "Rezlidhia (Olutasidenib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow REZLIDHIA capsules whole. Do not break, open or chew the capsules",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215814s000lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow REZLIDHIA capsules whole. Do not break, open or chew the capsules",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215814s000lbl.pdf"
  },
  {
    "id": "571",
    "name": "Rezurock (Belumosudil)",
    "genericName": "Rezurock (Belumosudil)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow REZUROCK tablets whole. Do not cut, crush, or chew tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214783s007lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow REZUROCK tablets whole. Do not cut, crush, or chew tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214783s007lbl.pdf"
  },
  {
    "id": "572",
    "name": "Ribasphere (Ribavirin)",
    "genericName": "Ribasphere (Ribavirin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Manufacture recommendation. Must be swallowed whole and never crushed or chewed.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/76203LBL_Ribasphere.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Manufacture recommendation. Must be swallowed whole and never crushed or chewed.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/76203LBL_Ribasphere.pdf"
  },
  {
    "id": "573",
    "name": "Rinvoq (Upadacitinib)",
    "genericName": "Rinvoq (Upadacitinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Must be swallowed whole and never crushed or chewed.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211675s025lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Must be swallowed whole and never crushed or chewed.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211675s025lbl.pdf"
  },
  {
    "id": "574",
    "name": "Risperidone M-Tab",
    "genericName": "Risperidone M-Tab",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Orally disintegrating. Do not chew or break tablet, after dissolving under tongue, tablet maybe swallowed",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "Orally disintegrating. Do not chew or break tablet, after dissolving under tongue, tablet maybe swallowed",
    "reference": ""
  },
  {
    "id": "575",
    "name": "Rilalin La (Methylphenidate)",
    "genericName": "Rilalin La (Methylphenidate)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Capsules may be swallowed whole or opened and the entire contents sprinkled on applesauce (2.2). • Should not be crushed, chewed, or divided",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021284s042s046lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Capsules may be swallowed whole or opened and the entire contents sprinkled on applesauce (2.2). • Should not be crushed, chewed, or divided",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021284s042s046lbl.pdf"
  },
  {
    "id": "576",
    "name": "Ritalin-Sr (Methylphenidate)",
    "genericName": "Ritalin-Sr (Methylphenidate)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Must be swallowed whole and never crushed or chewed.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/010187s091,018029s059lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Must be swallowed whole and never crushed or chewed.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/010187s091,018029s059lbl.pdf"
  },
  {
    "id": "577",
    "name": "Roszet (Ezetimibe And Rosuvastatin)",
    "genericName": "Roszet (Ezetimibe And Rosuvastatin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow tablets whole; do not crush, dissolve or chew",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/213072s004lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow tablets whole; do not crush, dissolve or chew",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/213072s004lbl.pdf"
  },
  {
    "id": "578",
    "name": "Roweepra (Levetiracetam)",
    "genericName": "Roweepra (Levetiracetam)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Due to taste. Swallow tablet whole, do not crush, chew.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212725s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Due to taste. Swallow tablet whole, do not crush, chew.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212725s000lbl.pdf"
  },
  {
    "id": "579",
    "name": "Roweepra Er (Levetiracetam)",
    "genericName": "Roweepra Er (Levetiracetam)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Must be swallowed whole and never crushed or chewed.",
        "reference": ""
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Must be swallowed whole and never crushed or chewed.",
    "reference": ""
  },
  {
    "id": "580",
    "name": "Rozlytrek (Entrectinib)",
    "genericName": "Rozlytrek (Entrectinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow capsules whole. Do not open, crush, chew, or dissolve the contents of the capsule.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212725s000lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow capsules whole. Do not open, crush, chew, or dissolve the contents of the capsule.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212725s000lbl.pdf"
  },
  {
    "id": "581",
    "name": "Rukobia (Fostemsvir)",
    "genericName": "Rukobia (Fostemsvir)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow tablets whole. Do not chew, crush, or split tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212950s000lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow tablets whole. Do not chew, crush, or split tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212950s000lbl.pdf"
  },
  {
    "id": "582",
    "name": "Rybelsus (Semaglutide)",
    "genericName": "Rybelsus (Semaglutide)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "must be swallowed whole and not",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "must be swallowed whole and not",
    "reference": ""
  },
  {
    "id": "583",
    "name": "Rydapt (Midostaurin)",
    "genericName": "Rydapt (Midostaurin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "chewed, cut, or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207997s010lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "chewed, cut, or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207997s010lbl.pdf"
  },
  {
    "id": "584",
    "name": "Rytary (Carbidopa And Levodopa)",
    "genericName": "Rytary (Carbidopa And Levodopa)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "RYTARY may be taken with or without food; do not chew, divide or crush",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203312s000lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "RYTARY may be taken with or without food; do not chew, divide or crush",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203312s000lbl.pdf"
  },
  {
    "id": "585",
    "name": "Rythmol Sr (Propafenone)",
    "genericName": "Rythmol Sr (Propafenone)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "RYTHMOL SR can be taken with or without food. Do not crush or further divide the contents of the capsule",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021416s015lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "RYTHMOL SR can be taken with or without food. Do not crush or further divide the contents of the capsule",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021416s015lbl.pdf"
  },
  {
    "id": "586",
    "name": "Scemblix (Asciminib)",
    "genericName": "Scemblix (Asciminib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "swallow SCEMBLIX tablets whole. Do not break, crush, or chew the tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215358s000Orig2lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "swallow SCEMBLIX tablets whole. Do not break, crush, or chew the tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215358s000Orig2lbl.pdf"
  },
  {
    "id": "587",
    "name": "Cinacalcet",
    "genericName": "Cinacalcet",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Tablets are not scored and cutting may cause inaccurate dosage",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021688s027lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Tablets are not scored and cutting may cause inaccurate dosage",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021688s027lbl.pdf"
  },
  {
    "id": "588",
    "name": "Sensipar (Cinacalcet)",
    "genericName": "Sensipar (Cinacalcet)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Tablets are not scored and cutting may cause inaccurate dosage",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021688s027lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Tablets are not scored and cutting may cause inaccurate dosage",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021688s027lbl.pdf"
  },
  {
    "id": "589",
    "name": "Quetiapine Er",
    "genericName": "Quetiapine Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow tablets whole and do not split, chew or crush",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022047s048lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow tablets whole and do not split, chew or crush",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022047s048lbl.pdf"
  },
  {
    "id": "590",
    "name": "Seroquel Xr",
    "genericName": "Seroquel Xr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow tablets whole and do not split, chew or crush",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022047s048lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow tablets whole and do not split, chew or crush",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022047s048lbl.pdf"
  },
  {
    "id": "591",
    "name": "Siklos (Hydroxyurea)",
    "genericName": "Siklos (Hydroxyurea)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "For patients who are not able to swallow the tablets, these can be dispersed immediately before use in a small quantity of water in a teaspoon.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208843s004lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "For patients who are not able to swallow the tablets, these can be dispersed immediately before use in a small quantity of water in a teaspoon.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208843s004lbl.pdf"
  },
  {
    "id": "592",
    "name": "Simcor (Niacin And Simvastatin )",
    "genericName": "Simcor (Niacin And Simvastatin )",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "must be swallowed whole and not",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "must be swallowed whole and not",
    "reference": ""
  },
  {
    "id": "593",
    "name": "Carbidopa And Levodopa Er",
    "genericName": "Carbidopa And Levodopa Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "chewed, cut, or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019856s016s024s028lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "chewed, cut, or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019856s016s024s028lbl.pdf"
  },
  {
    "id": "594",
    "name": "Sinemet Cr (Carbidopa And Levodopa )",
    "genericName": "Sinemet Cr (Carbidopa And Levodopa )",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "SINEMET CR should not be chewed or crushed.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019856s016s024s028lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "SINEMET CR should not be chewed or crushed.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019856s016s024s028lbl.pdf"
  },
  {
    "id": "595",
    "name": "Sirturo (Bedaquiline)",
    "genericName": "Sirturo (Bedaquiline)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "The SIRTURO tablet should be \nswallowed whole with water.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/204384s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "The SIRTURO tablet should be \nswallowed whole with water.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/204384s000lbl.pdf"
  },
  {
    "id": "596",
    "name": "Sitavig (Acyclovir)",
    "genericName": "Sitavig (Acyclovir)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Buccal tablet, swallowing whole or crushing eliminates or reduces effectiveness",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203791s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Buccal tablet, swallowing whole or crushing eliminates or reduces effectiveness",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203791s000lbl.pdf"
  },
  {
    "id": "597",
    "name": "Niacin Er",
    "genericName": "Niacin Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Take NIASPAN tablets whole. Do not break, crush or chew NIASPAN tablets before swallowing.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020381s055lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Take NIASPAN tablets whole. Do not break, crush or chew NIASPAN tablets before swallowing.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020381s055lbl.pdf"
  },
  {
    "id": "598",
    "name": "Slo-Niacin (Niacin)",
    "genericName": "Slo-Niacin (Niacin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Take NIASPAN tablets whole. Do not break, crush or chew NIASPAN tablets before swallowing.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020381s055lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Take NIASPAN tablets whole. Do not break, crush or chew NIASPAN tablets before swallowing.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020381s055lbl.pdf"
  },
  {
    "id": "599",
    "name": "Slow Fe (Ferrous Sulfate)",
    "genericName": "Slow Fe (Ferrous Sulfate)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not crush, cut or chew tablets. Swallow tablets whole",
        "reference": ""
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Do not crush, cut or chew tablets. Swallow tablets whole",
    "reference": ""
  },
  {
    "id": "600",
    "name": "Slow Iron (Ferrous Sulfate )",
    "genericName": "Slow Iron (Ferrous Sulfate )",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not crush, cut or chew tablets. Swallow tablets whole",
        "reference": ""
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Do not crush, cut or chew tablets. Swallow tablets whole",
    "reference": ""
  },
  {
    "id": "601",
    "name": "Slow- Mag (Magnesium Chloride)",
    "genericName": "Slow- Mag (Magnesium Chloride)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not crush, cut or chew tablets. Swallow tablets whole",
        "reference": ""
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Do not crush, cut or chew tablets. Swallow tablets whole",
    "reference": ""
  },
  {
    "id": "602",
    "name": "Slynd (Drospirenone)",
    "genericName": "Slynd (Drospirenone)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Manufacture recommendation, Hazardous Substance",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211367s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Manufacture recommendation, Hazardous Substance",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211367s000lbl.pdf"
  },
  {
    "id": "603",
    "name": "Soriatane (Acitretin)",
    "genericName": "Soriatane (Acitretin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Teratogenic potential, Hazardous Substance",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019821s029lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Teratogenic potential, Hazardous Substance",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019821s029lbl.pdf"
  },
  {
    "id": "604",
    "name": "Sporanox (Itraconazole)",
    "genericName": "Sporanox (Itraconazole)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Capsules must be swallowed whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020083s070lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Capsules must be swallowed whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020083s070lbl.pdf"
  },
  {
    "id": "605",
    "name": "Sprycel (Dasatinib)",
    "genericName": "Sprycel (Dasatinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not crush, cut or chew tablets. Swallow tablets whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021986s028lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not crush, cut or chew tablets. Swallow tablets whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021986s028lbl.pdf"
  },
  {
    "id": "606",
    "name": "Stalevo (Levodopa, Carbidopa And Entacapone)",
    "genericName": "Stalevo (Levodopa, Carbidopa And Entacapone)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "ndividual tablets should not be split or fractionated",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021485s042lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "ndividual tablets should not be split or fractionated",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021485s042lbl.pdf"
  },
  {
    "id": "607",
    "name": "Staxyn (Verdenafil)",
    "genericName": "Staxyn (Verdenafil)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Sublingual Tablet",
        "alteration": "Orally disintegrating tablet, sublingual form",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/200179lbl.pdf"
      }
    ],
    "form": "Sublingual Tablet",
    "alteration": "Orally disintegrating tablet, sublingual form",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/200179lbl.pdf"
  },
  {
    "id": "608",
    "name": "Stivarga (Rogorafenib)",
    "genericName": "Stivarga (Rogorafenib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow tablet whole with water after a low-fat meal that contains less than \n600 calories and less than 30% fat",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/203085s016lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow tablet whole with water after a low-fat meal that contains less than \n600 calories and less than 30% fat",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/203085s016lbl.pdf"
  },
  {
    "id": "609",
    "name": "Strattera (Atomoxetine)",
    "genericName": "Strattera (Atomoxetine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Capsule contents can cause ocular irritation",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21411_strattera_lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Capsule contents can cause ocular irritation",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21411_strattera_lbl.pdf"
  },
  {
    "id": "610",
    "name": "Buprenorphine And Naloxone Film",
    "genericName": "Buprenorphine And Naloxone Film",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Sublingual Buccal Film",
        "alteration": "SUBOXONE sublingual film must be administered whole. Do not cut, \nchew, or swallow SUBOXONE sublingual film (2.5",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022410s056lbl.pdf"
      }
    ],
    "form": "Film, Sublingual Buccal",
    "alteration": "SUBOXONE sublingual film must be administered whole. Do not cut, \nchew, or swallow SUBOXONE sublingual film (2.5",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022410s056lbl.pdf"
  },
  {
    "id": "611",
    "name": "Suboxone (Buprenorphine And Naloxone)",
    "genericName": "Suboxone (Buprenorphine And Naloxone)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Sublingual Buccal Film",
        "alteration": "SUBOXONE sublingual film must be administered whole. Do not cut, \nchew, or swallow SUBOXONE sublingual film (2.5",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022410s056lbl.pdf"
      }
    ],
    "form": "Film, Sublingual Buccal",
    "alteration": "SUBOXONE sublingual film must be administered whole. Do not cut, \nchew, or swallow SUBOXONE sublingual film (2.5",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022410s056lbl.pdf"
  },
  {
    "id": "612",
    "name": "Sudafed 12-Hour (Pseudoephedrine)",
    "genericName": "Sudafed 12-Hour (Pseudoephedrine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Swallow whole. Do not crush or chew or divide",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020021Orig1s012lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Swallow whole. Do not crush or chew or divide",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020021Orig1s012lbl.pdf"
  },
  {
    "id": "613",
    "name": "Sudafed 24-Hour (Pseudoephedrine)",
    "genericName": "Sudafed 24-Hour (Pseudoephedrine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Swallow whole. Do not crush or chew or divide",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020021Orig1s012lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Swallow whole. Do not crush or chew or divide",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020021Orig1s012lbl.pdf"
  },
  {
    "id": "614",
    "name": "Sular (Nisoldipine)",
    "genericName": "Sular (Nisoldipine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "SULAR is an extended release dosage form and tablets should be swallowed whole, not bitten, divided or crushed.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020356s027lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "SULAR is an extended release dosage form and tablets should be swallowed whole, not bitten, divided or crushed.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020356s027lbl.pdf"
  },
  {
    "id": "615",
    "name": "Supeudol (Oxycodone)",
    "genericName": "Supeudol (Oxycodone)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Canadian Manufacture recommendation",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020356s027lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Canadian Manufacture recommendation",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020356s027lbl.pdf"
  },
  {
    "id": "616",
    "name": "Efavirenz",
    "genericName": "Efavirenz",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "SUSTIVA capsules or tablets should be swallowed intact with liquid. For patients who cannot swallow capsules  tablets, the capsule sprinkle method of administration is recommended",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021360s047,020972s059lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "SUSTIVA capsules or tablets should be swallowed intact with liquid. For patients who cannot swallow capsules  tablets, the capsule sprinkle method of administration is recommended",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021360s047,020972s059lbl.pdf"
  },
  {
    "id": "617",
    "name": "Sustiva (Efavirenz)",
    "genericName": "Sustiva (Efavirenz)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "SUSTIVA capsules or tablets should be swallowed intact with liquid. For patients who cannot swallow capsules  tablets, the capsule sprinkle method of administration is recommended",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021360s047,020972s059lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "SUSTIVA capsules or tablets should be swallowed intact with liquid. For patients who cannot swallow capsules  tablets, the capsule sprinkle method of administration is recommended",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021360s047,020972s059lbl.pdf"
  },
  {
    "id": "618",
    "name": "Symdeko (Tezacaftor And Ivacaftor(",
    "genericName": "Symdeko (Tezacaftor And Ivacaftor(",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Manufacture recommendation. Pharmacokinetic amorphous solid dispersion technology may be affected",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "Manufacture recommendation. Pharmacokinetic amorphous solid dispersion technology may be affected",
    "reference": ""
  },
  {
    "id": "619",
    "name": "Synjardy Xr (Empagliflozin And Metformin)",
    "genericName": "Synjardy Xr (Empagliflozin And Metformin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow synjardy XR tablet whole. Do not break, crush, cut, dissolve or chew tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/206111s045,208658s032lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow synjardy XR tablet whole. Do not break, crush, cut, dissolve or chew tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/206111s045,208658s032lbl.pdf"
  },
  {
    "id": "620",
    "name": "Syprine (Trientine)",
    "genericName": "Syprine (Trientine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Manufacture recommendation, pharmacokinetic amorphous solid dispersion technology may be affected",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/019194Orig1s000rev.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Manufacture recommendation, pharmacokinetic amorphous solid dispersion technology may be affected",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/019194Orig1s000rev.pdf"
  },
  {
    "id": "621",
    "name": "Tafinlar (Dabrafenib)",
    "genericName": "Tafinlar (Dabrafenib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not open, crush, or break TAFINLAR capsules.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/202806s038,217514s009lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not open, crush, or break TAFINLAR capsules.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/202806s038,217514s009lbl.pdf"
  },
  {
    "id": "622",
    "name": "Tagrisso (Osimertinib)",
    "genericName": "Tagrisso (Osimertinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Disperse tablet in 4 tablespoons (approximately 50 mL) of non-carbonated water only. Stir until tablet is completely dispersed and swallow or administer through naso-gastric tube immediately.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/208065s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Disperse tablet in 4 tablespoons (approximately 50 mL) of non-carbonated water only. Stir until tablet is completely dispersed and swallow or administer through naso-gastric tube immediately.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/208065s000lbl.pdf"
  },
  {
    "id": "623",
    "name": "Talicia (Omeprazole, Amoxicillin, And Rifabutin)",
    "genericName": "Talicia (Omeprazole, Amoxicillin, And Rifabutin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow whole. Do not crush or chew",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/213004s014lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow whole. Do not crush or chew",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/213004s014lbl.pdf"
  },
  {
    "id": "624",
    "name": "Talwin (Pentazocine)",
    "genericName": "Talwin (Pentazocine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Manufacture recommendation. Swallow whole. Do not crush or chew",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "Manufacture recommendation. Swallow whole. Do not crush or chew",
    "reference": ""
  },
  {
    "id": "625",
    "name": "Talzenna (Talazoparib)",
    "genericName": "Talzenna (Talazoparib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow TALZENNA capsules whole. Do not open or dissolve",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217439s000lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow TALZENNA capsules whole. Do not open or dissolve",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217439s000lbl.pdf"
  },
  {
    "id": "626",
    "name": "Tamoxifen",
    "genericName": "Tamoxifen",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Hazardous substance",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/17970s37s44s49lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Hazardous substance",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/17970s37s44s49lbl.pdf"
  },
  {
    "id": "627",
    "name": "Targiniq Er (Oxycodone And Naloxone)",
    "genericName": "Targiniq Er (Oxycodone And Naloxone)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "swallow tablets intact and not to cut, break, chew, crush, or dissolve tablets (risk of potentially fatal overdose)",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205777s010s011lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "swallow tablets intact and not to cut, break, chew, crush, or dissolve tablets (risk of potentially fatal overdose)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205777s010s011lbl.pdf"
  },
  {
    "id": "628",
    "name": "Tarpeyo (Budesonide)",
    "genericName": "Tarpeyo (Budesonide)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Swallow whole. Do not open, crush or chew",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215935s005lbl.pdf"
      }
    ],
    "form": "Delayed Released Capsule",
    "alteration": "Swallow whole. Do not open, crush or chew",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215935s005lbl.pdf"
  },
  {
    "id": "629",
    "name": "Tasigna (Nilotinib)",
    "genericName": "Tasigna (Nilotinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "swallow the capsules whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022068s041lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "swallow the capsules whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022068s041lbl.pdf"
  },
  {
    "id": "630",
    "name": "Tazverik (Tazemetostat)",
    "genericName": "Tazverik (Tazemetostat)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow tablets whole. Do not cut, crush, or chew tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/211723s005lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow tablets whole. Do not cut, crush, or chew tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/211723s005lbl.pdf"
  },
  {
    "id": "631",
    "name": "Tecfidera(Dimethyl Fumarate)",
    "genericName": "Tecfidera(Dimethyl Fumarate)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow TECFIDERA capsules whole and intact. Do not crush, chew, or sprinkle capsule contents on food",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204063s031lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow TECFIDERA capsules whole and intact. Do not crush, chew, or sprinkle capsule contents on food",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204063s031lbl.pdf"
  },
  {
    "id": "632",
    "name": "Carbamazepine",
    "genericName": "Carbamazepine",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Chewable Tablet",
        "alteration": "Crushable",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/016608s115_018281_s058_018927s055_020234_s047.pdf"
      },
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016608s121_018927s60_020234s054lbl.pdf"
      }
    ],
    "form": "Chewable Tablet",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/016608s115_018281_s058_018927s055_020234_s047.pdf"
  },
  {
    "id": "633",
    "name": "Tegretol-Xr (Carbamazepine)",
    "genericName": "Tegretol-Xr (Carbamazepine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Tegretol-XR tablets must be swallowed whole and never crushed or chewed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016608s121_018927s60_020234s054lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Tegretol-XR tablets must be swallowed whole and never crushed or chewed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016608s121_018927s60_020234s054lbl.pdf"
  },
  {
    "id": "634",
    "name": "Temodar (Temozolomide)",
    "genericName": "Temodar (Temozolomide)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "TEMODAR capsules should be swallowed whole and NEVER \nCHEWED.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/21029s035lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "TEMODAR capsules should be swallowed whole and NEVER \nCHEWED.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/21029s035lbl.pdf"
  },
  {
    "id": "635",
    "name": "Tepmetko",
    "genericName": "Tepmetko",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow TEPMETKO tablets. Do not chew, crush or split tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214096s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow TEPMETKO tablets. Do not chew, crush or split tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214096s000lbl.pdf"
  },
  {
    "id": "636",
    "name": "Thalidomide",
    "genericName": "Thalidomide",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Film Coated Tablet",
        "alteration": "Manufacture recommendation, teratogenic potential, hazardous substance",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020785s069lbl.pdf"
      }
    ],
    "form": "Tablet (Film coated tablet)",
    "alteration": "Manufacture recommendation, teratogenic potential, hazardous substance",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020785s069lbl.pdf"
  },
  {
    "id": "637",
    "name": "Thalomid (Thalidomide)",
    "genericName": "Thalomid (Thalidomide)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Manufacture recommendation, teratogenic potential, hazardous substance",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020785s069lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Manufacture recommendation, teratogenic potential, hazardous substance",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020785s069lbl.pdf"
  },
  {
    "id": "638",
    "name": "Theo-24 (Theophyline)",
    "genericName": "Theo-24 (Theophyline)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Extended release, containes beads that dissolves through GI tract",
        "reference": ""
      }
    ],
    "form": "Capsule",
    "alteration": "Extended release, containes beads that dissolves through GI tract",
    "reference": ""
  },
  {
    "id": "639",
    "name": "Tiazac",
    "genericName": "Tiazac",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Tiazac (diltiazem hydrochloride) Extended-Release Capsules may also be administered by carefully \nopening the capsule and sprinkling the capsule contents on a spoonful of applesauce. The applesauce \nshould be swallowed immediately without chewing and followed with a glass of cool water to ensure \ncomplete swallowing of the capsule contents. The applesauce should not be hot, and it should be soft \nenough to be swallowed without chewing. Any capsule contents/applesauce mixture should be used \nimmediately and not stored for future use. Subdividing the contents of a Tiazac (diltiazem hydrochloride) \nExtended-Release Capsule is not recommended.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020401s044lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Tiazac (diltiazem hydrochloride) Extended-Release Capsules may also be administered by carefully \nopening the capsule and sprinkling the capsule contents on a spoonful of applesauce. The applesauce \nshould be swallowed immediately without chewing and followed with a glass of cool water to ensure \ncomplete swallowing of the capsule contents. The applesauce should not be hot, and it should be soft \nenough to be swallowed without chewing. Any capsule contents/applesauce mixture should be used \nimmediately and not stored for future use. Subdividing the contents of a Tiazac (diltiazem hydrochloride) \nExtended-Release Capsule is not recommended.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020401s044lbl.pdf"
  },
  {
    "id": "640",
    "name": "Tibsovo (Ivosidenib)",
    "genericName": "Tibsovo (Ivosidenib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not split or crush TIBSOVO tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211192s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not split or crush TIBSOVO tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211192s000lbl.pdf"
  },
  {
    "id": "641",
    "name": "Tirosint (Levothyroxine)",
    "genericName": "Tirosint (Levothyroxine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow TIROSINT capsules whole, do not cut, crush, or chew",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021924Orig1s021lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow TIROSINT capsules whole, do not cut, crush, or chew",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021924Orig1s021lbl.pdf"
  },
  {
    "id": "642",
    "name": "Itraconazole",
    "genericName": "Itraconazole",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow whole. Do not chew crush or break.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208901s000lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow whole. Do not chew crush or break.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208901s000lbl.pdf"
  },
  {
    "id": "643",
    "name": "Tolsura (Itraconazole)",
    "genericName": "Tolsura (Itraconazole)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow whole. Do not chew crush or break.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208901s000lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow whole. Do not chew crush or break.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208901s000lbl.pdf"
  },
  {
    "id": "644",
    "name": "Topamax Sprinkle",
    "genericName": "Topamax Sprinkle",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "TOPAMAX Sprinkle Capsules may be swallowed whole or may be administered by carefully \nopening the capsule and sprinkling the entire contents on a small amount (teaspoon) of soft food. \nThis drug/food mixture should be swallowed immediately and not chewed. It should not be stored \nfor future use.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020505s067,020844s058lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "TOPAMAX Sprinkle Capsules may be swallowed whole or may be administered by carefully \nopening the capsule and sprinkling the entire contents on a small amount (teaspoon) of soft food. \nThis drug/food mixture should be swallowed immediately and not chewed. It should not be stored \nfor future use.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020505s067,020844s058lbl.pdf"
  },
  {
    "id": "645",
    "name": "Topiramate",
    "genericName": "Topiramate",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "TOPAMAX Sprinkle Capsules may be swallowed whole or may be administered by carefully \nopening the capsule and sprinkling the entire contents on a small amount (teaspoon) of soft food. \nThis drug/food mixture should be swallowed immediately and not chewed. It should not be stored \nfor future use.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020505s067,020844s058lbl.pdf"
      },
      {
        "form": "Tablet",
        "alteration": "Because of the bitter taste, tablets should not be broken",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020505s067,020844s058lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020505s067,020844s058lbl.pdf"
  },
  {
    "id": "646",
    "name": "Metoprolol Succinate",
    "genericName": "Metoprolol Succinate",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Tablets are scored and can be divided; however, do not crush or chew the whole or half tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019962s050s052lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Tablets are scored and can be divided; however, do not crush or chew the whole or half tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019962s050s052lbl.pdf"
  },
  {
    "id": "647",
    "name": "Toprol Xl (Metoprolol Succinate)",
    "genericName": "Toprol Xl (Metoprolol Succinate)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "TOPROL-XL tablets are scored and can be divided; however, do not crush or chew the whole or half tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019962s050s052lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "TOPROL-XL tablets are scored and can be divided; however, do not crush or chew the whole or half tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019962s050s052lbl.pdf"
  },
  {
    "id": "648",
    "name": "Toviaz (Fesoterpdome)",
    "genericName": "Toviaz (Fesoterpdome)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Toviaz should be taken with liquid and swallowed whole. Toviaz can be administered with or without food, and should not be chewed, divided, or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022030lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Toviaz should be taken with liquid and swallowed whole. Toviaz can be administered with or without food, and should not be chewed, divided, or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022030lbl.pdf"
  },
  {
    "id": "649",
    "name": "Tracleer (Bosentan)",
    "genericName": "Tracleer (Bosentan)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Teratogenic potential, hazardous substance. Women who are or may be pregnant should not handle crushed or broken tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021290s047,209279s014lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Teratogenic potential, hazardous substance. Women who are or may be pregnant should not handle crushed or broken tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021290s047,209279s014lbl.pdf"
  },
  {
    "id": "650",
    "name": "Tramadol Er",
    "genericName": "Tramadol Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "swallow ULTRAM ER tablets whole [see Patient Counseling Information (17)], and to take it \nwith liquid. Crushing, chewing, splitting, or dissolving ULTRAM ER tablets will result in uncontrolled delivery \nof tramadol and can lead to overdose or death [",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021692s015lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "swallow ULTRAM ER tablets whole [see Patient Counseling Information (17)], and to take it \nwith liquid. Crushing, chewing, splitting, or dissolving ULTRAM ER tablets will result in uncontrolled delivery \nof tramadol and can lead to overdose or death [",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021692s015lbl.pdf"
  },
  {
    "id": "651",
    "name": "Tranexamic Acid",
    "genericName": "Tranexamic Acid",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Tablet should be take as a whole not chewed or broken apart",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202093Orig1s000.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Tablet should be take as a whole not chewed or broken apart",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202093Orig1s000.pdf"
  },
  {
    "id": "652",
    "name": "Pentoxifylline",
    "genericName": "Pentoxifylline",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Take as a whole",
        "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074425"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Take as a whole",
    "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074425"
  },
  {
    "id": "653",
    "name": "Trental (Pentoxifylline)",
    "genericName": "Trental (Pentoxifylline)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Take as a whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018631s041lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Take as a whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018631s041lbl.pdf"
  },
  {
    "id": "654",
    "name": "Treximet (Sumatriptan And Naproxen)",
    "genericName": "Treximet (Sumatriptan And Naproxen)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Tablets should not be split, crushed, or chewed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021926s019lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Tablets should not be split, crushed, or chewed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021926s019lbl.pdf"
  },
  {
    "id": "655",
    "name": "Triglide (Fenofibrate And Derivatives)",
    "genericName": "Triglide (Fenofibrate And Derivatives)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Advise patients to swallow Triglide tablets whole. Do not split, crush, dissolve, or \nchew tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021350s024lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Advise patients to swallow Triglide tablets whole. Do not split, crush, dissolve, or \nchew tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021350s024lbl.pdf"
  },
  {
    "id": "656",
    "name": "Trijardy Xr (Empagliflozin, Linagliptin And Metformin)",
    "genericName": "Trijardy Xr (Empagliflozin, Linagliptin And Metformin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Administer TRIKAFTA tablets (swallow the tablets whole)",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/212273Orig1s013;217660Orig1s005correctedlbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Administer TRIKAFTA tablets (swallow the tablets whole)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/212273Orig1s013;217660Orig1s005correctedlbl.pdf"
  },
  {
    "id": "657",
    "name": "Trikafta (Elexacaftor, Tezacaftor And Ivacaftor)",
    "genericName": "Trikafta (Elexacaftor, Tezacaftor And Ivacaftor)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Manufacturer recommendation, pharmacokinetic amorhpous solid dispersion technology maybe affected",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/212273Orig1s013;217660Orig1s005correctedlbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Manufacturer recommendation, pharmacokinetic amorhpous solid dispersion technology maybe affected",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/212273Orig1s013;217660Orig1s005correctedlbl.pdf"
  },
  {
    "id": "658",
    "name": "Trilipix (Fenofribate)",
    "genericName": "Trilipix (Fenofribate)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Advise patients to swallow Trilipix capsules whole. Do not crush, break, dissolve, or chew capsules.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022224s018lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Advise patients to swallow Trilipix capsules whole. Do not crush, break, dissolve, or chew capsules.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022224s018lbl.pdf"
  },
  {
    "id": "659",
    "name": "Topamax",
    "genericName": "Topamax",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "TOPAMAX Sprinkle Capsules may be swallowed whole or may be administered by carefully opening the capsule and sprinkling the entire contents on a small amount (teaspoon) of soft food. This drug/food mixture should be swallowed immediately and not chewed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020505s067,020844s058lbl.pdf"
      },
      {
        "form": "Tablet",
        "alteration": "Because of the bitter taste, tablets should not be broken.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020505s067,020844s058lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020505s067,020844s058lbl.pdf"
  },
  {
    "id": "660",
    "name": "Trokendi Xr",
    "genericName": "Trokendi Xr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Swallow capsule whole and intact. Do not sprinkle on food, chew, or crush",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/201635s036lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Swallow capsule whole and intact. Do not sprinkle on food, chew, or crush",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/201635s036lbl.pdf"
  },
  {
    "id": "661",
    "name": "Topiramate Er",
    "genericName": "Topiramate Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Swallow capsule whole and intact. Do not sprinkle on food, chew, or crush",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/201635s036lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Swallow capsule whole and intact. Do not sprinkle on food, chew, or crush",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/201635s036lbl.pdf"
  },
  {
    "id": "662",
    "name": "Trulance (Plecanatide)",
    "genericName": "Trulance (Plecanatide)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow a tablet whole for each dose. \n•\t For adult patients with swallowing difficulties, TRULANCE tablets can be crushed and administered orally either in \napplesauce or with water or administered with water via a nasogastric or gastric feeding tube. Mixing TRULANCE \ncrushed tablets in other soft foods or in other liquids has not been tested",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208745s011lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow a tablet whole for each dose. \n•\t For adult patients with swallowing difficulties, TRULANCE tablets can be crushed and administered orally either in \napplesauce or with water or administered with water via a nasogastric or gastric feeding tube. Mixing TRULANCE \ncrushed tablets in other soft foods or in other liquids has not been tested",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208745s011lbl.pdf"
  },
  {
    "id": "663",
    "name": "Truseltiq",
    "genericName": "Truseltiq",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow capsules whole with a glass of water. Do not crush, chew or \ndissolve. (",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214622s000lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow capsules whole with a glass of water. Do not crush, chew or \ndissolve. (",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214622s000lbl.pdf"
  },
  {
    "id": "664",
    "name": "Tukysa (Tucatinib)",
    "genericName": "Tukysa (Tucatinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "swallow TUKYSA tablets whole and not to chew, crush, or split prior to swallowing. Advise \npatients not to ingest tablet if it is broken, cracked, or not otherwise intact.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213411s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "swallow TUKYSA tablets whole and not to chew, crush, or split prior to swallowing. Advise \npatients not to ingest tablet if it is broken, cracked, or not otherwise intact.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213411s000lbl.pdf"
  },
  {
    "id": "665",
    "name": "Turalio (Pexidartinib)",
    "genericName": "Turalio (Pexidartinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow TURALIO capsules whole. Do not open, break, or chew the capsules",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211810s013lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow TURALIO capsules whole. Do not open, break, or chew the capsules",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211810s013lbl.pdf"
  },
  {
    "id": "666",
    "name": "Tylenol 8 Hour (Acetaminophen)",
    "genericName": "Tylenol 8 Hour (Acetaminophen)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "extended release caplet",
        "reference": ""
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "extended release caplet",
    "reference": ""
  },
  {
    "id": "667",
    "name": "Uceris (Budesonide)",
    "genericName": "Uceris (Budesonide)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "UCERIS should be swallowed whole and not chewed, crushed or broken.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/203634s012lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "UCERIS should be swallowed whole and not chewed, crushed or broken.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/203634s012lbl.pdf"
  },
  {
    "id": "668",
    "name": "Ukoniq(Umbralisib)",
    "genericName": "Ukoniq(Umbralisib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow tablets whole. Do not crush, break, cut, or chew tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213176s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow tablets whole. Do not crush, break, cut, or chew tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213176s000lbl.pdf"
  },
  {
    "id": "669",
    "name": "Tramadol",
    "genericName": "Tramadol",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020281s040lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020281s040lbl.pdf"
  },
  {
    "id": "670",
    "name": "Ultram",
    "genericName": "Ultram",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020281s040lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020281s040lbl.pdf"
  },
  {
    "id": "671",
    "name": "Ultram Er",
    "genericName": "Ultram Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "swallow ULTRAM ER tablets whole [see Patient Counseling Information (17)], and to take it \nwith liquid. Crushing, chewing, splitting, or dissolving ULTRAM ER tablets will result in uncontrolled delivery \nof tramadol and can lead to overdose or death [",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021692s015lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "swallow ULTRAM ER tablets whole [see Patient Counseling Information (17)], and to take it \nwith liquid. Crushing, chewing, splitting, or dissolving ULTRAM ER tablets will result in uncontrolled delivery \nof tramadol and can lead to overdose or death [",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021692s015lbl.pdf"
  },
  {
    "id": "672",
    "name": "Theophylline Er",
    "genericName": "Theophylline Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not split, crush, or chew tablets.",
        "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=087943"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Do not split, crush, or chew tablets.",
    "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=087943"
  },
  {
    "id": "673",
    "name": "Uptravi (Selexipag)",
    "genericName": "Uptravi (Selexipag)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Film Coated Tablet",
        "alteration": "Do not split, crush, or chew tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207947s009lbl.pdf"
      }
    ],
    "form": "Tablet (Film coated tablet)",
    "alteration": "Do not split, crush, or chew tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207947s009lbl.pdf"
  },
  {
    "id": "674",
    "name": "Urocit0K (Potassium Citrate)",
    "genericName": "Urocit0K (Potassium Citrate)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Tell patients to take each dose without crushing, chewing or sucking the tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019071s013lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Tell patients to take each dose without crushing, chewing or sucking the tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019071s013lbl.pdf"
  },
  {
    "id": "675",
    "name": "Uroxatral (Alfuzosin)",
    "genericName": "Uroxatral (Alfuzosin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Tablets should not be chewed or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021287s024lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Tablets should not be chewed or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021287s024lbl.pdf"
  },
  {
    "id": "676",
    "name": "Valcyte (Valganciclovir)",
    "genericName": "Valcyte (Valganciclovir)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Crushable",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021304.s17_22257s12lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Crushable",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021304.s17_22257s12lbl.pdf"
  },
  {
    "id": "677",
    "name": "Vascepa (Omega-3 Fatty Acids)",
    "genericName": "Vascepa (Omega-3 Fatty Acids)",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Patients should be advised to swallow VASCEPA capsules whole. Do not\n \nbreak open, crush, dissolve, or chew VASCEPA",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202057s019lbl.pdf"
      },
      {
        "form": "Capsule",
        "alteration": "Advise patients to swallow capsules whole. Do not break open, crush, dissolve, or chew",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202057s035lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202057s019lbl.pdf"
  },
  {
    "id": "678",
    "name": "Venclexta (Venetoclax)",
    "genericName": "Venclexta (Venetoclax)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not chew, crush, or break tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208573s013lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not chew, crush, or break tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208573s013lbl.pdf"
  },
  {
    "id": "679",
    "name": "Effexor Xr (Venlafaxine)",
    "genericName": "Effexor Xr (Venlafaxine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Capsules should be taken whole; do not divide, crush, chew, or dissolve",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020699s118lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Capsules should be taken whole; do not divide, crush, chew, or dissolve",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020699s118lbl.pdf"
  },
  {
    "id": "680",
    "name": "Venlafaxine Er",
    "genericName": "Venlafaxine Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Capsules should be taken whole; do not divide, crush, chew, or dissolve",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020699s118lbl.pdf"
      }
    ],
    "form": "Extended Released Capsule",
    "alteration": "Capsules should be taken whole; do not divide, crush, chew, or dissolve",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020699s118lbl.pdf"
  },
  {
    "id": "681",
    "name": "Verapamil Sr",
    "genericName": "Verapamil Sr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "The caplets are designed \nfor sustained release of the drug in the gastrointestinal tract; sustained-release \ncharacteristics are not altered when the caplet is divided in half.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019152s044lbl.pdf"
      }
    ],
    "form": "Extended Release Extended",
    "alteration": "The caplets are designed \nfor sustained release of the drug in the gastrointestinal tract; sustained-release \ncharacteristics are not altered when the caplet is divided in half.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019152s044lbl.pdf"
  },
  {
    "id": "682",
    "name": "Verelan (Verapamil )",
    "genericName": "Verelan (Verapamil )",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow tablets whole. Do not chew, divide, or crush. \n• For patients who cannot swallow tablets whole, use tablets or oral \ngranules to create a suspension or a mixture\n• VIJOICE suspension made with water can be administered orally or via \na nasogastric or gastric tube",
        "reference": ""
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow tablets whole. Do not chew, divide, or crush. \n• For patients who cannot swallow tablets whole, use tablets or oral \ngranules to create a suspension or a mixture\n• VIJOICE suspension made with water can be administered orally or via \na nasogastric or gastric tube",
    "reference": ""
  },
  {
    "id": "683",
    "name": "Verelan Pm (Verapamil)",
    "genericName": "Verelan Pm (Verapamil)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "Do not crush or chew capsule contents; swallow capsule whole or sprinkle entire contents onto applesauce",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020943s035lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "Do not crush or chew capsule contents; swallow capsule whole or sprinkle entire contents onto applesauce",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020943s035lbl.pdf"
  },
  {
    "id": "684",
    "name": "Verzenio (Abemaciclib)",
    "genericName": "Verzenio (Abemaciclib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "swallow VERZENIO tablets whole and not to chew, crush, or split tablets before swallowing. Instruct \npatients not to ingest VERZENIO tablets if broken, cracked, or otherwise not intact.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208716Orig1s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "swallow VERZENIO tablets whole and not to chew, crush, or split tablets before swallowing. Instruct \npatients not to ingest VERZENIO tablets if broken, cracked, or otherwise not intact.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208716Orig1s000lbl.pdf"
  },
  {
    "id": "685",
    "name": "Solifenancin",
    "genericName": "Solifenancin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "swallowed whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21518lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "swallowed whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21518lbl.pdf"
  },
  {
    "id": "686",
    "name": "Vesicare (Solifenancin)",
    "genericName": "Vesicare (Solifenancin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "VESIcare should be taken with liquids and swallowed whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21518lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "VESIcare should be taken with liquids and swallowed whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21518lbl.pdf"
  },
  {
    "id": "687",
    "name": "Videx Ec (Didanosin)",
    "genericName": "Videx Ec (Didanosin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "VIDEX EC Delayed-Release Capsules \nshould be swallowed intact.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021183s029lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "VIDEX EC Delayed-Release Capsules \nshould be swallowed intact.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021183s029lbl.pdf"
  },
  {
    "id": "688",
    "name": "Viekira Xr (Ombitasvir, Paritaprevir, Ritonavir And Dasabuvir)",
    "genericName": "Viekira Xr (Ombitasvir, Paritaprevir, Ritonavir And Dasabuvir)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow tablets whole. Splitting, crushing, or chewing tablets may compromise the\n \nextended-release performance, efficacy, and/or safety of VIEKIRA XR",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208624s008lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow tablets whole. Splitting, crushing, or chewing tablets may compromise the\n \nextended-release performance, efficacy, and/or safety of VIEKIRA XR",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208624s008lbl.pdf"
  },
  {
    "id": "689",
    "name": "Vijoice (Alpelisib)",
    "genericName": "Vijoice (Alpelisib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow tablets whole. Do not chew, divide, or crush. \n• For patients who cannot swallow tablets whole, use tablets or oral \ngranules to create a suspension or a mixture\n• VIJOICE suspension made with water can be administered orally or via \na nasogastric or gastric tube",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215039s003,218466s001lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow tablets whole. Do not chew, divide, or crush. \n• For patients who cannot swallow tablets whole, use tablets or oral \ngranules to create a suspension or a mixture\n• VIJOICE suspension made with water can be administered orally or via \na nasogastric or gastric tube",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215039s003,218466s001lbl.pdf"
  },
  {
    "id": "690",
    "name": "Vimovo (Naproxen And Esomeprazole)",
    "genericName": "Vimovo (Naproxen And Esomeprazole)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Tablet",
        "alteration": "Swallow tablets whole. Do not chew, divide, or crush. \n• For patients who cannot swallow tablets whole, use tablets or oral \ngranules to create a suspension or a mixture. (2.4)\n• VIJOICE suspension made with water can be administered orally or via \na nasogastric or gastric tube",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022511lbl.pdf"
      }
    ],
    "form": "Delayed Released Tablet",
    "alteration": "Swallow tablets whole. Do not chew, divide, or crush. \n• For patients who cannot swallow tablets whole, use tablets or oral \ngranules to create a suspension or a mixture. (2.4)\n• VIJOICE suspension made with water can be administered orally or via \na nasogastric or gastric tube",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022511lbl.pdf"
  },
  {
    "id": "691",
    "name": "Lacosamide",
    "genericName": "Lacosamide",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "VIMPAT tablets should be swallowed whole with liquid. Do not divide VIMPAT tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022253s057,022254s047,022255s039lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "VIMPAT tablets should be swallowed whole with liquid. Do not divide VIMPAT tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022253s057,022254s047,022255s039lbl.pdf"
  },
  {
    "id": "692",
    "name": "Vimpat (Lacosamide)",
    "genericName": "Vimpat (Lacosamide)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "VIMPAT tablets should be swallowed whole with liquid. Do not divide VIMPAT tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022253s057,022254s047,022255s039lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "VIMPAT tablets should be swallowed whole with liquid. Do not divide VIMPAT tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022253s057,022254s047,022255s039lbl.pdf"
  },
  {
    "id": "693",
    "name": "Viokace (Pancrelipase)",
    "genericName": "Viokace (Pancrelipase)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "VIOKACE tablets should be swallowed whole. Do not crush or chew tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022542s000lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "VIOKACE tablets should be swallowed whole. Do not crush or chew tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022542s000lbl.pdf"
  },
  {
    "id": "694",
    "name": "Viramune Xr(Nevirapine)",
    "genericName": "Viramune Xr(Nevirapine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Must be swallowed whole and must not be chewed, crushed, or divided.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/201152s015lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Must be swallowed whole and must not be chewed, crushed, or divided.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/201152s015lbl.pdf"
  },
  {
    "id": "695",
    "name": "Vitrakvi (Larotrectinib)",
    "genericName": "Vitrakvi (Larotrectinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow capsules whole with water. Do not chew or crush the capsules.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210861s000lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow capsules whole with water. Do not chew or crush the capsules.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210861s000lbl.pdf"
  },
  {
    "id": "696",
    "name": "Vivjoa (Oteseconazole)",
    "genericName": "Vivjoa (Oteseconazole)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow the capsules whole.\nDo not chew, crush, dissolve, or open the capsules.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215888s002lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow the capsules whole.\nDo not chew, crush, dissolve, or open the capsules.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215888s002lbl.pdf"
  },
  {
    "id": "697",
    "name": "Vivotif (Typhoid Vaccine)",
    "genericName": "Vivotif (Typhoid Vaccine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "must be swallowed whole and not",
        "reference": ""
      }
    ],
    "form": "capsule",
    "alteration": "must be swallowed whole and not",
    "reference": ""
  },
  {
    "id": "698",
    "name": "Diclofennac Er",
    "genericName": "Diclofennac Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "chewed, cut, or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020254s030lbl.pdf"
      }
    ],
    "form": "Extended released Tablet",
    "alteration": "chewed, cut, or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020254s030lbl.pdf"
  },
  {
    "id": "699",
    "name": "Voltaren-Xr (Diclofenac)",
    "genericName": "Voltaren-Xr (Diclofenac)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Must be swallowed whole and must not be chewed, crushed, or divided.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020254s030lbl.pdf"
      }
    ],
    "form": "Extended released tablet",
    "alteration": "Must be swallowed whole and must not be chewed, crushed, or divided.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020254s030lbl.pdf"
  },
  {
    "id": "700",
    "name": "Vonjo (Pacritinib)",
    "genericName": "Vonjo (Pacritinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow capsules whole. Do not open, break, or chew capsules.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208712s000lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow capsules whole. Do not open, break, or chew capsules.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208712s000lbl.pdf"
  },
  {
    "id": "701",
    "name": "Votrient (Pazopanib)",
    "genericName": "Votrient (Pazopanib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow tablets whole. Do not crush tablets due to the potential for increased rate of absorption, which may\naffect systemic exposure",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022465s036lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow tablets whole. Do not crush tablets due to the potential for increased rate of absorption, which may\naffect systemic exposure",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022465s036lbl.pdf"
  },
  {
    "id": "702",
    "name": "Vumerity (Diroximel Fumrate)",
    "genericName": "Vumerity (Diroximel Fumrate)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow VUMERITY capsules whole and intact. Do not crush, chew, or sprinkle capsule contents on food",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/211855s015lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow VUMERITY capsules whole and intact. Do not crush, chew, or sprinkle capsule contents on food",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/211855s015lbl.pdf"
  },
  {
    "id": "703",
    "name": "Vyndamax (Tafamidis)",
    "genericName": "Vyndamax (Tafamidis)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "The capsules should be swallowed whole and not crushed or cut.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211996s002,212161s002lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "The capsules should be swallowed whole and not crushed or cut.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211996s002,212161s002lbl.pdf"
  },
  {
    "id": "704",
    "name": "Vyndaqel (Tafamidis)",
    "genericName": "Vyndaqel (Tafamidis)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "The capsules should be swallowed whole and not crushed or cut.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211996s002,212161s002lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "The capsules should be swallowed whole and not crushed or cut.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211996s002,212161s002lbl.pdf"
  },
  {
    "id": "705",
    "name": "Wakix (Pitolisant )",
    "genericName": "Wakix (Pitolisant )",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Canadian manufactuer recommendation",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211150s007lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Canadian manufactuer recommendation",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211150s007lbl.pdf"
  },
  {
    "id": "706",
    "name": "Xalkori (Crizotinib)",
    "genericName": "Xalkori (Crizotinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow capsules whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202570s031lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow capsules whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202570s031lbl.pdf"
  },
  {
    "id": "707",
    "name": "Xanax Xr (Alprazolam)",
    "genericName": "Xanax Xr (Alprazolam)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow tablets whole; do not divide, crush, or chew",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021434s022lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow tablets whole; do not divide, crush, or chew",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021434s022lbl.pdf"
  },
  {
    "id": "708",
    "name": "Xartemis Xr (Oxycodone And Acetaminophen )",
    "genericName": "Xartemis Xr (Oxycodone And Acetaminophen )",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Extended release tablet, tablet disruption may cause a potentially fatal overdose",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204031s004s005lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Extended release tablet, tablet disruption may cause a potentially fatal overdose",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204031s004s005lbl.pdf"
  },
  {
    "id": "709",
    "name": "Xcopri (Cenobamate)",
    "genericName": "Xcopri (Cenobamate)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "XCOPRI can be taken whole or the tablets can be crushed. The crushed\ntablet can be mixed with water and either administered by mouth as an oral\nsuspension or administered via a nasogastric tube. (",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/212839s009s010lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "XCOPRI can be taken whole or the tablets can be crushed. The crushed\ntablet can be mixed with water and either administered by mouth as an oral\nsuspension or administered via a nasogastric tube. (",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/212839s009s010lbl.pdf"
  },
  {
    "id": "710",
    "name": "Xeljanz (Tocfacotib)",
    "genericName": "Xeljanz (Tocfacotib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Extended release tablet, Manufacture recommendation)",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203214s000lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Extended release tablet, Manufacture recommendation)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203214s000lbl.pdf"
  },
  {
    "id": "711",
    "name": "Xeloda (Capecitabine)",
    "genericName": "Xeloda (Capecitabine)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow XELODA tablets whole with water within 30 minutes after a meal. Do not chew, cut,\nor crush XELODA tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020896s044s045s046s047s048s049s050s051lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow XELODA tablets whole with water within 30 minutes after a meal. Do not chew, cut,\nor crush XELODA tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020896s044s045s046s047s048s049s050s051lbl.pdf"
  },
  {
    "id": "712",
    "name": "Xigduo Xr (Dapagliflozin And Metformin)",
    "genericName": "Xigduo Xr (Dapagliflozin And Metformin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow XIGDUO XR tablets whole and never crush, cut, or chew",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205649s021lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow XIGDUO XR tablets whole and never crush, cut, or chew",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205649s021lbl.pdf"
  },
  {
    "id": "713",
    "name": "Ximino (Minocycline)",
    "genericName": "Ximino (Minocycline)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": ". The capsules should be swallowed whole without chewing, crushing or splitting.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/201922s000lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": ". The capsules should be swallowed whole without chewing, crushing or splitting.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/201922s000lbl.pdf"
  },
  {
    "id": "714",
    "name": "Xospata (Gilteritinib)",
    "genericName": "Xospata (Gilteritinib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not break or crush XOSPATA tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211349s003lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not break or crush XOSPATA tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211349s003lbl.pdf"
  },
  {
    "id": "715",
    "name": "Xpovio (Selinexor)",
    "genericName": "Xpovio (Selinexor)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "must be swallowed whole and not",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212306s011lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "must be swallowed whole and not",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212306s011lbl.pdf"
  },
  {
    "id": "716",
    "name": "Xtampza Er (Oxycodone)",
    "genericName": "Xtampza Er (Oxycodone)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Capsule",
        "alteration": "chewed, cut, or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208090s021lbl.pdf"
      }
    ],
    "form": "Extended released Capsule",
    "alteration": "chewed, cut, or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208090s021lbl.pdf"
  },
  {
    "id": "717",
    "name": "Xtandi (Enzalutamide)",
    "genericName": "Xtandi (Enzalutamide)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule/Tablet",
        "alteration": "Advise patients to take each capsule or tablet whole with a sufficient amount of water to ensure that all medication is\nsuccessfully swallowed. Do NOT chew, dissolve, or open the capsules. Do NOT cut, crush, or chew the tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/203415s024,213674s012lbl.pdf"
      }
    ],
    "form": "Capsule/tablet",
    "alteration": "Advise patients to take each capsule or tablet whole with a sufficient amount of water to ensure that all medication is\nsuccessfully swallowed. Do NOT chew, dissolve, or open the capsules. Do NOT cut, crush, or chew the tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/203415s024,213674s012lbl.pdf"
  },
  {
    "id": "718",
    "name": "Yonsa (Abiraterone)",
    "genericName": "Yonsa (Abiraterone)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "The tablets should be swallowed whole with water. Do not crush or\nchew tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210308s003lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "The tablets should be swallowed whole with water. Do not crush or\nchew tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210308s003lbl.pdf"
  },
  {
    "id": "719",
    "name": "Yosprala (Aspirin And Omeprazole)",
    "genericName": "Yosprala (Aspirin And Omeprazole)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Tablet",
        "alteration": "Do not split, chew, crush or dissolve the tablet.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/205103s010lbl.pdf"
      }
    ],
    "form": "Delayed Released Tablet",
    "alteration": "Do not split, chew, crush or dissolve the tablet.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/205103s010lbl.pdf"
  },
  {
    "id": "720",
    "name": "Zegerid Otc (Omeprazole And Sodium Bicarbonate)",
    "genericName": "Zegerid Otc (Omeprazole And Sodium Bicarbonate)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Do not crush or chew the capsule. Swallow whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022281Orig1s014Lbl.pdf"
      }
    ],
    "form": "Delayed Released Capsule",
    "alteration": "Do not crush or chew the capsule. Swallow whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022281Orig1s014Lbl.pdf"
  },
  {
    "id": "721",
    "name": "Zejula (Niraparib)",
    "genericName": "Zejula (Niraparib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "swallow tablets whole and not to chew, crush, or split ZEJULA prior to swallowing",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/214876s003s004lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "swallow tablets whole and not to chew, crush, or split ZEJULA prior to swallowing",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/214876s003s004lbl.pdf"
  },
  {
    "id": "722",
    "name": "Zelboraf (Vemurafenib)",
    "genericName": "Zelboraf (Vemurafenib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Do not crush or chew the tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202429s019lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Do not crush or chew the tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202429s019lbl.pdf"
  },
  {
    "id": "723",
    "name": "Zenatane (Isotretinoin)",
    "genericName": "Zenatane (Isotretinoin)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Mucous membrane irritant, teratogenic potential",
        "reference": ""
      }
    ],
    "form": "Capsule",
    "alteration": "Mucous membrane irritant, teratogenic potential",
    "reference": ""
  },
  {
    "id": "724",
    "name": "Zenpep (Pancrelispase)",
    "genericName": "Zenpep (Pancrelispase)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Swallow capsules whole. For patients unable to swallow intact capsule(s),\nthe capsule contents may be sprinkled on soft acidic food (e.g., applesauce,\nbananas, pears).\n Do not crush or chew ZENPEP capsules or capsule contents.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022210s026lbl.pdf"
      }
    ],
    "form": "Delayed Released Capsule",
    "alteration": "Swallow capsules whole. For patients unable to swallow intact capsule(s),\nthe capsule contents may be sprinkled on soft acidic food (e.g., applesauce,\nbananas, pears).\n Do not crush or chew ZENPEP capsules or capsule contents.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022210s026lbl.pdf"
  },
  {
    "id": "725",
    "name": "Zeposia (Ozanimod)",
    "genericName": "Zeposia (Ozanimod)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "must be swallowed whole and not",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209899s011s012lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "must be swallowed whole and not",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209899s011s012lbl.pdf"
  },
  {
    "id": "726",
    "name": "Zohydro Er (Hydrocodone)",
    "genericName": "Zohydro Er (Hydrocodone)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "chewed, cut, or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202880s020lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "chewed, cut, or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202880s020lbl.pdf"
  },
  {
    "id": "727",
    "name": "Zokinvy (Lonafarnib)",
    "genericName": "Zokinvy (Lonafarnib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Administer ZOKINVY capsules whole with a sufficient amount of water. Do not chew \nthe capsules. The entire contents of ZOKINVY capsules can be mixed with Ora Blend SF® or \nOra-Plus® or, for patients unable to access or tolerate Ora Blend SF or Ora-Plus, the \ncontents of ZOKINVY capsules can be mixed with orange juice or applesauce (",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/213969s002s003lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Administer ZOKINVY capsules whole with a sufficient amount of water. Do not chew \nthe capsules. The entire contents of ZOKINVY capsules can be mixed with Ora Blend SF® or \nOra-Plus® or, for patients unable to access or tolerate Ora Blend SF or Ora-Plus, the \ncontents of ZOKINVY capsules can be mixed with orange juice or applesauce (",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/213969s002s003lbl.pdf"
  },
  {
    "id": "728",
    "name": "Zolinza( Vorinostat)",
    "genericName": "Zolinza( Vorinostat)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "ZOLINZA capsules should not be opened or crushed [",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021991s009lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "ZOLINZA capsules should not be opened or crushed [",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021991s009lbl.pdf"
  },
  {
    "id": "729",
    "name": "Zomig-Zmt (Zolmitriptan)",
    "genericName": "Zomig-Zmt (Zolmitriptan)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not break ZOMIG orally disintegrating tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020768s019s021,021231s010s011lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not break ZOMIG orally disintegrating tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020768s019s021,021231s010s011lbl.pdf"
  },
  {
    "id": "730",
    "name": "Zonatuss (Benzonatate )",
    "genericName": "Zonatuss (Benzonatate )",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow whole, pharmacologic action may cause choking if cheewed or opened and swallowed",
        "reference": ""
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow whole, pharmacologic action may cause choking if cheewed or opened and swallowed",
    "reference": ""
  },
  {
    "id": "731",
    "name": "Zortress",
    "genericName": "Zortress",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Manufacturer recommendaiton, mucous membrane irritant , hazardous substance. Pharmacokinetic amorphous solid dispersion technology may be affected",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021560s032lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Manufacturer recommendaiton, mucous membrane irritant , hazardous substance. Pharmacokinetic amorphous solid dispersion technology may be affected",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021560s032lbl.pdf"
  },
  {
    "id": "732",
    "name": "Zubsolv",
    "genericName": "Zubsolv",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Sublingual Tablet",
        "alteration": "Sublingual form",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204242s031lbl.pdf"
      }
    ],
    "form": "Sublingual Tablet",
    "alteration": "Sublingual form",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204242s031lbl.pdf"
  },
  {
    "id": "733",
    "name": "Buprenorphine And Naloxone",
    "genericName": "Buprenorphine And Naloxone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Sublingual Tablet",
        "alteration": "Sublingual form",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204242s031lbl.pdf"
      }
    ],
    "form": "Sublingual Tablet",
    "alteration": "Sublingual form",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204242s031lbl.pdf"
  },
  {
    "id": "734",
    "name": "Zuplenz",
    "genericName": "Zuplenz",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Sublingual Film",
        "alteration": "Film, Sublingual form",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022524s007lbl.pdf"
      }
    ],
    "form": "Film, Sublingual Film",
    "alteration": "Film, Sublingual form",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022524s007lbl.pdf"
  },
  {
    "id": "735",
    "name": "Zyban",
    "genericName": "Zyban",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "ZYBAN should be swallowed whole and not crushed, divided, or chewed, as this may lead to an \nincreased risk of adverse effects including seizures",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020711s052lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "ZYBAN should be swallowed whole and not crushed, divided, or chewed, as this may lead to an \nincreased risk of adverse effects including seizures",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020711s052lbl.pdf"
  },
  {
    "id": "736",
    "name": "Zydelig (Idelaisib)",
    "genericName": "Zydelig (Idelaisib)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow tablets whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205858s016lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow tablets whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205858s016lbl.pdf"
  },
  {
    "id": "737",
    "name": "Zyflo",
    "genericName": "Zyflo",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "When you take your dose of ZYFLO, the tablets may be swallowed whole or split in half to make them easier to swallow",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020471s017lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "When you take your dose of ZYFLO, the tablets may be swallowed whole or split in half to make them easier to swallow",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020471s017lbl.pdf"
  },
  {
    "id": "738",
    "name": "Zyflo Cr (Zileuton)",
    "genericName": "Zyflo Cr (Zileuton)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Tablets should not be chewed, cut or crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022052s014lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Tablets should not be chewed, cut or crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022052s014lbl.pdf"
  },
  {
    "id": "739",
    "name": "Abiraterone",
    "genericName": "Abiraterone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "The tablets must be swallowed whole with water. Do not crush or \nchew tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202379s035lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "The tablets must be swallowed whole with water. Do not crush or \nchew tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202379s035lbl.pdf"
  },
  {
    "id": "740",
    "name": "Zytiga",
    "genericName": "Zytiga",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "The tablets must be swallowed whole with water. Do not crush or \nchew tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202379s035lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "The tablets must be swallowed whole with water. Do not crush or \nchew tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202379s035lbl.pdf"
  },
  {
    "id": "741",
    "name": "Glucophage Xr",
    "genericName": "Glucophage Xr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow GLUCOPHAGE XR tablets whole and never crush, cut or chew",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020357s034,021202s018lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow GLUCOPHAGE XR tablets whole and never crush, cut or chew",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020357s034,021202s018lbl.pdf"
  },
  {
    "id": "742",
    "name": "Glucohage",
    "genericName": "Glucohage",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Film Coated Tablet",
        "alteration": "Acceptable to be crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020357s034,021202s018lbl.pdf"
      }
    ],
    "form": "Tablet (Film coated tablet)",
    "alteration": "Acceptable to be crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020357s034,021202s018lbl.pdf"
  },
  {
    "id": "743",
    "name": "Metformin",
    "genericName": "Metformin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Acceptable to be crushed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020357s034,021202s018lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Acceptable to be crushed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020357s034,021202s018lbl.pdf"
  },
  {
    "id": "744",
    "name": "Prinivil",
    "genericName": "Prinivil",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "For individuals who have difficulty swallowing tablets, crushing lisinopril can be an option.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019558s063lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "For individuals who have difficulty swallowing tablets, crushing lisinopril can be an option.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019558s063lbl.pdf"
  },
  {
    "id": "745",
    "name": "Lisinopril",
    "genericName": "Lisinopril",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "For individuals who have difficulty swallowing tablets, crushing lisinopril can be an option.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019558s063lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "For individuals who have difficulty swallowing tablets, crushing lisinopril can be an option.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019558s063lbl.pdf"
  },
  {
    "id": "746",
    "name": "Synthroid",
    "genericName": "Synthroid",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Administer Levothyroxine Sodium Tablets to infants and children who cannot swallow intact Reference ID: 4422438 This label may not be the latest approved by FDA. For current labeling information, please visit https://www.fda.gov/drugsatfda tablets by crushing the tablet, suspending the freshly crushed tablet in a small amount (5 mL to 10 mL or 1 teaspoon to 2 teaspoons) of water and immediately administering the suspension by spoon or dropper",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021116s017lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Administer Levothyroxine Sodium Tablets to infants and children who cannot swallow intact Reference ID: 4422438 This label may not be the latest approved by FDA. For current labeling information, please visit https://www.fda.gov/drugsatfda tablets by crushing the tablet, suspending the freshly crushed tablet in a small amount (5 mL to 10 mL or 1 teaspoon to 2 teaspoons) of water and immediately administering the suspension by spoon or dropper",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021116s017lbl.pdf"
  },
  {
    "id": "747",
    "name": "Levothyroxine",
    "genericName": "Levothyroxine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Administer Levothyroxine Sodium Tablets to infants and children who cannot swallow intact Reference ID: 4422438 This label may not be the latest approved by FDA. For current labeling information, please visit https://www.fda.gov/drugsatfda tablets by crushing the tablet, suspending the freshly crushed tablet in a small amount (5 mL to 10 mL or 1 teaspoon to 2 teaspoons) of water and immediately administering the suspension by spoon or dropper",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021116s017lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Administer Levothyroxine Sodium Tablets to infants and children who cannot swallow intact Reference ID: 4422438 This label may not be the latest approved by FDA. For current labeling information, please visit https://www.fda.gov/drugsatfda tablets by crushing the tablet, suspending the freshly crushed tablet in a small amount (5 mL to 10 mL or 1 teaspoon to 2 teaspoons) of water and immediately administering the suspension by spoon or dropper",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021116s017lbl.pdf"
  },
  {
    "id": "748",
    "name": "Norvac",
    "genericName": "Norvac",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019787s062lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019787s062lbl.pdf"
  },
  {
    "id": "749",
    "name": "Amlodipine",
    "genericName": "Amlodipine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019787s062lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019787s062lbl.pdf"
  },
  {
    "id": "750",
    "name": "Lopressor",
    "genericName": "Lopressor",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017963Orig1s076lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017963Orig1s076lbl.pdf"
  },
  {
    "id": "751",
    "name": "Metoprolol Tartrate",
    "genericName": "Metoprolol Tartrate",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017963Orig1s076lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017963Orig1s076lbl.pdf"
  },
  {
    "id": "752",
    "name": "Cozaar",
    "genericName": "Cozaar",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Tablet may be crushed or split",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020386s069lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Tablet may be crushed or split",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020386s069lbl.pdf"
  },
  {
    "id": "753",
    "name": "Losartan",
    "genericName": "Losartan",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Tablet may be crushed or split",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020386s069lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Tablet may be crushed or split",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020386s069lbl.pdf"
  },
  {
    "id": "754",
    "name": "Zoloft",
    "genericName": "Zoloft",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Tablet may be crushed or split",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019839s108,20990s062lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Tablet may be crushed or split",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019839s108,20990s062lbl.pdf"
  },
  {
    "id": "755",
    "name": "Sertraline",
    "genericName": "Sertraline",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Tablet may be crushed or split",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019839s108,20990s062lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Tablet may be crushed or split",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019839s108,20990s062lbl.pdf"
  },
  {
    "id": "756",
    "name": "Inzirqo",
    "genericName": "Inzirqo",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/219141s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/219141s000lbl.pdf"
  },
  {
    "id": "757",
    "name": "Hydrochlorothiazide (Hctz)",
    "genericName": "Hydrochlorothiazide (Hctz)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/219141s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/219141s000lbl.pdf"
  },
  {
    "id": "758",
    "name": "Crestor",
    "genericName": "Crestor",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021366s046lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021366s046lbl.pdf"
  },
  {
    "id": "759",
    "name": "Rosuvastatin",
    "genericName": "Rosuvastatin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021366s046lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021366s046lbl.pdf"
  },
  {
    "id": "760",
    "name": "Lexapro",
    "genericName": "Lexapro",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021323s058lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021323s058lbl.pdf"
  },
  {
    "id": "761",
    "name": "Escitalopram",
    "genericName": "Escitalopram",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021323s058lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021323s058lbl.pdf"
  },
  {
    "id": "762",
    "name": "Singulair",
    "genericName": "Singulair",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020829s074,020830s076,021409s052lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020829s074,020830s076,021409s052lbl.pdf"
  },
  {
    "id": "763",
    "name": "Montelukast",
    "genericName": "Montelukast",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020829s074,020830s076,021409s052lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020829s074,020830s076,021409s052lbl.pdf"
  },
  {
    "id": "764",
    "name": "Raldesy",
    "genericName": "Raldesy",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow tablet whole or as a half tablet by breaking along the score line.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218637s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow tablet whole or as a half tablet by breaking along the score line.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218637s000lbl.pdf"
  },
  {
    "id": "765",
    "name": "Trazodone",
    "genericName": "Trazodone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow tablet whole or as a half tablet by breaking along the score line.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218637s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow tablet whole or as a half tablet by breaking along the score line.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218637s000lbl.pdf"
  },
  {
    "id": "766",
    "name": "Zocor",
    "genericName": "Zocor",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019766s104lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019766s104lbl.pdf"
  },
  {
    "id": "767",
    "name": "Simvastatin",
    "genericName": "Simvastatin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019766s104lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019766s104lbl.pdf"
  },
  {
    "id": "768",
    "name": "Vicodin",
    "genericName": "Vicodin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/088058s027lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/088058s027lbl.pdf"
  },
  {
    "id": "769",
    "name": "Acetaminophen/Hydrocodone",
    "genericName": "Acetaminophen/Hydrocodone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/088058s027lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/088058s027lbl.pdf"
  },
  {
    "id": "770",
    "name": "Lasix",
    "genericName": "Lasix",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/016273s061lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/016273s061lbl.pdf"
  },
  {
    "id": "771",
    "name": "Furosemide",
    "genericName": "Furosemide",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/016273s061lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/016273s061lbl.pdf"
  },
  {
    "id": "772",
    "name": "Amoxicillin Tablet",
    "genericName": "Amoxicillin Tablet",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet/Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42f935ca-45ba-4b3e-8b40-9b2d4eb56281"
      }
    ],
    "form": "Tablet/Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42f935ca-45ba-4b3e-8b40-9b2d4eb56281"
  },
  {
    "id": "773",
    "name": "Amoxicillin Capsule",
    "genericName": "Amoxicillin Capsule",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet/Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42f935ca-45ba-4b3e-8b40-9b2d4eb56281"
      }
    ],
    "form": "Tablet/Capsulle",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42f935ca-45ba-4b3e-8b40-9b2d4eb56281"
  },
  {
    "id": "774",
    "name": "Eliquis",
    "genericName": "Eliquis",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202155s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202155s000lbl.pdf"
  },
  {
    "id": "775",
    "name": "Apixaban",
    "genericName": "Apixaban",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202155s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202155s000lbl.pdf"
  },
  {
    "id": "776",
    "name": "Mobic",
    "genericName": "Mobic",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020938s030lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020938s030lbl.pdf"
  },
  {
    "id": "777",
    "name": "Meloxicam",
    "genericName": "Meloxicam",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020938s030lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020938s030lbl.pdf"
  },
  {
    "id": "778",
    "name": "Prednisone",
    "genericName": "Prednisone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3400d26a-41cb-40e4-99b4-780e1e0ec561"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3400d26a-41cb-40e4-99b4-780e1e0ec561"
  },
  {
    "id": "779",
    "name": "Advil",
    "genericName": "Advil",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/018989Orig1s104lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/018989Orig1s104lbl.pdf"
  },
  {
    "id": "780",
    "name": "Ibuprofen",
    "genericName": "Ibuprofen",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/018989Orig1s104lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/018989Orig1s104lbl.pdf"
  },
  {
    "id": "781",
    "name": "Aspirin Ec",
    "genericName": "Aspirin Ec",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Enteric Coated Tablet",
        "alteration": "Tablet should be take as a whole not chewed or broken apart",
        "reference": ""
      }
    ],
    "form": "EC Tablet",
    "alteration": "Tablet should be take as a whole not chewed or broken apart",
    "reference": ""
  },
  {
    "id": "782",
    "name": "Pravachol",
    "genericName": "Pravachol",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019898s070lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019898s070lbl.pdf"
  },
  {
    "id": "783",
    "name": "Pravastatin",
    "genericName": "Pravastatin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019898s070lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019898s070lbl.pdf"
  },
  {
    "id": "784",
    "name": "Zyloprim",
    "genericName": "Zyloprim",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016084s048s051s052lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016084s048s051s052lbl.pdf"
  },
  {
    "id": "785",
    "name": "Allopurinol",
    "genericName": "Allopurinol",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016084s048s051s052lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016084s048s051s052lbl.pdf"
  },
  {
    "id": "786",
    "name": "Celexa",
    "genericName": "Celexa",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020822s055lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020822s055lbl.pdf"
  },
  {
    "id": "787",
    "name": "Citalopram",
    "genericName": "Citalopram",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020822s055lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020822s055lbl.pdf"
  },
  {
    "id": "788",
    "name": "Xanax",
    "genericName": "Xanax",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018276s059lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018276s059lbl.pdf"
  },
  {
    "id": "789",
    "name": "Alprazolam",
    "genericName": "Alprazolam",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018276s059lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018276s059lbl.pdf"
  },
  {
    "id": "790",
    "name": "Certirizine",
    "genericName": "Certirizine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218895"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218895"
  },
  {
    "id": "791",
    "name": "Venlafaxine",
    "genericName": "Venlafaxine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/076690s020lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/076690s020lbl.pdf"
  },
  {
    "id": "792",
    "name": "Hydroxyzine",
    "genericName": "Hydroxyzine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010392"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010392"
  },
  {
    "id": "793",
    "name": "Plavix",
    "genericName": "Plavix",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020839s078lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020839s078lbl.pdf"
  },
  {
    "id": "794",
    "name": "Clopidogrel",
    "genericName": "Clopidogrel",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020839s078lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020839s078lbl.pdf"
  },
  {
    "id": "795",
    "name": "Famotidine",
    "genericName": "Famotidine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019462s040lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019462s040lbl.pdf"
  },
  {
    "id": "796",
    "name": "Spironolactone",
    "genericName": "Spironolactone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/012151s079lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/012151s079lbl.pdf"
  },
  {
    "id": "797",
    "name": "Aldactone",
    "genericName": "Aldactone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/012151s079lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/012151s079lbl.pdf"
  },
  {
    "id": "798",
    "name": "Prinzide",
    "genericName": "Prinzide",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019778s049lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019778s049lbl.pdf"
  },
  {
    "id": "799",
    "name": "Hydrochlrothiazide (Htcz)/Lisinopril",
    "genericName": "Hydrochlrothiazide (Htcz)/Lisinopril",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019778s049lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019778s049lbl.pdf"
  },
  {
    "id": "800",
    "name": "Buspar",
    "genericName": "Buspar",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018731s051lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018731s051lbl.pdf"
  },
  {
    "id": "801",
    "name": "Buspirone",
    "genericName": "Buspirone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018731s051lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018731s051lbl.pdf"
  },
  {
    "id": "802",
    "name": "Jardiance",
    "genericName": "Jardiance",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204629s040lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204629s040lbl.pdf"
  },
  {
    "id": "803",
    "name": "Empagliflozin",
    "genericName": "Empagliflozin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204629s040lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204629s040lbl.pdf"
  },
  {
    "id": "804",
    "name": "Clonazepam",
    "genericName": "Clonazepam",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018276s059lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018276s059lbl.pdf"
  },
  {
    "id": "805",
    "name": "Oxycodone",
    "genericName": "Oxycodone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": ""
  },
  {
    "id": "806",
    "name": "Ondansetron",
    "genericName": "Ondansetron",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020103s039,020605s023,020781s023lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020103s039,020605s023,020781s023lbl.pdf"
  },
  {
    "id": "807",
    "name": "Zofran Odt",
    "genericName": "Zofran Odt",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Disintegrating Tablet",
        "alteration": "IMMEDIATELY place the ZOFRAN ODT orally disintegrating tablet on top of the tongue where it will dissolve in seconds, then swallow with saliva. Administration with liquid is not necessary.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020103s039,020605s023,020781s023lbl.pdf"
      }
    ],
    "form": "Disintegrating tablet",
    "alteration": "IMMEDIATELY place the ZOFRAN ODT orally disintegrating tablet on top of the tongue where it will dissolve in seconds, then swallow with saliva. Administration with liquid is not necessary.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020103s039,020605s023,020781s023lbl.pdf"
  },
  {
    "id": "808",
    "name": "Ondansetron Odt",
    "genericName": "Ondansetron Odt",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Disintegrating Tablet",
        "alteration": "IMMEDIATELY place the ZOFRAN ODT orally disintegrating tablet on top of the tongue where it will dissolve in seconds, then swallow with saliva. Administration with liquid is not necessary.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020103s039,020605s023,020781s023lbl.pdf"
      }
    ],
    "form": "Disintegrating tablet",
    "alteration": "IMMEDIATELY place the ZOFRAN ODT orally disintegrating tablet on top of the tongue where it will dissolve in seconds, then swallow with saliva. Administration with liquid is not necessary.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020103s039,020605s023,020781s023lbl.pdf"
  },
  {
    "id": "809",
    "name": "Cholecalciferol",
    "genericName": "Cholecalciferol",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": ""
  },
  {
    "id": "810",
    "name": "Atenolol",
    "genericName": "Atenolol",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018240s047lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018240s047lbl.pdf"
  },
  {
    "id": "811",
    "name": "Amaryl",
    "genericName": "Amaryl",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020496s021lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020496s021lbl.pdf"
  },
  {
    "id": "812",
    "name": "Glimepiride",
    "genericName": "Glimepiride",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020496s021lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020496s021lbl.pdf"
  },
  {
    "id": "813",
    "name": "Folilc Acid",
    "genericName": "Folilc Acid",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/087438.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/087438.pdf"
  },
  {
    "id": "814",
    "name": "Zolpidem",
    "genericName": "Zolpidem",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019908s40s044s047lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019908s40s044s047lbl.pdf"
  },
  {
    "id": "815",
    "name": "Zolpidem Er",
    "genericName": "Zolpidem Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "AMBIEN CR extended-release tablets should be swallowed whole, and not be divided, crushed, or chewed. The effect of AMBIEN CR may be slowed by ingestion with or immediately after a meal.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021774s021s025s028lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "AMBIEN CR extended-release tablets should be swallowed whole, and not be divided, crushed, or chewed. The effect of AMBIEN CR may be slowed by ingestion with or immediately after a meal.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021774s021s025s028lbl.pdf"
  },
  {
    "id": "816",
    "name": "Vyvanse",
    "genericName": "Vyvanse",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow VYVANSE capsules whole, or\n• Open capsules, empty and mix the entire contents with yogurt, water, or orange juice. If \nthe contents of the capsule include any compacted powder, a spoon may be used to break \napart the powder. The contents should be mixed until completely dispersed. Consume the \nentire mixture immediately. It should not be stored. The active ingredient dissolves \ncompletely once dispersed; however, a film containing the inactive ingredients may \nremain in the glass or container once the mixture is consumed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021977s054,208510s011lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow VYVANSE capsules whole, or\n• Open capsules, empty and mix the entire contents with yogurt, water, or orange juice. If \nthe contents of the capsule include any compacted powder, a spoon may be used to break \napart the powder. The contents should be mixed until completely dispersed. Consume the \nentire mixture immediately. It should not be stored. The active ingredient dissolves \ncompletely once dispersed; however, a film containing the inactive ingredients may \nremain in the glass or container once the mixture is consumed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021977s054,208510s011lbl.pdf"
  },
  {
    "id": "817",
    "name": "Lixdexamphetamine",
    "genericName": "Lixdexamphetamine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow capsules whole, or • Open capsules, empty and mix the entire contents with yogurt, water, or orange juice. If the contents of the capsule include any compacted powder, a spoon may be used to break apart the powder. The contents should be mixed until completely dispersed. Consume the entire mixture immediately. It should not be stored. The active ingredient dissolves completely once dispersed; however, a film containing the inactive ingredients may remain in the glass or container once the mixture is consumed",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021977s054,208510s011lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow capsules whole, or • Open capsules, empty and mix the entire contents with yogurt, water, or orange juice. If the contents of the capsule include any compacted powder, a spoon may be used to break apart the powder. The contents should be mixed until completely dispersed. Consume the entire mixture immediately. It should not be stored. The active ingredient dissolves completely once dispersed; however, a film containing the inactive ingredients may remain in the glass or container once the mixture is consumed",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021977s054,208510s011lbl.pdf"
  },
  {
    "id": "818",
    "name": "Clonidine",
    "genericName": "Clonidine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/017407s034lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/017407s034lbl.pdf"
  },
  {
    "id": "819",
    "name": "Loratadine",
    "genericName": "Loratadine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f0db3a13-43e6-4243-9a3a-7808ddd005e1"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f0db3a13-43e6-4243-9a3a-7808ddd005e1"
  },
  {
    "id": "820",
    "name": "Hyzaar",
    "genericName": "Hyzaar",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Film Coated Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020387s076lbl.pdf"
      }
    ],
    "form": "Film coated tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020387s076lbl.pdf"
  },
  {
    "id": "821",
    "name": "Hydrochlorothiazide (Hctz)/ Losartan",
    "genericName": "Hydrochlorothiazide (Hctz)/ Losartan",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Film Coated Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020387s076lbl.pdf"
      }
    ],
    "form": "Film coated tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020387s076lbl.pdf"
  },
  {
    "id": "822",
    "name": "Inderal",
    "genericName": "Inderal",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/016418s080,016762s017,017683s008lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/016418s080,016762s017,017683s008lbl.pdf"
  },
  {
    "id": "823",
    "name": "Propranolol",
    "genericName": "Propranolol",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/016418s080,016762s017,017683s008lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/016418s080,016762s017,017683s008lbl.pdf"
  },
  {
    "id": "824",
    "name": "Azithromycin",
    "genericName": "Azithromycin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050670s036,050710s051,050784s037,050711s050lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050670s036,050710s051,050784s037,050711s050lbl.pdf"
  },
  {
    "id": "825",
    "name": "Zetia",
    "genericName": "Zetia",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021445s043lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021445s043lbl.pdf"
  },
  {
    "id": "826",
    "name": "Ezetimibe",
    "genericName": "Ezetimibe",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021445s043lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021445s043lbl.pdf"
  },
  {
    "id": "827",
    "name": "Ativan",
    "genericName": "Ativan",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017794s049lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017794s049lbl.pdf"
  },
  {
    "id": "828",
    "name": "Lorazepam",
    "genericName": "Lorazepam",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017794s049lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017794s049lbl.pdf"
  },
  {
    "id": "829",
    "name": "Seroquel",
    "genericName": "Seroquel",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020639s074lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020639s074lbl.pdf"
  },
  {
    "id": "830",
    "name": "Quetiapine",
    "genericName": "Quetiapine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020639s074lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020639s074lbl.pdf"
  },
  {
    "id": "831",
    "name": "Coumadin",
    "genericName": "Coumadin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009218s118lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009218s118lbl.pdf"
  },
  {
    "id": "832",
    "name": "Warfarin",
    "genericName": "Warfarin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009218s118lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009218s118lbl.pdf"
  },
  {
    "id": "833",
    "name": "Januvia",
    "genericName": "Januvia",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021995lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021995lbl.pdf"
  },
  {
    "id": "834",
    "name": "Sitagliptin",
    "genericName": "Sitagliptin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021995lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021995lbl.pdf"
  },
  {
    "id": "835",
    "name": "Tricor",
    "genericName": "Tricor",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021203s009lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021203s009lbl.pdf"
  },
  {
    "id": "836",
    "name": "Fenofibrate",
    "genericName": "Fenofibrate",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021203s009lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021203s009lbl.pdf"
  },
  {
    "id": "837",
    "name": "Trilipix",
    "genericName": "Trilipix",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Advise patients to swallow Trilipix capsules whole. Do not crush, break, dissolve, or chew capsules",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022224s018lbl.pdf"
      }
    ],
    "form": "Delayed Released Capsule",
    "alteration": "Advise patients to swallow Trilipix capsules whole. Do not crush, break, dissolve, or chew capsules",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022224s018lbl.pdf"
  },
  {
    "id": "838",
    "name": "Fenofibrate Er",
    "genericName": "Fenofibrate Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Capsule",
        "alteration": "Advise patients to swallow capsules whole. Do not crush, break, dissolve, or chew capsules",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022224s018lbl.pdf"
      }
    ],
    "form": "Delayed Released Capsule",
    "alteration": "Advise patients to swallow capsules whole. Do not crush, break, dissolve, or chew capsules",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022224s018lbl.pdf"
  },
  {
    "id": "839",
    "name": "Naprosyn",
    "genericName": "Naprosyn",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017581s117,018164s067,020067s026lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017581s117,018164s067,020067s026lbl.pdf"
  },
  {
    "id": "840",
    "name": "Hyzaar (Hydrochlorothiazide; Losartan Potassium)",
    "genericName": "Hyzaar (Hydrochlorothiazide; Losartan Potassium)",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017581s117,018164s067,020067s026lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017581s117,018164s067,020067s026lbl.pdf"
  },
  {
    "id": "841",
    "name": "Naproxen Er",
    "genericName": "Naproxen Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Tablet should not be broken, crushed or chewed during ingestion",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017581s117,018164s067,020067s026lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Tablet should not be broken, crushed or chewed during ingestion",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017581s117,018164s067,020067s026lbl.pdf"
  },
  {
    "id": "842",
    "name": "Xarelto",
    "genericName": "Xarelto",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "For adult patients who are unable to swallow whole tablets, XARELTO tablets (all strengths) \nmay be crushed and mixed with applesauce immediately prior to use and administered orally",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022406s044,215859s005lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "For adult patients who are unable to swallow whole tablets, XARELTO tablets (all strengths) \nmay be crushed and mixed with applesauce immediately prior to use and administered orally",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022406s044,215859s005lbl.pdf"
  },
  {
    "id": "843",
    "name": "Rivaroxaban",
    "genericName": "Rivaroxaban",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "For adult patients who are unable to swallow whole tablets, Rivaroxaban tablets (all strengths) may be crushed and mixed with applesauce immediately prior to use and administered orally",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022406s044,215859s005lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "For adult patients who are unable to swallow whole tablets, Rivaroxaban tablets (all strengths) may be crushed and mixed with applesauce immediately prior to use and administered orally",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022406s044,215859s005lbl.pdf"
  },
  {
    "id": "844",
    "name": "Paxil",
    "genericName": "Paxil",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Tablet can be crushed. Paroxetine is equally bioavailable from the oral suspension and tablet.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020031s083,020710s051lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Tablet can be crushed. Paroxetine is equally bioavailable from the oral suspension and tablet.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020031s083,020710s051lbl.pdf"
  },
  {
    "id": "845",
    "name": "Paroxetine",
    "genericName": "Paroxetine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Tablet can be crushed. Paroxetine is equally bioavailable from the oral suspension and tablet.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020031s083,020710s051lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Tablet can be crushed. Paroxetine is equally bioavailable from the oral suspension and tablet.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020031s083,020710s051lbl.pdf"
  },
  {
    "id": "846",
    "name": "Paxil Cr",
    "genericName": "Paxil Cr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow tablet whole; do not chew or crush",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020936Orig1s065lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow tablet whole; do not chew or crush",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020936Orig1s065lbl.pdf"
  },
  {
    "id": "847",
    "name": "Paroxetine Er",
    "genericName": "Paroxetine Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow tablet whole; do not chew or crush",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020936Orig1s065lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow tablet whole; do not chew or crush",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020936Orig1s065lbl.pdf"
  },
  {
    "id": "848",
    "name": "Celebrex",
    "genericName": "Celebrex",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "In healthy adult volunteers, the overall systemic exposure (AUC) of celecoxib was equivalent when celecoxib was administered as intact capsule or capsule contents sprinkled on applesauc",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020998s058lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "In healthy adult volunteers, the overall systemic exposure (AUC) of celecoxib was equivalent when celecoxib was administered as intact capsule or capsule contents sprinkled on applesauc",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020998s058lbl.pdf"
  },
  {
    "id": "849",
    "name": "Celecoxib",
    "genericName": "Celecoxib",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "In healthy adult volunteers, the overall systemic exposure (AUC) of celecoxib was equivalent when celecoxib was administered as intact capsule or capsule contents sprinkled on applesauc",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020998s058lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "In healthy adult volunteers, the overall systemic exposure (AUC) of celecoxib was equivalent when celecoxib was administered as intact capsule or capsule contents sprinkled on applesauc",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020998s058lbl.pdf"
  },
  {
    "id": "850",
    "name": "Zanaflex",
    "genericName": "Zanaflex",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020397Orig1s029,021447Orig1s017lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020397Orig1s029,021447Orig1s017lbl.pdf"
  },
  {
    "id": "851",
    "name": "Tizanidine",
    "genericName": "Tizanidine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020397Orig1s029,021447Orig1s017lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020397Orig1s029,021447Orig1s017lbl.pdf"
  },
  {
    "id": "852",
    "name": "Benicar",
    "genericName": "Benicar",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021286s040lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021286s040lbl.pdf"
  },
  {
    "id": "853",
    "name": "Olmesartan",
    "genericName": "Olmesartan",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021286s040lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021286s040lbl.pdf"
  },
  {
    "id": "854",
    "name": "Percocet",
    "genericName": "Percocet",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/040330s052lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/040330s052lbl.pdf"
  },
  {
    "id": "855",
    "name": "Acetaminophen/ Oxycodone",
    "genericName": "Acetaminophen/ Oxycodone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/040330s052lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/040330s052lbl.pdf"
  },
  {
    "id": "856",
    "name": "Keflex",
    "genericName": "Keflex",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050405s110lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050405s110lbl.pdf"
  },
  {
    "id": "857",
    "name": "Cephalexin",
    "genericName": "Cephalexin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050405s110lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050405s110lbl.pdf"
  },
  {
    "id": "858",
    "name": "Baclofen",
    "genericName": "Baclofen",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=346af8fe-3816-49de-bfd3-5a7425e728f9"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=346af8fe-3816-49de-bfd3-5a7425e728f9"
  },
  {
    "id": "859",
    "name": "Abilify",
    "genericName": "Abilify",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021436s046s050lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021436s046s050lbl.pdf"
  },
  {
    "id": "860",
    "name": "Aripiprazole",
    "genericName": "Aripiprazole",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021436s046s050lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021436s046s050lbl.pdf"
  },
  {
    "id": "861",
    "name": "Ferrous Sulfate Ec",
    "genericName": "Ferrous Sulfate Ec",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Enteric Coated Tablet",
        "alteration": "should not chew, divide, or crush tablets. Swallow whole tablet",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4d8d8739-8b59-4570-8994-304fa1e96ee0"
      }
    ],
    "form": "Enteric Coated Tablet",
    "alteration": "should not chew, divide, or crush tablets. Swallow whole tablet",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4d8d8739-8b59-4570-8994-304fa1e96ee0"
  },
  {
    "id": "862",
    "name": "Thaliton",
    "genericName": "Thaliton",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019574s017lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019574s017lbl.pdf"
  },
  {
    "id": "863",
    "name": "Chlorthalidone",
    "genericName": "Chlorthalidone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019574s017lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019574s017lbl.pdf"
  },
  {
    "id": "864",
    "name": "Oxybutynine",
    "genericName": "Oxybutynine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/017577s038lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/017577s038lbl.pdf"
  },
  {
    "id": "865",
    "name": "Oxybutynine Er",
    "genericName": "Oxybutynine Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "should not chew, divide, or crush tablets. Swallow whole tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20897lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "should not chew, divide, or crush tablets. Swallow whole tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20897lbl.pdf"
  },
  {
    "id": "866",
    "name": "Plaquenil",
    "genericName": "Plaquenil",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not crush or divide the tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/009768s054lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not crush or divide the tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/009768s054lbl.pdf"
  },
  {
    "id": "867",
    "name": "Valtrex",
    "genericName": "Valtrex",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020487s022lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020487s022lbl.pdf"
  },
  {
    "id": "868",
    "name": "Valacyclovir",
    "genericName": "Valacyclovir",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020487s022lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020487s022lbl.pdf"
  },
  {
    "id": "869",
    "name": "Acetaminophen",
    "genericName": "Acetaminophen",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Crushable",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "Crushable",
    "reference": ""
  },
  {
    "id": "870",
    "name": "Farxiga",
    "genericName": "Farxiga",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202293s030lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202293s030lbl.pdf"
  },
  {
    "id": "871",
    "name": "Dapagliflozin",
    "genericName": "Dapagliflozin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202293s030lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202293s030lbl.pdf"
  },
  {
    "id": "872",
    "name": "Dyazide",
    "genericName": "Dyazide",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/016042s079lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/016042s079lbl.pdf"
  },
  {
    "id": "873",
    "name": "Hydrochlorothiazide/Triamterene",
    "genericName": "Hydrochlorothiazide/Triamterene",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/016042s079lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/016042s079lbl.pdf"
  },
  {
    "id": "874",
    "name": "Diovan",
    "genericName": "Diovan",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "If your child cannot swallow tablets, or if tablets are not available in the prescribed strength, your pharmacist will mix DIOVAN as a liquid suspension for your child",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021283s053lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "If your child cannot swallow tablets, or if tablets are not available in the prescribed strength, your pharmacist will mix DIOVAN as a liquid suspension for your child",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021283s053lbl.pdf"
  },
  {
    "id": "875",
    "name": "Valssartan",
    "genericName": "Valssartan",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "If your child cannot swallow tablets, or if tablets are not available in the prescribed strength, your pharmacist will mix DIOVAN as a liquid suspension for your child",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021283s053lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "If your child cannot swallow tablets, or if tablets are not available in the prescribed strength, your pharmacist will mix DIOVAN as a liquid suspension for your child",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021283s053lbl.pdf"
  },
  {
    "id": "876",
    "name": "Actos",
    "genericName": "Actos",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021073s035lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021073s035lbl.pdf"
  },
  {
    "id": "877",
    "name": "Piglitazone",
    "genericName": "Piglitazone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021073s035lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021073s035lbl.pdf"
  },
  {
    "id": "878",
    "name": "Hydralazine",
    "genericName": "Hydralazine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1fd8cf42-66ae-4af5-a5ae-7c9679a0e532"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1fd8cf42-66ae-4af5-a5ae-7c9679a0e532"
  },
  {
    "id": "879",
    "name": "Robaxin",
    "genericName": "Robaxin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/011011Orig1s070s071lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/011011Orig1s070s071lbl.pdf"
  },
  {
    "id": "880",
    "name": "Methocarbamol",
    "genericName": "Methocarbamol",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/011011Orig1s070s071lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/011011Orig1s070s071lbl.pdf"
  },
  {
    "id": "881",
    "name": "Antivert",
    "genericName": "Antivert",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/010721s063lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/010721s063lbl.pdf"
  },
  {
    "id": "882",
    "name": "Meclizine",
    "genericName": "Meclizine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/010721s063lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/010721s063lbl.pdf"
  },
  {
    "id": "883",
    "name": "Meclizine Er",
    "genericName": "Meclizine Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not cut, chew, or crush the tablet.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/010721s063lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Do not cut, chew, or crush the tablet.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/010721s063lbl.pdf"
  },
  {
    "id": "884",
    "name": "Cyanocobalamin",
    "genericName": "Cyanocobalamin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3c810a40-9e90-4ca7-b364-20d9ac61b120"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3c810a40-9e90-4ca7-b364-20d9ac61b120"
  },
  {
    "id": "885",
    "name": "Metrotrexate",
    "genericName": "Metrotrexate",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Hazardous substance",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "Hazardous substance",
    "reference": ""
  },
  {
    "id": "886",
    "name": "Flagyl",
    "genericName": "Flagyl",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/012623s072lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/012623s072lbl.pdf"
  },
  {
    "id": "887",
    "name": "Metronidazole",
    "genericName": "Metronidazole",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/012623s072lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/012623s072lbl.pdf"
  },
  {
    "id": "888",
    "name": "Zovirax",
    "genericName": "Zovirax",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/018828s030,020089s019,019909s020lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/018828s030,020089s019,019909s020lbl.pdf"
  },
  {
    "id": "889",
    "name": "Acyclovir",
    "genericName": "Acyclovir",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/018828s030,020089s019,019909s020lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/018828s030,020089s019,019909s020lbl.pdf"
  },
  {
    "id": "890",
    "name": "Ms Contin",
    "genericName": "Ms Contin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Instruct patients to swallow MS CONTIN tablets intact and not to cut, break, chew, crush, or dissolve MS CONTIN (risk of potentially fatal dose)",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019516s058lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Instruct patients to swallow MS CONTIN tablets intact and not to cut, break, chew, crush, or dissolve MS CONTIN (risk of potentially fatal dose)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019516s058lbl.pdf"
  },
  {
    "id": "891",
    "name": "Morphine Er",
    "genericName": "Morphine Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Instruct patients to swallow MS CONTIN tablets intact and not to cut, break, chew, crush, or dissolve MS CONTIN (risk of potentially fatal dose)",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019516s058lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Instruct patients to swallow MS CONTIN tablets intact and not to cut, break, chew, crush, or dissolve MS CONTIN (risk of potentially fatal dose)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019516s058lbl.pdf"
  },
  {
    "id": "892",
    "name": "Vasotec",
    "genericName": "Vasotec",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018998s083lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018998s083lbl.pdf"
  },
  {
    "id": "893",
    "name": "Enalapril",
    "genericName": "Enalapril",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018998s083lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018998s083lbl.pdf"
  },
  {
    "id": "894",
    "name": "Bactrim Ds",
    "genericName": "Bactrim Ds",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/017377s085lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/017377s085lbl.pdf"
  },
  {
    "id": "895",
    "name": "Sulfamethaxzone, Trimethoprim",
    "genericName": "Sulfamethaxzone, Trimethoprim",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/017377s085lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/017377s085lbl.pdf"
  },
  {
    "id": "896",
    "name": "Clindamycin",
    "genericName": "Clindamycin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=24595bb3-07ea-4d5f-9bb3-2c2332a1fc62"
      }
    ],
    "form": "Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=24595bb3-07ea-4d5f-9bb3-2c2332a1fc62"
  },
  {
    "id": "897",
    "name": "Phentermine",
    "genericName": "Phentermine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/085128s065lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/085128s065lbl.pdf"
  },
  {
    "id": "898",
    "name": "Xyzal",
    "genericName": "Xyzal",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022064s040,022157s022lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022064s040,022157s022lbl.pdf"
  },
  {
    "id": "899",
    "name": "Levocetirizine",
    "genericName": "Levocetirizine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022064s040,022157s022lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022064s040,022157s022lbl.pdf"
  },
  {
    "id": "900",
    "name": "Medrol",
    "genericName": "Medrol",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/011153s083lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/011153s083lbl.pdf"
  },
  {
    "id": "901",
    "name": "Methylprednisolone",
    "genericName": "Methylprednisolone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/011153s083lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/011153s083lbl.pdf"
  },
  {
    "id": "902",
    "name": "Viagra",
    "genericName": "Viagra",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020895s048lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020895s048lbl.pdf"
  },
  {
    "id": "903",
    "name": "Sildenafil",
    "genericName": "Sildenafil",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020895s048lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020895s048lbl.pdf"
  },
  {
    "id": "904",
    "name": "Macrobid",
    "genericName": "Macrobid",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020064Orig1s029lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020064Orig1s029lbl.pdf"
  },
  {
    "id": "905",
    "name": "Nitrofurantoin",
    "genericName": "Nitrofurantoin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020064Orig1s029lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020064Orig1s029lbl.pdf"
  },
  {
    "id": "906",
    "name": "Lotensin",
    "genericName": "Lotensin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019851s054lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019851s054lbl.pdf"
  },
  {
    "id": "907",
    "name": "Benazepril",
    "genericName": "Benazepril",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019851s054lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019851s054lbl.pdf"
  },
  {
    "id": "908",
    "name": "Diflucan",
    "genericName": "Diflucan",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/019949s072lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/019949s072lbl.pdf"
  },
  {
    "id": "909",
    "name": "Fluconazole",
    "genericName": "Fluconazole",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/019949s072lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/019949s072lbl.pdf"
  },
  {
    "id": "910",
    "name": "Paxlovid",
    "genericName": "Paxlovid",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow the tablets whole. Do not chew, break, or crush the tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/217188s010lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow the tablets whole. Do not chew, break, or crush the tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/217188s010lbl.pdf"
  },
  {
    "id": "911",
    "name": "Nirmatrelvir/Ritonavir",
    "genericName": "Nirmatrelvir/Ritonavir",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow the tablets whole. Do not chew, break, or crush the tablets.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/217188s010lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow the tablets whole. Do not chew, break, or crush the tablets.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/217188s010lbl.pdf"
  },
  {
    "id": "912",
    "name": "Sascubitril Valsartan",
    "genericName": "Sascubitril Valsartan",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Pellets Capsule",
        "alteration": "Do not swallow the capsules. Do not chew or crush \nthe oral pellets.To administer ENTRESTO oral pellets, open the capsule and sprinkle the full content onto 1 to 2 teaspoons of soft food. Consume the food containing the oral pellets immediately after adding them. Empty capsule shells must be discarded after use and not swallowed. Do not administer ENTRESTO oral pellets via nasogastric, gastrostomy, or other enteral tubes because it may cause obstruction of enteral tubes",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218591Orig1s000,207620Orig1s025lbl.pdf"
      },
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218591Orig1s000,207620Orig1s025lbl.pdf"
      }
    ],
    "form": "Pellets Capsule",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218591Orig1s000,207620Orig1s025lbl.pdf"
  },
  {
    "id": "913",
    "name": "Entresto Sprinkle",
    "genericName": "Entresto Sprinkle",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Pellets Capsule",
        "alteration": "Do not swallow the capsules. Do not chew or crush \nthe oral pellets.To administer ENTRESTO oral pellets, open the capsule and sprinkle the full content onto 1 to 2 teaspoons of soft food. Consume the food containing the oral pellets immediately after adding them. Empty capsule shells must be discarded after use and not swallowed. Do not administer ENTRESTO oral pellets via nasogastric, gastrostomy, or other enteral tubes because it may cause obstruction of enteral tubes",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218591Orig1s000,207620Orig1s025lbl.pdf"
      }
    ],
    "form": "Pellets Capsule",
    "alteration": "Do not swallow the capsules. Do not chew or crush \nthe oral pellets.To administer ENTRESTO oral pellets, open the capsule and sprinkle the full content onto 1 to 2 teaspoons of soft food. Consume the food containing the oral pellets immediately after adding them. Empty capsule shells must be discarded after use and not swallowed. Do not administer ENTRESTO oral pellets via nasogastric, gastrostomy, or other enteral tubes because it may cause obstruction of enteral tubes",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218591Orig1s000,207620Orig1s025lbl.pdf"
  },
  {
    "id": "914",
    "name": "Entresto",
    "genericName": "Entresto",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218591Orig1s000,207620Orig1s025lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218591Orig1s000,207620Orig1s025lbl.pdf"
  },
  {
    "id": "915",
    "name": "Acetamiophen/Codeine",
    "genericName": "Acetamiophen/Codeine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4ad84de7-80c6-41dd-875c-3dd33d19ab45"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4ad84de7-80c6-41dd-875c-3dd33d19ab45"
  },
  {
    "id": "916",
    "name": "Trileptal",
    "genericName": "Trileptal",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021014s050lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021014s050lbl.pdf"
  },
  {
    "id": "917",
    "name": "Oxcarbazepine",
    "genericName": "Oxcarbazepine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021014s050lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021014s050lbl.pdf"
  },
  {
    "id": "918",
    "name": "Oxtellar Xr",
    "genericName": "Oxtellar Xr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not cut, chew, or crush the tablet.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202810s020lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Do not cut, chew, or crush the tablet.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202810s020lbl.pdf"
  },
  {
    "id": "919",
    "name": "Valium",
    "genericName": "Valium",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/013263Orig1s098lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/013263Orig1s098lbl.pdf"
  },
  {
    "id": "920",
    "name": "Diazepam",
    "genericName": "Diazepam",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/013263Orig1s098lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/013263Orig1s098lbl.pdf"
  },
  {
    "id": "921",
    "name": "Lotrel",
    "genericName": "Lotrel",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020364Orig1s068lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020364Orig1s068lbl.pdf"
  },
  {
    "id": "922",
    "name": "Amlodipine  Benazepril",
    "genericName": "Amlodipine  Benazepril",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020364Orig1s068lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020364Orig1s068lbl.pdf"
  },
  {
    "id": "923",
    "name": "Zyprexa",
    "genericName": "Zyprexa",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020592s077,021086s050,021253s047s066lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020592s077,021086s050,021253s047s066lbl.pdf"
  },
  {
    "id": "924",
    "name": "Olanzapine",
    "genericName": "Olanzapine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020592s077,021086s050,021253s047s066lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020592s077,021086s050,021253s047s066lbl.pdf"
  },
  {
    "id": "925",
    "name": "Olanzapine Odt",
    "genericName": "Olanzapine Odt",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "place entire tablet in the mouth. Tablet disintegration occurs rapidly in saliva so it can be easily swallowed with or without liquid",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020592s077,021086s050,021253s047s066lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "place entire tablet in the mouth. Tablet disintegration occurs rapidly in saliva so it can be easily swallowed with or without liquid",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020592s077,021086s050,021253s047s066lbl.pdf"
  },
  {
    "id": "926",
    "name": "Cialis",
    "genericName": "Cialis",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not split CIALIS tablets; entire dose should be taken",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021368s030lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not split CIALIS tablets; entire dose should be taken",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021368s030lbl.pdf"
  },
  {
    "id": "927",
    "name": "Tadalafil",
    "genericName": "Tadalafil",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not split tablets; entire dose should be taken",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021368s030lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not split tablets; entire dose should be taken",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021368s030lbl.pdf"
  },
  {
    "id": "928",
    "name": "Bystolic",
    "genericName": "Bystolic",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021742s028lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021742s028lbl.pdf"
  },
  {
    "id": "929",
    "name": "Nebivolol",
    "genericName": "Nebivolol",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021742s028lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021742s028lbl.pdf"
  },
  {
    "id": "930",
    "name": "Ketoconazole",
    "genericName": "Ketoconazole",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018533s041lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018533s041lbl.pdf"
  },
  {
    "id": "931",
    "name": "Dicyclomine",
    "genericName": "Dicyclomine",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/007409s042,008370s033lbl.pdf"
      },
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/007409s042,008370s033lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/007409s042,008370s033lbl.pdf"
  },
  {
    "id": "932",
    "name": "Arimidex",
    "genericName": "Arimidex",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020541s036lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020541s036lbl.pdf"
  },
  {
    "id": "933",
    "name": "Anastrozole",
    "genericName": "Anastrozole",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020541s036lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020541s036lbl.pdf"
  },
  {
    "id": "934",
    "name": "Ciprofloxacin",
    "genericName": "Ciprofloxacin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "CIPRO Tablets comes as 250 mg and 500 mg scored tablets that can be taken whole or may be broken in half at the scored line.Do not crush or chew the \ntablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/019537s095,020780s050lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "CIPRO Tablets comes as 250 mg and 500 mg scored tablets that can be taken whole or may be broken in half at the scored line.Do not crush or chew the \ntablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/019537s095,020780s050lbl.pdf"
  },
  {
    "id": "935",
    "name": "Metformin Sitagliptin Er",
    "genericName": "Metformin Sitagliptin Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not split, crush or chew  tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216778s000lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Do not split, crush or chew  tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216778s000lbl.pdf"
  },
  {
    "id": "936",
    "name": "Zituvimet Xr",
    "genericName": "Zituvimet Xr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not split, crush or chew ZITUVIMET XR tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216778s000lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Do not split, crush or chew ZITUVIMET XR tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216778s000lbl.pdf"
  },
  {
    "id": "937",
    "name": "Zituvimet",
    "genericName": "Zituvimet",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not split or divide ZITUVIMET tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216743s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not split or divide ZITUVIMET tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216743s000lbl.pdf"
  },
  {
    "id": "938",
    "name": "Metformin Sitagliptin",
    "genericName": "Metformin Sitagliptin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Do not split or divide ZITUVIMET tablets",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216743s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Do not split or divide ZITUVIMET tablets",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216743s000lbl.pdf"
  },
  {
    "id": "939",
    "name": "Risperdal",
    "genericName": "Risperdal",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020272s088,020588s074,021444s060lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020272s088,020588s074,021444s060lbl.pdf"
  },
  {
    "id": "940",
    "name": "Rispteridone",
    "genericName": "Rispteridone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020272s088,020588s074,021444s060lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020272s088,020588s074,021444s060lbl.pdf"
  },
  {
    "id": "941",
    "name": "Torsemide",
    "genericName": "Torsemide",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213218s000lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213218s000lbl.pdf"
  },
  {
    "id": "942",
    "name": "Rizatriptan Disintegrating Tablet",
    "genericName": "Rizatriptan Disintegrating Tablet",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Disintegrating Tablet",
        "alteration": "the orally disintegrating tablet placed on the tongue, where it will dissolve and be swallowed with the saliva.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020864s023,020865s024lbl.pdf"
      }
    ],
    "form": "Disintegrating tablet",
    "alteration": "the orally disintegrating tablet placed on the tongue, where it will dissolve and be swallowed with the saliva.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020864s023,020865s024lbl.pdf"
  },
  {
    "id": "943",
    "name": "Maxalt-Mlt",
    "genericName": "Maxalt-Mlt",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Disintegrating Tablet",
        "alteration": "the orally disintegrating tablet placed on the tongue, where it will dissolve and be swallowed with the saliva.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020864s023,020865s024lbl.pdf"
      }
    ],
    "form": "Disintegrating tablet",
    "alteration": "the orally disintegrating tablet placed on the tongue, where it will dissolve and be swallowed with the saliva.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020864s023,020865s024lbl.pdf"
  },
  {
    "id": "944",
    "name": "Maxalt",
    "genericName": "Maxalt",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020864s023,020865s024lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020864s023,020865s024lbl.pdf"
  },
  {
    "id": "945",
    "name": "Rizatriptan",
    "genericName": "Rizatriptan",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020864s023,020865s024lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020864s023,020865s024lbl.pdf"
  },
  {
    "id": "946",
    "name": "Nortriptyline",
    "genericName": "Nortriptyline",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=90a6bfcf-faf9-21c0-e053-2995a90ad69f"
      }
    ],
    "form": "Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=90a6bfcf-faf9-21c0-e053-2995a90ad69f"
  },
  {
    "id": "947",
    "name": "Mirapex Er",
    "genericName": "Mirapex Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Tablets must be swallowed whole and must not be chewed, crushed, or \ndivided",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022421s023lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Tablets must be swallowed whole and must not be chewed, crushed, or \ndivided",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022421s023lbl.pdf"
  },
  {
    "id": "948",
    "name": "Pramipexole Xr",
    "genericName": "Pramipexole Xr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Tablets must be swallowed whole and must not be chewed, crushed, or \ndivided",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022421s023lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Tablets must be swallowed whole and must not be chewed, crushed, or \ndivided",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022421s023lbl.pdf"
  },
  {
    "id": "949",
    "name": "Nitrostat",
    "genericName": "Nitrostat",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Sublingual Tablet",
        "alteration": "Allow tablet to dissolve without swallowing",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021134s010lbl.pdf"
      }
    ],
    "form": "Sublingual Tablet",
    "alteration": "Allow tablet to dissolve without swallowing",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021134s010lbl.pdf"
  },
  {
    "id": "950",
    "name": "Colcrys",
    "genericName": "Colcrys",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022351lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022351lbl.pdf"
  },
  {
    "id": "951",
    "name": "Cochocine",
    "genericName": "Cochocine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022351lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022351lbl.pdf"
  },
  {
    "id": "952",
    "name": "Promethazine",
    "genericName": "Promethazine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=05907a49-537f-4bf2-8a5f-5e905f19fece"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=05907a49-537f-4bf2-8a5f-5e905f19fece"
  },
  {
    "id": "953",
    "name": "Irbesartan",
    "genericName": "Irbesartan",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020757s080lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020757s080lbl.pdf"
  },
  {
    "id": "954",
    "name": "Cortef",
    "genericName": "Cortef",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/008697s040lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/008697s040lbl.pdf"
  },
  {
    "id": "955",
    "name": "Hydrocortisone",
    "genericName": "Hydrocortisone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/008697s040lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/008697s040lbl.pdf"
  },
  {
    "id": "956",
    "name": "Brillinta",
    "genericName": "Brillinta",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "For patients who are unable to swallow tablets whole, BRILINTA tablets can be crushed, mixed with water, and drunk. The mixture can also be administered via a nasogastric tube (CH8 or greater)",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022433s037lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "For patients who are unable to swallow tablets whole, BRILINTA tablets can be crushed, mixed with water, and drunk. The mixture can also be administered via a nasogastric tube (CH8 or greater)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022433s037lbl.pdf"
  },
  {
    "id": "957",
    "name": "Ticagrelor",
    "genericName": "Ticagrelor",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "For patients who are unable to swallow tablets whole, BRILINTA tablets can be crushed, mixed with water, and drunk. The mixture can also be administered via a nasogastric tube (CH8 or greater)",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022433s037lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "For patients who are unable to swallow tablets whole, BRILINTA tablets can be crushed, mixed with water, and drunk. The mixture can also be administered via a nasogastric tube (CH8 or greater)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022433s037lbl.pdf"
  },
  {
    "id": "958",
    "name": "Liothyronine",
    "genericName": "Liothyronine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/010379s054lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/010379s054lbl.pdf"
  },
  {
    "id": "959",
    "name": "Tamiflu",
    "genericName": "Tamiflu",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Manufacture does not have recommendation. Capsule maybe open",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021087s057lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Manufacture does not have recommendation. Capsule maybe open",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021087s057lbl.pdf"
  },
  {
    "id": "960",
    "name": "Oseltamivir",
    "genericName": "Oseltamivir",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Manufacture does not have recommendation. Capsule maybe open",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021087s057lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Manufacture does not have recommendation. Capsule maybe open",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021087s057lbl.pdf"
  },
  {
    "id": "961",
    "name": "Vesicare",
    "genericName": "Vesicare",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "VESIcare should be taken with water and swallowed whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021518s017lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "VESIcare should be taken with water and swallowed whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021518s017lbl.pdf"
  },
  {
    "id": "962",
    "name": "Solifenacin",
    "genericName": "Solifenacin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Tablet should be taken with water and swallowed whole",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021518s017lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Tablet should be taken with water and swallowed whole",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021518s017lbl.pdf"
  },
  {
    "id": "963",
    "name": "Lithium",
    "genericName": "Lithium",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d1800f34-3d67-4b2f-874e-8639b125d853"
      }
    ],
    "form": "Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d1800f34-3d67-4b2f-874e-8639b125d853"
  },
  {
    "id": "964",
    "name": "Lithobid",
    "genericName": "Lithobid",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow tablets whole; do not crush, break, or chew.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018027s069lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow tablets whole; do not crush, break, or chew.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018027s069lbl.pdf"
  },
  {
    "id": "965",
    "name": "Lithium Er",
    "genericName": "Lithium Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow tablets whole; do not crush, break, or chew.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018027s069lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow tablets whole; do not crush, break, or chew.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018027s069lbl.pdf"
  },
  {
    "id": "966",
    "name": "Atomoxetine",
    "genericName": "Atomoxetine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Do not chew, crush, or open the capsules",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021411s050lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Do not chew, crush, or open the capsules",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021411s050lbl.pdf"
  },
  {
    "id": "967",
    "name": "Strattera",
    "genericName": "Strattera",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Do not chew, crush, or open the capsules",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021411s050lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Do not chew, crush, or open the capsules",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021411s050lbl.pdf"
  },
  {
    "id": "968",
    "name": "Carafate",
    "genericName": "Carafate",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018333s034,019183s016lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018333s034,019183s016lbl.pdf"
  },
  {
    "id": "969",
    "name": "Sucralfate",
    "genericName": "Sucralfate",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018333s034,019183s016lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018333s034,019183s016lbl.pdf"
  },
  {
    "id": "970",
    "name": "Labetalol",
    "genericName": "Labetalol",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018716s036lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018716s036lbl.pdf"
  },
  {
    "id": "971",
    "name": "Melatonin",
    "genericName": "Melatonin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "crushable",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=92b2ccdc-2eed-4307-af45-da455f557cf8"
      }
    ],
    "form": "Tablet",
    "alteration": "crushable",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=92b2ccdc-2eed-4307-af45-da455f557cf8"
  },
  {
    "id": "972",
    "name": "Melatonin Er",
    "genericName": "Melatonin Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow whole; do not chew",
        "reference": ""
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow whole; do not chew",
    "reference": ""
  },
  {
    "id": "973",
    "name": "Doxepine",
    "genericName": "Doxepine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/016798s057,017516s026lbl.pdf"
      }
    ],
    "form": "capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/016798s057,017516s026lbl.pdf"
  },
  {
    "id": "974",
    "name": "Myrbetrig",
    "genericName": "Myrbetrig",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow Myrbetriq whole with water. Do not chew, divide, or crush.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202611s017,213801s000lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow Myrbetriq whole with water. Do not chew, divide, or crush.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202611s017,213801s000lbl.pdf"
  },
  {
    "id": "975",
    "name": "Ketorolac",
    "genericName": "Ketorolac",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019645s019lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019645s019lbl.pdf"
  },
  {
    "id": "976",
    "name": "Lansoprazole",
    "genericName": "Lansoprazole",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Swallow whole; do not chew",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022287s038lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Swallow whole; do not chew",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022287s038lbl.pdf"
  },
  {
    "id": "977",
    "name": "Ascorbic Acid",
    "genericName": "Ascorbic Acid",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "crushable",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b22c2ad8-0d4a-4b78-8d6e-dc917a777ab6"
      }
    ],
    "form": "Tablet",
    "alteration": "crushable",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b22c2ad8-0d4a-4b78-8d6e-dc917a777ab6"
  },
  {
    "id": "978",
    "name": "Micardis",
    "genericName": "Micardis",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020850s045lbl.pdf"
      }
    ],
    "form": "tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020850s045lbl.pdf"
  },
  {
    "id": "979",
    "name": "Telmisartan",
    "genericName": "Telmisartan",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020850s045lbl.pdf"
      }
    ],
    "form": "tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020850s045lbl.pdf"
  },
  {
    "id": "980",
    "name": "Icosapent Ethyl",
    "genericName": "Icosapent Ethyl",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Advise patients to swallow capsules whole. Do not break open, crush, dissolve, or chew",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202057s035lbl.pdf"
      }
    ],
    "form": "capsule",
    "alteration": "Advise patients to swallow capsules whole. Do not break open, crush, dissolve, or chew",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202057s035lbl.pdf"
  },
  {
    "id": "981",
    "name": "Lopid",
    "genericName": "Lopid",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018422s059lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018422s059lbl.pdf"
  },
  {
    "id": "982",
    "name": "Gemfibrozil",
    "genericName": "Gemfibrozil",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018422s059lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018422s059lbl.pdf"
  },
  {
    "id": "983",
    "name": "Ranexa",
    "genericName": "Ranexa",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Swallow tablets whole; do not crush, break, or chew.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021526s035lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Swallow tablets whole; do not crush, break, or chew.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021526s035lbl.pdf"
  },
  {
    "id": "984",
    "name": "Hydromorphone",
    "genericName": "Hydromorphone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019891s031,019892s041lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019891s031,019892s041lbl.pdf"
  },
  {
    "id": "985",
    "name": "Dexanethasone",
    "genericName": "Dexanethasone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Manufacture does not have recommendation. Crushable if tablet is not enteric coated or extend-released formulation",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/011664s064lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Manufacture does not have recommendation. Crushable if tablet is not enteric coated or extend-released formulation",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/011664s064lbl.pdf"
  },
  {
    "id": "986",
    "name": "Benicar Hct",
    "genericName": "Benicar Hct",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Film coated Tablet. Manufacture does not have recommendation",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021532s038lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Film coated Tablet. Manufacture does not have recommendation",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021532s038lbl.pdf"
  },
  {
    "id": "987",
    "name": "Hydrochlorothiazide (Hctz)/Olmesartan",
    "genericName": "Hydrochlorothiazide (Hctz)/Olmesartan",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "Film coated Tablet. Manufacture does not have recommendation",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021532s038lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "Film coated Tablet. Manufacture does not have recommendation",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021532s038lbl.pdf"
  },
  {
    "id": "988",
    "name": "Amiodarone",
    "genericName": "Amiodarone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018972s054lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018972s054lbl.pdf"
  },
  {
    "id": "989",
    "name": "Nabumetone",
    "genericName": "Nabumetone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/019583s025lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/019583s025lbl.pdf"
  },
  {
    "id": "990",
    "name": "Fioricet",
    "genericName": "Fioricet",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020232s047lbl.pdf"
      }
    ],
    "form": "capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020232s047lbl.pdf"
  },
  {
    "id": "991",
    "name": "Acetaminophen/Butabital/Caffeine",
    "genericName": "Acetaminophen/Butabital/Caffeine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020232s047lbl.pdf"
      }
    ],
    "form": "capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020232s047lbl.pdf"
  },
  {
    "id": "992",
    "name": "Bisoprolol",
    "genericName": "Bisoprolol",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019982s016lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019982s016lbl.pdf"
  },
  {
    "id": "993",
    "name": "Levaquin",
    "genericName": "Levaquin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020634s073lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020634s073lbl.pdf"
  },
  {
    "id": "994",
    "name": "Levofloxacin",
    "genericName": "Levofloxacin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020634s073lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020634s073lbl.pdf"
  },
  {
    "id": "995",
    "name": "Lamisil",
    "genericName": "Lamisil",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020539s033lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020539s033lbl.pdf"
  },
  {
    "id": "996",
    "name": "Terbinafine",
    "genericName": "Terbinafine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020539s033lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020539s033lbl.pdf"
  },
  {
    "id": "997",
    "name": "Indocin",
    "genericName": "Indocin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/016059s102lbl.pdf"
      }
    ],
    "form": "capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/016059s102lbl.pdf"
  },
  {
    "id": "998",
    "name": "Indomethacin",
    "genericName": "Indomethacin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/016059s102lbl.pdf"
      }
    ],
    "form": "capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/016059s102lbl.pdf"
  },
  {
    "id": "999",
    "name": "Allergra",
    "genericName": "Allergra",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/20625lbl.pdf"
      }
    ],
    "form": "capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/20625lbl.pdf"
  },
  {
    "id": "1000",
    "name": "Fexofenadine",
    "genericName": "Fexofenadine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/20625lbl.pdf"
      }
    ],
    "form": "capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/20625lbl.pdf"
  },
  {
    "id": "1001",
    "name": "Diphnehydramine",
    "genericName": "Diphnehydramine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=61c340e5-ace6-4ec1-9d3e-e965fca1263a"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=61c340e5-ace6-4ec1-9d3e-e965fca1263a"
  },
  {
    "id": "1002",
    "name": "Penicillin V",
    "genericName": "Penicillin V",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=060711"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=060711"
  },
  {
    "id": "1003",
    "name": "Senna/Docusate",
    "genericName": "Senna/Docusate",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Film Coated Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=68d0fe5d-5de2-4853-bf8b-0042f14e8757"
      }
    ],
    "form": "Film coated tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=68d0fe5d-5de2-4853-bf8b-0042f14e8757"
  },
  {
    "id": "1004",
    "name": "Minocin",
    "genericName": "Minocin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow whole capsule",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/050649s029lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow whole capsule",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/050649s029lbl.pdf"
  },
  {
    "id": "1005",
    "name": "Minocycline",
    "genericName": "Minocycline",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow whole capsule",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/050649s029lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow whole capsule",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/050649s029lbl.pdf"
  },
  {
    "id": "1006",
    "name": "Erythromycin",
    "genericName": "Erythromycin",
    "category": "Medication",
    "description": "Available in 2 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Tablet",
        "alteration": "Delayed released enteric coated tablet. Do not crush, chew or break tablets before swallowing",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/062298s068lbl.pdf"
      },
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6d8c343b-30d9-4cdb-8f55-2a20983a71c1"
      }
    ],
    "form": "Delayed Released Tablet",
    "alteration": "Multiple forms available (2 forms)",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/062298s068lbl.pdf"
  },
  {
    "id": "1007",
    "name": "Ery-Tab",
    "genericName": "Ery-Tab",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Delayed Released Tablet",
        "alteration": "Delayed released enteric coated tablet. Do not crush, chew or break tablets before swallowing",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/062298s068lbl.pdf"
      }
    ],
    "form": "Delayed Released Tablet",
    "alteration": "Delayed released enteric coated tablet. Do not crush, chew or break tablets before swallowing",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/062298s068lbl.pdf"
  },
  {
    "id": "1008",
    "name": "Guanfacine",
    "genericName": "Guanfacine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019032s021lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019032s021lbl.pdf"
  },
  {
    "id": "1009",
    "name": "Guanfacine Er",
    "genericName": "Guanfacine Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not crush, chew or break tablets before swallowing",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022037s019lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Do not crush, chew or break tablets before swallowing",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022037s019lbl.pdf"
  },
  {
    "id": "1010",
    "name": "Medroxyprogesterone",
    "genericName": "Medroxyprogesterone",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Swallow whole capsule",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/019781s025lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "Swallow whole capsule",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/019781s025lbl.pdf"
  },
  {
    "id": "1011",
    "name": "Calcium Carbonate",
    "genericName": "Calcium Carbonate",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cd45c29d-f9e1-4c1e-b7fe-f51a0423fc92"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cd45c29d-f9e1-4c1e-b7fe-f51a0423fc92"
  },
  {
    "id": "1012",
    "name": "Sinemet",
    "genericName": "Sinemet",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017555s072lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017555s072lbl.pdf"
  },
  {
    "id": "1013",
    "name": "Carbidopa/Levodopa",
    "genericName": "Carbidopa/Levodopa",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017555s072lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017555s072lbl.pdf"
  },
  {
    "id": "1014",
    "name": "Sinemet Cr",
    "genericName": "Sinemet Cr",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "the whole or half tablet should be swallowed without chewing or crushing.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019856s016s024s028lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "the whole or half tablet should be swallowed without chewing or crushing.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019856s016s024s028lbl.pdf"
  },
  {
    "id": "1015",
    "name": "Carbidopa/Levodopa Er",
    "genericName": "Carbidopa/Levodopa Er",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "the whole or half tablet should be swallowed without chewing or crushing.",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019856s016s024s028lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "the whole or half tablet should be swallowed without chewing or crushing.",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019856s016s024s028lbl.pdf"
  },
  {
    "id": "1016",
    "name": "Sennosides",
    "genericName": "Sennosides",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=39f4f4b3-726a-41b4-9fb9-78e466bbfc0b"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=39f4f4b3-726a-41b4-9fb9-78e466bbfc0b"
  },
  {
    "id": "1017",
    "name": "Lomotil",
    "genericName": "Lomotil",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012462s048lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012462s048lbl.pdf"
  },
  {
    "id": "1018",
    "name": "Atropine/Diphenoxylate",
    "genericName": "Atropine/Diphenoxylate",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012462s048lbl.pdf"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012462s048lbl.pdf"
  },
  {
    "id": "1019",
    "name": "Thiamine",
    "genericName": "Thiamine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cdc2e185-c683-4ec6-a498-5db3a1c80919"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cdc2e185-c683-4ec6-a498-5db3a1c80919"
  },
  {
    "id": "1020",
    "name": "Mucinex Dm",
    "genericName": "Mucinex Dm",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not crush or chew tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021620Orig1s045lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Do not crush or chew tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021620Orig1s045lbl.pdf"
  },
  {
    "id": "1021",
    "name": "Dextomethophan/Guaifenesin",
    "genericName": "Dextomethophan/Guaifenesin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not crush or chew Tablet",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021620Orig1s045lbl.pdf"
      }
    ],
    "form": "Extended Released Tablet",
    "alteration": "Do not crush or chew Tablet",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021620Orig1s045lbl.pdf"
  },
  {
    "id": "1022",
    "name": "Chlorpheniramine",
    "genericName": "Chlorpheniramine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=31dec627-f2e4-6dbe-e054-00144ff8d46c"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=31dec627-f2e4-6dbe-e054-00144ff8d46c"
  },
  {
    "id": "1023",
    "name": "Cyproheptadin",
    "genericName": "Cyproheptadin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206553"
      }
    ],
    "form": "Tablet",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206553"
  },
  {
    "id": "1024",
    "name": "Guaifensin",
    "genericName": "Guaifensin",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Extended Released Tablet",
        "alteration": "Do not crush or chew",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021282Orig1s055lbl.pdf"
      }
    ],
    "form": "ER tablet",
    "alteration": "Do not crush or chew",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021282Orig1s055lbl.pdf"
  },
  {
    "id": "1025",
    "name": "Imodium",
    "genericName": "Imodium",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017690s005lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017690s005lbl.pdf"
  },
  {
    "id": "1026",
    "name": "Loperamide",
    "genericName": "Loperamide",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
        "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017690s005lbl.pdf"
      }
    ],
    "form": "Capsule",
    "alteration": "\"Manufacturer does not provide data on whether the tablet can be crushed, split, or otherwise altered. Additionally, the manufacturer does not indicate that the medication should not be crushed or altered. Please consult alternative resources or a pharmacist for further guidance.\"",
    "reference": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017690s005lbl.pdf"
  },
  {
    "id": "1027",
    "name": "Bumetanide",
    "genericName": "Bumetanide",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "",
    "reference": ""
  },
  {
    "id": "1028",
    "name": "Busulfan",
    "genericName": "Busulfan",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "",
    "reference": ""
  },
  {
    "id": "1029",
    "name": "Cabergoline",
    "genericName": "Cabergoline",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "",
    "reference": ""
  },
  {
    "id": "1030",
    "name": "Calcitriol",
    "genericName": "Calcitriol",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "Do not crush or Chew",
        "reference": ""
      }
    ],
    "form": "capsule",
    "alteration": "Do not crush or Chew",
    "reference": ""
  },
  {
    "id": "1031",
    "name": "Calcium - Vitamin D",
    "genericName": "Calcium - Vitamin D",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "",
    "reference": ""
  },
  {
    "id": "1032",
    "name": "Calcium Acetate",
    "genericName": "Calcium Acetate",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "",
        "reference": ""
      }
    ],
    "form": "Capsule",
    "alteration": "",
    "reference": ""
  },
  {
    "id": "1033",
    "name": "Oyster Shell",
    "genericName": "Oyster Shell",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "",
    "reference": ""
  },
  {
    "id": "1034",
    "name": "Candesartan",
    "genericName": "Candesartan",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "",
    "reference": ""
  },
  {
    "id": "1035",
    "name": "Capecitabine",
    "genericName": "Capecitabine",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "",
    "reference": ""
  },
  {
    "id": "1036",
    "name": "Captopril",
    "genericName": "Captopril",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Tablet",
        "alteration": "",
        "reference": ""
      }
    ],
    "form": "Tablet",
    "alteration": "",
    "reference": ""
  },
  {
    "id": "1037",
    "name": "Cefadroxil",
    "genericName": "Cefadroxil",
    "category": "Medication",
    "description": "Available in 1 dosage form(s)",
    "dosage": "As prescribed",
    "sideEffects": [],
    "contraindications": [],
    "manufacturer": "Various",
    "dosageForms": [
      {
        "form": "Capsule",
        "alteration": "",
        "reference": ""
      }
    ],
    "form": "Capsule",
    "alteration": "",
    "reference": ""
  }
]